#agiosnews: Today, we reported our third quarter 2026 financial results and business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
Agios Pharmaceuticals
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. More on Wikipedia
-
Agios
@AgiosPharma
-
Agios
@AgiosPharma
At #ash26, we'll highlight rare #hematology progress: RISE UP Phase 3 analyses of our pyruvate kinase activator in #sicklecelldisease and first clinical data for our TMPRSS6 siRNA supporting potential best-in-class profile in #polycythemiavera. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: The PDUFA goal date for the U.S. sNDA of our first-in-class PK activator in sickle cell disease has been extended by three months to February 1, 2027. Read our press release for more information: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: RISE UP Phase 3 results were published in The Lancet, highlighting the strong anti-hemolytic profile of our first-in-class pyruvate kinase (PK) activator and its therapeutic potential for patients with #sicklecelldisease.
Read the publication: www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, November 5, at 8:00 a.m. ET to report and discuss our third quarter 2026 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re live at #ascat2026 and are thrilled to connect with the #sicklecelldisease and #thalassemia communities and our partners. We’re excited to share research updates and continue important conversations about these rare diseases. Visit us at Booth 24!
-
Agios
@AgiosPharma
#agiosnews: ENERGIZE-T Phase 3 results were published in The Lancet, highlighting that our first-in-class pyruvate kinase (PK) activator can reduce transfusion burden in patients with transfusion dependent #thalssemia.
Read the publication: www.thelancet.com/journals/lancet/article/PIIS0140-6736(2… -
Agios
@AgiosPharma
#agiosnews: Today we reported our second quarter 2026 financial results and business highlights. Read our press release and tune into our webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Our topline Phase 2 data showed hemoglobin improvements for our mid-stage pyruvate kinase (PK) activator, consistent with PK activation, but results did not establish differentiation to continue development in #sicklecelldisease.
Read more: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
#agiosnews: @US_FDA accepted the supplemental New Drug Application (sNDA) for our first-in-class pyruvate kinase (PK) activator in #sicklecelldisease with a Priority Review. The PDUFA goal date is November 1, 2026. Read more: investor.agios.com/news-releases/news-release-details/us-…
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, July 30, at 8:00 a.m. ET to report and discuss our second quarter 2026 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Today we presented detailed RISE UP Phase 3 results of our first-in-class pyruvate kinase (PK) activator in #sicklecelldisease, including new data reinforcing its anti-hemolytic profile, at the #eha2026 Plenary Abstracts Session.
Read more: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
✈️ We're live at #eha2026, ready to connect with the global #hematology community and present the latest data highlighting our first-in-class pyruvate kinase (PK) activator. Meet us at booth # A1.04 and visit our microsite for more information: www.agios.com/eha-2026/
-
Agios
@AgiosPharma
#agiosnews: We have obtained exclusive global rights to a novel, next‑generation, oral spleen tyrosine kinase (SYK) inhibitor from Oscotec, and will advance this for immune thrombocytopenia (ITP), a rare autoimmune blood disorder.
Read more: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
#agiosnews: We will not advance our next-generation oral pyruvate kinase (PK) activator in lower-risk myelodysplastic syndromes (LR-MDS), following Phase 2b results that did not meet our predefined threshold to support further development.
Read more: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
#agiosnews: @EU_Commission granted authorization for our first-in-class oral pyruvate kinase (PK) activator in adults for the treatment of anemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: We submitted an sNDA to the @US_FDA for U.S. accelerated approval of our first-in-class pyruvate kinase (PK) activator in #sicklecelldisease. We expect acceptance notice in the third quarter of 2026, following FDA’s 60-day review period. Read more:
-
Agios
@AgiosPharma
At #eha2026, we’re excited to showcase new data highlighting our first-in-class pyruvate kinase (PK) activator – including a plenary session with RISE UP Phase 3 #sicklecelldisease trial results – and connect with the #hematology community. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Members of our Leadership Team will participate in fireside chats at the Bank of America (May 12) and RBC Capital Markets (May 19) 2026 healthcare conferences.
Live webcasts and replays will be on the Investors section of our website.
Listen and learn more: -
Agios
@AgiosPharma
Great conversations at the 2026 @amcporg Annual Meeting. Our team’s #heor research on #sicklecelldisease confirms that progress demands system-wide approaches to address the real barriers patients face.
#amcp #raredisease -
Agios
@AgiosPharma
We're at the 2026 @ASPHO_hq Conference, ready to explore scientific advances in pediatric #hematology and connect with #raredisease communities. Find us at booth #307 to learn about the latest progress from our pyruvate kinase activation portfolio.
#aspho2026 -
Agios
@AgiosPharma
#agiosnews: Today we reported our first quarter 2026 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our 2026 Environmental, Social, and Governance (ESG) report is now available. It highlights our partnerships with rare disease communities to advance science and access to new medicines, and our commitment to a safe, inclusive, and purpose-driven workplace:
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Wednesday, April 29, at 8:00 a.m. ET to report and discuss our first quarter 2026 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: We will pursue U.S. accelerated approval for our first-in-class oral pyruvate kinase (PK) activator in #sicklecelldisease, following completion of our pre-supplemental New Drug Application (sNDA) meeting with the @US_FDA. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: @EDE_UAE approved our first-in-class oral pyruvate kinase (PK) activator for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia – the only medicine approved in the UAE for this population. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Members of our Leadership Team will join a fireside chat at the TD Cowen Health Care Conference on March 2.
The live webcast will be on the Investors section of our website, with a replay archived for at least 2 weeks. Listen and learn more: investor.agios.com/news-events/events-presentations -
Agios
@AgiosPharma
#agiosnews: Today we reported our fourth quarter and full year 2025 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, February 12, at 8:00 a.m. ET to report and discuss our fourth quarter and full year 2025 financial results and other business highlights. Instructions on how to join the webcast are available here:
-
Agios
@AgiosPharma
We’re on-site for #jpm26. Ahead of the meeting, we outlined our 2026 strategic priorities and key milestones across our #raredisease portfolio. Read our press release and tune in to our presentation on Wednesday, 1/14, at 8:15 a.m. PT to learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
At #jpm26, we will share updates on our 2026 strategic priorities, our #raredisease pipeline, and the future outlook for the company.
Learn more by tuning into our company presentation on Wednesday, January 14 at 8:15 a.m. PT / 11:15 a.m. ET: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
#agiosnews: @US_FDA approved our first-in-class pyruvate kinase (PK) activator for the treatment of anemia in adults with alpha- or beta-thalassemia – regardless of transfusion status.
Read more here: investor.agios.com/news-releases/news-release-details/us-… -
Agios
@AgiosPharma
#agiosnews: Today we announced that the @US_FDA has not yet issued a decision on the sNDA for our first-in-class pyruvate kinase activator in adults with thalassemia and that the sNDA remains under active review.
Read more here: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
We're at #ash25 (booth #1661), connecting with the #hematology and #raredisease communities to explore the latest advances and share the progress of our pyruvate kinase (PK) activation franchise in rare blood disorders. Learn more about our presence at the meeting:
-
Agios
@AgiosPharma
#agiosnews: We announced topline results from the RISE UP Phase 3 trial of our first-in-class pyruvate kinase (PK) activator in patients aged 16+ with sickle cell disease. We intend to file for potential U.S. regulatory approval.
Read about the results: investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
At #ash25, we’re excited to showcase new data highlighting our first-in-class pyruvate kinase (PK) activator, share research led by two of our advisory councils, and strengthen our connections with the #hematology and #raredisease communities. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Today, we reported our third quarter 2025 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: EMA’s CHMP adopted a positive opinion for our first-in-class PK activator for the treatment of anemia in adult patients with #thalassemia. Decision from European Commission is expected by early 2026. Read our press release: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, October 30, at 8:00 a.m. ET to report and discuss our third quarter 2025 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re at #ascat2025, joining the #sicklecelldisease and #thalassemia communities and our other partners to share scientific progress and advance support for people living with these rare diseases. Visit us at booth #14 – we’d love to connect.
-
Agios
@AgiosPharma
#agiosnews: The PDUFA goal date for the U.S. sNDA of our first-in-class PK activator for the treatment of adult patients with thalassemia has been extended by three months, from September 7, 2025, to December 7, 2025. Read our press release for more information:
-
Agios
@AgiosPharma
#agiosnews: @Saudi_fda_en approved our first-in-class pyruvate kinase (PK) activator for the treatment of adult patients with thalassemia. This marks the first regulatory approval for this medicine in thalassemia. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Today, we reported our second quarter 2025 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, July 31, at 8:00 a.m. ET to report and discuss our second quarter 2025 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Dr. Jay Backstrom has been appointed to our Board of Directors and will serve on the Science and Technology Committee. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re at #eha2025 (booth # C04), connecting with the #hematology community and our partners to explore the latest research and share the progress of our pyruvate kinase activation portfolio in rare blood disorders. Learn more about our presence at the meeting:
-
Agios
@AgiosPharma
#agiosnews: Our Leadership Team will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 9, at 8:40 a.m. ET. We’ll highlight our 2025 strategic priorities, current progress, and future outlook. Learn more and listen here: investor.agios.com/news-events/events-presentations
-
Agios
@AgiosPharma
We’re excited to return to #eha2025 to connect with the #hematology community and share our clinical results and scientific insights, highlighting the potential of our pyruvate kinase (PK) activation portfolio in treating rare blood disorders. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: This month, our Leadership Team will present at the BofA Securities and RBC Capital Markets 2025 healthcare conferences. We’ll share updates on our 2025 strategic priorities and engage investors in conversations about our long-term vision. Learn more:
-
Agios
@AgiosPharma
#agiosnews: Today, we reported our first quarter 2025 financial results, along with recent business highlights. Read the press release and tune into the webcast this morning at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re fueled by connections – to one another and to the rare disease communities we serve. Read our 2025 ESG report to learn how we engage with the community to develop and deliver innovative medicines, advance research, and foster a purpose-driven culture.
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, May 1, at 8:00 a.m. ET to report and discuss our first quarter 2025 financial results and other business highlights. Instructions on how to join the webcast are available here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
For our last Women’s Leadership & Inclusion (WL&I) Spotlight, we are recognizing Yola Pesha, Associate Director, Analytical Development. Inspired by her mother, a mentor, and her daughter, Yola champions resilience and empowerment. Thank you for joining us in celebrating these inspiring stories throughout #womenshistorymonth! #inclusionandimpact
-
Agios
@AgiosPharma
For this week’s Women’s Leadership & Inclusion (WL&I) Spotlight, we are recognizing Karen Norton, Director, Program Management. Karen is passionate about science, inclusion, and the power of women supporting women. Her advice? Be brave. Try new things. Thrive. Stay tuned next week for our final WL&I Spotlight! #womenshistorymonth #inclusionandimpact
-
Agios
@AgiosPharma
For our first Women’s Leadership & Inclusion (WL&I) Spotlight this #womenshistorymonth, we are recognizing Parija Patel and Clive Patience – the driving forces behind our WL&I employee resource group. Their leadership has made a meaningful impact on their colleagues and #womeninstem. We appreciate their contributions and look forward to sharing more inspiring stories. Stay tuned for next week’s spotlight! #inclusionandimpact
-
Agios
@AgiosPharma
#agiosnews: This week, members of our Leadership Team will attend and present at the Leerink Global Healthcare Conference 2025 and the Barclays 27th Annual Global Healthcare Conference. We will provide key updates on our 2025 strategic priorities and engage investors in meaningful discussions about our long-term vision.
-
Agios
@AgiosPharma
#internationalwomensday honors the achievements of women while highlighting the need for gender equality. This year’s theme, #accelerateaction, underscores the urgency of progress. We are proud of the remarkable women on our team – their impact continues to inspire change. #iwd2025 #womeninbiotech #inclusionandimpact
-
Agios
@AgiosPharma
In honor of #employeeappreciationday, we express gratitude to our team for making our company a wonderful place to work. While our employees picked different words to describe their teams, we all agree that our colleagues and the culture we have built together are the keys to our success. #gratitude #teamwork
-
Agios
@AgiosPharma
Krishnan Viswanadhan, Pharm.D, joined us today as our new Chief Corporate Development and Strategy Officer. As a member of our Leadership Team, he will spearhead strategic planning and corporate development initiatives that drive continued growth for our company. With a distinguished career, Krishnan brings extensive experience in global strategy, scientific innovation, and industry leadership, having held senior and executive roles in small and large biopharmaceutical companies.
Read his bio and learn more here: www.agios.com/about-us/leadership/krishnan-viswanadhan/ -
Agios
@AgiosPharma
#agiosnews: Today, our Leadership Team attended the TD Cowen 45th Annual Healthcare Conference, sharing key insights on our 2025 strategic priorities and engaging with investors on our vision for the future.
-
Agios
@AgiosPharma
Women have long been pioneers in STEM – pushing boundaries and shaping the world we know today. This #womenshistorymonth, our Women’s Leadership & Inclusion (WL&I) employee resource group is celebrating their impact and sharing stories of the women and allies who are part of WL&I and inspiring the next generation. Stay tuned! #whm #womeninstem #inclusionandimpact
-
Agios
@AgiosPharma
#rarediseaseday comes once a year, but for those living with a rare disease, every day is an opportunity to raise awareness, offer support, and inspire hope. We stand with patients, caregivers and physicians – because together, we can do more. Join us in honoring this community, today and every day. To learn more visit: www.agios.com #showyourstripes #lightupforrare
-
Agios
@AgiosPharma
For our final Agios Association of Black Professionals (#aaobp) spotlight this #blackhistorymonth, we celebrate Marley Abram, a dedicated Hemolytic Anemia Specialist. For Marley, this month is more than a time for reflection – it’s a call to action. While we honor the trailblazers who paved the way, we must also acknowledge the work still needed to drive meaningful change. We’re proud to celebrate AAoBP’s unwavering commitment to inclusivity, education, and impact. #bhm2025 #inclusionandimpact
-
Agios
@AgiosPharma
The latest episode of “Thal Pals: The Alpha Beta Revolution” is here! Join patient advocate NinaMaria and special guest Dr. Sujit Sheth as they explore the critical importance of building a dedicated care team for patients with thalassemia. Listen here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…. This podcast is not intended as medical advice. Please consult your healthcare team with any treatment-related questions.
-
Agios
@AgiosPharma
For our next Agios Association of Black Professionals (AAoBP) spotlight this #blackhistorymonth, we celebrate Stephanie Ewuoso, a Patient Support Manager on our Market Access team. Stephanie sees this month as a time to honor Black resilience and contributions. She champions representation and empowerment, ensuring Black voices are always heard. #bhm2025 #inclusionandimpact
-
Agios
@AgiosPharma
For our next Agios Association of Black Professionals (AAoBP) spotlight this #blackhistorymonth, we are celebrating Doug Rantin, one of our Senior Hemolytic Anemia Sales Specialists. Committed to mentorship and service, Doug actively supports students, volunteers with Alpha Phi Alpha Fraternity, Inc. and his church, and gives back to his community. To him, Black History Month is about honoring past contributions and inspiring future generations. #bhm2025 #inclusionandimpact
-
Agios
@AgiosPharma
#agiosnews: We reported our fourth quarter and full-year 2024 financial results and other business highlights. Read our press release and tune into our webcast this morning, 2/13, at 8:00 a.m. ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#agiosnews: Our ACTIVATE-Kids Phase 3 study of our late-stage pyruvate kinase (PK) activator in children aged 1 to <18 years with PK deficiency who are not regularly transfused achieved its primary endpoint. This is the first study to demonstrate efficacy of an oral therapy for children with #pkdeficiency who are not regularly transfused. With today’s news, the double-blind period of both of our pediatric PK deficiency trials – ACTIVATE-Kids and ACTIVATE-KidsT – has now been completed. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
On International Day of #womenandgirlsinscience, we honor the incredible women driving change in #stem – especially the inspiring scientists on our team. Their work paves the way for a more inclusive, innovative future. Learn more: www.agios.com/pipeline/ #womeninstem #stemcareers
-
Agios
@AgiosPharma
For our first Agios Association of Black Professionals (AAoBP) spotlight this #blackhistorymonth, we recognize Nefar Moran and Angela Acha – leaders of AAoBP and mentors to women in the life sciences industry. Their work drives inclusion, advocacy and career growth at Agios and beyond. Stay tuned for next week’s spotlight! #bhm2025 #inclusionandimpact
-
Agios
@AgiosPharma
We are hosting a conference call and live webcast on Thursday, February 13, at 8:00 a.m. ET to report and discuss our fourth quarter and full-year 2024 financial results and other business highlights. Instructions on how to join the webcast are available here:
-
Agios
@AgiosPharma
As #blackhistorymonth begins, we’re proud to amplify and celebrate the voices and stories of our Black colleagues. Follow along throughout February, as we’ll be spotlighting members of the Agios Association of Black Professionals (pictured here), sharing their journeys, leadership, and impact. Stay tuned! #bhm2025 #inclusionandimpact
-
Agios
@AgiosPharma
In the latest “Just Listen: Voices of PK Deficiency” podcast episode, Janie Davis, Director of Patient Advocacy at Agios, hosts patient advocates Tamara Schryver, Jill Welle, and Alejandra Watson to share highlights from the second Pyruvate Kinase (PK) Deficiency Conference, discussing global collaboration, key moments, and future plans. Listen here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…. This podcast is not intended as medical advice. Consult your healthcare team with any treatment-related questions.
-
Agios
@AgiosPharma
Today, we honor Dr. Martin Luther King Jr.’s legacy of justice, equality, and nonviolence. His teachings inspire unity, empathy, and action for a brighter, more equitable future. Our offices are closed today to reflect on his important message. #mlkday #honoringmlk
-
Agios
@AgiosPharma
#jpm25 kicks off today, and our Management Team is on-site in San Francisco. Ahead of the meeting, we announced our anticipated key 2025 milestones and value-driving catalysts through 2026 across our #raredisease portfolio. Read our press release and remember to tune in to our company presentation on Wednesday, January 15, at 7:30 a.m. PT / 10:30 a.m. ET to learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
At #jpm25, we will share updates on our promising #raredisease pipeline, our commercial potential and discuss the outlook for the year ahead and beyond. Learn more by tuning in to our company presentation on Wednesday, January 15, at 7:30 a.m. PT / 10:30 a.m. ET:
-
Agios
@AgiosPharma
New Thal Pals Episode Alert: Part 2 of Unlocking Nutrition Secrets for Hemolytic Anemias is live. Join Nina Maria and guest Tamara Schryver as they explore antioxidants' role, diet and exercise tips, managing eating disorders, and supplements versusnatural foods. Listen to the episode here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
This podcast is not intended as medical advice. Please consult your healthcare team with any treatment-related questions. -
Agios
@AgiosPharma
This holiday season, we are humbled and honored to partner with @caringfchildren (Frank & Rosemary Iovieno Caring for Children Foundation) to support 91 children living with life-threatening illnesses, including #sicklecelldisease, and their families. Together, we’re spreading hope, kindness, and brighter holidays. #givingback #caringforchildren
-
Agios
@AgiosPharma
The @EU_Commission adopted a positive decision for the designation of our late-stage PK activator as an orphan medicinal product for the treatment of #sicklecelldisease. Learn more: investor.agios.com/news-releases/news-release-details/eur…
-
Agios
@AgiosPharma
Closing out an incredible year, we’re honored to be named Biotech Company of the Year at the 2024 #scripawards! 🎉 Grateful to celebrate this milestone with the global biopharma community. A huge thank you to our amazing team and partners – this recognition inspires us to continue transforming the lives of patients with #rarediseases. 🌟 Learn more: www.agios.com
-
Agios
@AgiosPharma
As #ash24 comes to a close, we reflect on the breadth of research presented this year and the data highlighted across our robust pipeline. These opportunities to connect on the latest advances strengthen our partnerships and collaborative efforts within the scientific community. Hear from Dr. Sarah Gheuens, our Chief Medical Officer and Head of R&D, as she shares our key takeaways.
-
Agios
@AgiosPharma
We presented results at #ash24 from our Phase 3 ENERGIZE-T study in adults with transfusion-dependent alpha- or beta-thalassemia. Based on the results from this study and our Phase 3 ENERGIZE trial, we also announced that we filed for regulatory approval of our late-stage PK activator for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia in the U.S., European Union, Kingdom of Saudi Arabia and United Arab Emirates. Read our press release and tune into our webcast tomorrow (Monday, December 9) at 7:00 a.m. PT / 10:00 a.m. ET for more information: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We look forward to convening with the #hematology community at #ash24 to share our latest research on our two PK activators in rare blood disorders, including #thalassemia, #sicklecelldisease, and myelodysplastic syndromes (#mds). Explore our abstracts here and find us at booth 105: www.agios.com/ash-2025/
-
Agios
@AgiosPharma
For Jill and Tamara, living with #pkdeficiency isn’t just about managing a disease – it’s about the connections they’ve built with others on the same journey. These relationships provide vital support and strength. On #internationalpkdeficiencyday, we proudly partner with @TwPKDnonprofit to honor those impacted by PK deficiency. Let’s celebrate community, share stories, and show support. Learn more: www.agios.com/rare-diseases/pyruvate-kinase-deficiency/
-
Agios
@AgiosPharma
Our team came together for our annual #thanksgiving potluck to celebrate a year filled with growth, collaboration, and gratitude. With delicious food, laughter, and heartfelt reflections, it was a perfect time to appreciate all that we've accomplished together. We are incredibly #thankful for our dedicated employees, valued partners, and the patients and families who place their trust in our hands.
-
Agios
@AgiosPharma
New Thal Pals Alert! Dive into Part 1 of our special two-part series on #nutrition with #thalassemia! We chat with Tamara Schryver, the president of @TwPKDnonprofit. Discover practical tips on nutrition, advice on supplements, and much more. Whether you're a patient, caregiver, or healthcare professional, you'll find valuable insights to improve daily life. Tune in here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
We are proud to sponsor the 4th Annual Virtual Caregiver Summit hosted by the @SCCConsortium, which offers the opportunity for #sicklecelldisease caregivers to learn from experts and connect with others. Learn more and register today: www.scdcaregivers.org/2024summit
#nationalfamilycaregiversmonth -
Agios
@AgiosPharma
We made @biospace's 2025 Best Places to Work list. With more than 3,600 submissions received, this award spotlights the top 50 ranked life science employers in North America. Thank you to our employees who continue to build a community-centric culture that promotes collaboration, contribution and engagement for all. Access the full list here: www.biospace.com/best-places-to-work
-
Agios
@AgiosPharma
At #ash24, we’ll present new data and updates highlighting the clinical progress of our two PK activators in #thalassemia, #sicklecelldisease and myelodysplastic syndromes (#mds). Learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today, we reported our third quarter 2024 financial results and business highlights. Read our press release and tune into our webcast this morning, 10/31, at 8 AM ET: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Excited to share our latest episode of Cheat Codes: A Sickle Cell Podcast! Dr. Z & Dr. C talk to Tabatha McGee about her inspiring journey and the innovative work at @SCFoundationGA. A must-hear for all! Subscribe & listen: www.bloodstreammedia.com/cheat-codes-episodes/tabatha-mcg…
-
Agios
@AgiosPharma
We had an amazing time wrapping up October at the @SCDAAorg’s 52nd Annual Convention, learning about opportunities to advance care and collaboration in #sicklecelldisease and connecting with #sicklecellwarriors. Check out some of our favorite moments below!
-
Agios
@AgiosPharma
We were proud sponsors of the50th Annual 5K/1K Walk, Jog or Bike for a Cure, organized by the Sickle Cell Disease Association of Illinois (SCDAI)! Warriors, staff, and community members all came together in Chicago to raise #sicklecellawareness.
-
Agios
@AgiosPharma
A new episode of "Just Listen: Voices of PK Deficiency" just dropped! Special thanks to Dr. Tamara Schryver, president of @TwPKDnonprofit, for sharing invaluable insights on optimizing nutrition & physical activity for those with #pkdeficiency. Tune in now here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…
-
Agios
@AgiosPharma
We are thrilled to be named among the nation’s top companies in Energage’s October 2024 Top Workplaces Culture Excellence awards! We are honored to be recognized in the “Employee Well-Being”, “Professional Development” and "Appreciation" categories. Our special culture is guided by our three pillars of flexibility, psychological safety, and deliberate development.
Learn more about the Top Workplaces Culture Excellence Awards: www.businesswire.com/news/home/20241016479451/en/Energage… -
Agios
@AgiosPharma
A new episode of Thal Pals is live! Listen as hosts Dr. Kevin Kuo and NinaMaria Badalamenti discuss how how periods, diet, and illnesses can affect ferritin levels for some people living with #thalassemia and tips on keeping track of your health labs. www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
Today is #mdsworldawarenessday! We are proud to join the @MDSAlliance and other organizations in raising awareness of this disease. Myelodysplastic syndromes (#mds) are a group of bone marrow disorders in which the blood marrow does not produce enough healthy blood cells. At Agios, we are now enrolling a Phase 2b study of tebapivat in patients with lower-risk MDS.
Learn more about today’s awareness day here: www.mds-alliance.org/mds-world-awareness-day-2024/ -
Agios
@AgiosPharma
We are thrilled to be named one of Energage and Monster's 2024 Top Places for Remote Work. Based on employee feedback, this award highlights companies that have created a standout employee experience in a remote environment. This is a testament to our amazing Agioi and the culture we are building together, both online and in person. Check out the full list here: topworkplaces.com/award/remote-work/2024/150-499/
-
Agios
@AgiosPharma
We're dedicated to amplifying patients’ voices as we advance our mission on behalf of those with #hemolyticanemias. We aim to create opportunities for patients, caregivers, and physicians to collaboratively generate and present insights, driving truly patient-centered research and development.
-
Agios
@AgiosPharma
We are proud to sponsor “The Nod to Naz” traveling exhibit at the @SCDAAorg’s 52nd Annual Convention, which highlights the work of artist and #sicklecellwarrior Hertz Nazaire. Check out the Los Angeles Sentinel’s piece on the exhibit’s previous stop at the @CayenneWellness #sicklecelldisease Summit and its importance in bringing to life both the pain and triumph of the #sicklecell experience: lasentinel.net/hertz-nazaire-exhibit-highlights-pain-exem…
-
Agios
@AgiosPharma
We completed enrollment of our Phase 3 RISE UP trial in #sicklecelldisease. The topline results from this 52-week study are expected in late 2025. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re excited to sponsor and participate in the @SCDAAorg’s 52nd Annual Convention in Atlanta, GA! As part of this year’s theme “Momentum: A Journey into a New Sickle Cell Era”, we hope to see you at the “Nod to Naz” Traveling Exhibit, which showcases the artwork of the late Hertz Nazaire, the C.A.R.E.S Consortium presentation featuring Dr. Ahmar Zaidi, or at our booth. Learn more:
www.sicklecelldisease.org/get-involved/events/annual-nati… -
Agios
@AgiosPharma
A great conversation at the #nordsummit today. Thanks for having us!
Rare Disease Advisor
@RareDisease_Adv
💡#nordsummit CEO's Perspectives Panel.
Patrick Collins, VP of Community and Corporate Affairs at @RareDiseases, speaks with pharma CEOs Brian Goff (@AgiosPharma), Rachid Izzar (@Biogen), Kate Haviland (@BlueprintMeds), Giacomo Chiesi (@ChiesiGRD), and Julie Kim (@TakedaPharma) about their insights, hopes, and concerns for the future of rare disease therapies and innovation. @lluxner -
Agios
@AgiosPharma
We will be hosting a conference call and live webcast on Thursday, October 31, at 8 a.m. ET to report our third quarter 2024 financial results and other business highlights. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our CEO Brian Goff will be speaking at the #nord @RareDiseases Breakthrough Summit in Washington, D.C.! The CEO perspectives panel will discuss the role of industry in furthering meaningful #raredisease innovations and the importance of partnerships with patient communities.
-
Agios
@AgiosPharma
We’re thrilled to have made the 2024 @PharmaScrip Awards shortlist and are honored to be in the “Biotech Company of the Year” and “Clinical Advance of the Year” categories among our fellow nominees. We look forward to celebrating some of the finest innovations and accomplishments in global biopharma in December. www.citeline.com/en/awards/scripawards
-
Agios
@AgiosPharma
We had a blast kicking off autumn at our annual fall gathering! This event, hosted at our Cambridge HQ, included development sessions, a fun leadership panel, @CooleysAnemia Care Walk for thalessemia, and time for Agioi to mingle and connect. Check out some of our favorite moments below.
-
Agios
@AgiosPharma
We were excited to host a Care Walk at Agios as a part of our company fall gathering! Inspired by the work of the @CooleysAnemia Foundation, we were grateful for the opportunity to raise awareness and funds to support the #thalassemia community.
-
Agios
@AgiosPharma
It’s #hispanicheritagemonth! We are proud to celebrate the incredible contributions of the Hispanic community through our Latinx ERG, which is focused on enhancing understanding and knowledge of LatinX cultures. Hear from Cecilia Jones of our LatinX ERG on what this month means to her.
-
Agios
@AgiosPharma
Our Vice President & Head Of Medical Affairs Eva Gallagher will be participating in a panel next week at the Operationalize: Expanded Access Programs Summit in London to discuss access strategies for #raredisease treatments. Learn more about the event here: operationalise-early-access.com
-
Agios
@AgiosPharma
We’ve enjoyed connecting with community, advocacy, and scientific leaders at the 2024 @ascatconference in London. We are hosting a symposium as well as giving an oral and poster presentation and are thrilled to continue to advance innovation for people with #hemolyticanemias. For more information on the conference, see here: www.ascatconferences.com #ascat2024
-
Agios
@AgiosPharma
Our team is growing! We’re looking for a Hemolytic Anemia Specialist with a demonstrated track record of success in launching #raredisease medicines, and who is passionate about helping patient communities. Does that sound like you? Click here to view the position and apply: phe.tbe.taleo.net/phe03/ats/careers/v2/viewRequisition?or… #biotechjobs
-
Agios
@AgiosPharma
Agioi Audra Boscoe and Eva Gallagher have completed the @timmermanreport’s Timmerman Traverse for Sickle Forward! The team was able to reach their goal of raising $1 million for Sickle Forward, an organization dedicated to the support of rapid diagnosis and essential treatment of #sicklecelldisease in Africa. Eva carried a polished stone heart to the top of the mountain to represent the heart of all #sicklecellwarriors who overcome mountains every single day. Congratulations to these adventurous Agioi and all who accompanied them on the journey.
-
Agios
@AgiosPharma
While #sicklecellawarenessmonth comes to a close, the work and message continues. We recently organized a live recording of the Cheat Codes podcast. See below as a doctor, caregiver and #sicklecellwarrior share their hopes for the future of people living with #sicklecelldisease.
-
Agios
@AgiosPharma
We had a great time sponsoring and participating in the @CayenneWellness 16th Annual Sickle Cell Disease Educational Summit, connecting with #sicklecellwarriors and learning more about their experiences with #sicklecelldisease. Here are some of our highlights! #sicklecellawarenessmonth
-
Agios
@AgiosPharma
Our latest Thal Pals episode is live! Learn about the importance of #hemoglobin and ferritin for #thalassemia patients. Listen now here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
Congrats to Dr. Joshua Rivenbark of @UNCDeptMedicine & @UNC_SOM, winner of this year’s Agios Hemolytic Anemias Clinical Fellowship Competitive Grant! His research focuses on understanding the nationwide utilization of healthcare services & therapies in #sicklecelldisease. #nscam24 #healthequity
-
Agios
@AgiosPharma
We're thrilled to be presenting at the @CayenneWellness 16th Annual #sicklecelldisease Educational Summit! Don’t miss the “Emerging Therapies” panel discussion on Wednesday, September 18. We hope to see you there! cayennewellness.org/scd-educational-summit-2024/
-
Agios
@AgiosPharma
We're a proud sponsor of the @CayenneWellness 16th Annual Sickle Cell Disease Educational Summit. This year's theme is "Unpacking Sickle Cell: One Warrior at a Time" and the event will feature the “Nod to Naz” Traveling Art Exhibit. Learn more: cayennewellness.org/scd-educational-summit-2024/
-
Agios
@AgiosPharma
New episode alert! Dive into Just Listen: Voices of PK Deficiency as Dr. Rachael Grace talks with Dr. Sateesh Chonat about managing anemia in #pkdeficiency and the pros and cons of spleen removal. Listen here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…
-
Agios
@AgiosPharma
In honor of #sicklecellawarenessmonth, hear from #sicklecellwarrior Maurice as he shares about some of the challenges faced by those living with #sicklecelldisease, including regular transfusions and the uncertainties of living with a chronic disease.
-
Agios
@AgiosPharma
We're thrilled to announce that the U.S. FDA has granted orphan drug designation to our novel pyruvate kinase (PK) activator for the treatment of patients with #myelodysplasticsyndromes (MDS). This underscores the importance of bringing new oral treatment options to patients suffering from this disease. Read more in the announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Listen to Cheat Codes’ latest episode with the inspiring Dr. Simone Uwan! Discover her journey advocating for #sicklecell disease awareness, her personal story, and the incredible strides she's made in medicine and public health. #sicklecellawareness www.bloodstreammedia.com/cheat-codes-episodes/empowering-…
-
Agios
@AgiosPharma
September is #sicklecellawarenessmonth and we're shouting out #sicklecellwarriors! They're resilient & we're inspired daily by their stories. We're proud to stand with this community and work to make a positive impact for those living with #sicklecelldisease.
-
Agios
@AgiosPharma
We'll be presenting at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18 at 10:20 am ET. A live webcast of the presentation can be accessed on our website for at least two weeks following the presentation. Read more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
🎙️ Just wrapped an inspiring #thalpals live podcast at the @CooleysAnemia Foundation Patient-Family Conference in Atlanta! Join Dr. Kuo, Shae Ghosh, Pranav Saha, Dr. Pakbaz, & Robert Menino as they share how they thrive with #thalassemia. Listen in! www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
Our offices are closed this week for our annual summer shutdown! Agioi are using this as an opportunity to recharge and spend time with loved ones, and will return on September 3.
-
Agios
@AgiosPharma
Agioi Audra Boscoe and Eva Gallagher are preparing to embark on the @timmermanreport’s Timmerman Traverse for @SickleForward! They'll be joining a team of #biotech executives and investors on a hike to the summit of Mt. Kilimanjaro to raise $1M for #sicklecelldisease. (1/2)
Agios
@AgiosPharma
Contributions will support @SickleForward, an organization that supports rapid diagnosis and essential treatment of SCD in Africa. We’ll be cheering on Audra & Eva when the journey begins on September 8. Learn more about the expedition here: www.sickleforward.com/events (2/2)
-
Agios
@AgiosPharma
With patients at the center of all we do, we can ensure the positive change we're aiming for is the positive change patients want to see. Learn more about how we partner with patients in our clinical development for #hemolyticanemias from @ThePharmaLetter: www.thepharmaletter.com/agios-the-company-putting-patient…
-
Agios
@AgiosPharma
Our #regulatory team is growing! We’re looking for candidates that care about this important work, and who are driven to connect to our mission of helping patient communities. Does that sound like you? Click here view the roles and apply: phe.tbe.taleo.net/phe03/ats/careers/v2/searchResults?org=… #biotechjobs
-
Agios
@AgiosPharma
We welcomed Arielle Langer, MD, MPH, a hematologist at @BrighamWomens and a medical instructor at @harvardmed, to our office to speak to clinical and quality of life concerns that can occur in the care of #thalassemia patients. We're thankful for this learning experience!
-
Agios
@AgiosPharma
A is for Agios! Over 90% of our employees agree that our Diversity, Equity & Inclusion (#dei) efforts make a positive difference in our company culture.
Agios
@AgiosPharma
Read about our DE&I efforts and how we value differences on our website here: www.agios.com/inside-agios/diversity/
-
Agios
@AgiosPharma
At Agios, our team members embrace our values, which are ultimately designed to have a positive impact on our work for #raredisease patients.
Agios
@AgiosPharma
Learn more about our values and how we foster our culture here: www.agios.com/inside-agios/
-
Agios
@AgiosPharma
We're thrilled to share the FDA has approved vorasidenib, representing a significant step forward for patients. Congrats to @ServierPharma and the Agios team for their early discovery and development efforts. Read more: investor.agios.com/news-releases/news-release-details/agi…
Agios
@AgiosPharma
Today's important milestone will also complete the sale of our vorasidenib royalty to Royalty Pharma, supporting our ongoing innovation for those facing rare blood disorders.
-
Agios
@AgiosPharma
We're entering into a distribution agreement with @NewBridgePharma to advance regulatory filings & commercialization of PYRUKYND® in the Gulf Cooperation Council (GCC) region to help meet the treatment needs for those living with #rarediseases in the area. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today, we reported our second quarter 2024 financial results and other business highlights. Tune into the live webcast this morning at 8 a.m. ET or watch the replay on our website in the Events & Presentations section. Read the full announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We announced the topline results of our first pediatric data readout, ACTIVATE-KidsT, a clinical study in children with #pkdeficiency who are regularly transfused. See our press release for a high-level summary of the data: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
On this week’s episode, Dr. Z and Dr. C speak with Janie Davis, our Director of Patient Advocacy. Listen to learn about Janie’s work with the #sicklecell community as a patient ally here: www.bloodstreammedia.com/cheat-codes-episodes/janie-davis…
-
Agios
@AgiosPharma
We enjoyed attending @SCCConsortium's #warriorsconvention2024, themed “From Patient to Powerhouse,” and meeting with other members of the community. #sicklecellwarriors are amazing partners in our work and true powerhouses making a significant impact!
-
Agios
@AgiosPharma
Shoutout to our interns on #nationalinternday. This year, we welcomed seven interns to gain hands-on experience in the lab, participate in development and networking events, and share a capstone presentation with their learnings. We're excited to have their talents on board!
-
Agios
@AgiosPharma
We are fueled by our connections with the #raredisease community. People like NinaMaria, living with #thalassemia, inspire our team to create meaningful outcomes & develop better solutions for #hemolyticanemias. Hear NinaMaria’s story: vimeo.com/763828853
-
Agios
@AgiosPharma
Last week, we enjoyed presenting at @TwPKDnonprofit's 2nd International Pyruvate Kinase Deficiency Conference. Our team members discussed how the Peak Registry is seeking to make #pkdeficiency (PKD) data more accessible and shared insights from our Phase 3 ACTIVATE-KidsT study.
-
Agios
@AgiosPharma
There are new international guidelines for PK Deficiency and host Dr. Rachael Grace sits down with Tamara Schryver and Alejandra Watson to discuss them. Learn how these guidelines are revolutionizing care for patients and what it means for the community. bloodstreammedia.com/just-listen-voices-of-pk-deficiency-…
-
Agios
@AgiosPharma
We will be hosting a conference call and live webcast on Thursday, August 1, at 8 a.m. EDT to report our second quarter 2024 financial results and other business highlights. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Help doctors uncover more about monitoring and managing #pkdeficiency by participating in the Peak Registry. Participation does not require any lab testing or additional visits. Learn more: peakregistry.com/Home/publicpage/patients?page=patients
-
Agios
@AgiosPharma
Our team is presenting at @DynamicGlobalEv's #cposummit! They will discuss how our #patientadvocacy and HEOR leaders are building connections and uncovering valuable insights through Red Cell Revolution, an advocacy advisory council for #hemolyticanemias. dgevents.com/event/chief-patient-officer-summit/
-
Agios
@AgiosPharma
We’re proud that our #thalassemia awareness campaign, developed in partnership with patients and @EVERSANAINTOUCH, has been recognized by @MMMnews as its Campaign of the Week! 🏆 Read more: www.mmm-online.com/home/channel/campaigns/campaign-of-the…
-
Agios
@AgiosPharma
New Cheat Codes podcast episode! Dr. Z and Dr. C host a live panel of CBO leaders who have dedicated their lives to supporting #sicklecellwarriors. They discuss the vital roles CBOs play, their unique challenges, successes, and more. Tune in: www.bloodstreammedia.com/cheat-codes-episodes/the-importa…
-
Agios
@AgiosPharma
In commemoration of #independenceday in the U.S., our offices are closed tomorrow and Friday. We wish everyone a safe holiday with friends and family.
-
Agios
@AgiosPharma
This #pridemonth, our Pride ERG hosted an educational webinar with #lgbtqia advocate, Choon Young Tan. Thank you to those who contribute to our inclusive workplace and continue to provide a network that supports the professional development of LGBTQIA team members.
-
Agios
@AgiosPharma
We had a wonderful time at the @EHA_Hematology Congress 2024 presenting several abstracts and building connections with others passionate about creating breakthroughs for those with #rarediseases. Check out some snapshots of our time at #eha2024 below.
-
Agios
@AgiosPharma
In recognition of #juneteenth, the Agios Association of Black Professionals ERG group hosted a webinar to guide our team through scenarios related to conversations around race & social justice. We're continuously working toward fostering a more inclusive environment for all.
-
Agios
@AgiosPharma
Pyruvate kinase deficiency (PKD) may be a #raredisease, but it can occur in multiple family members. On this week’s episode of Just Listen, host Rachael Grace speaks with Jennifer and Jerry King who are raising two children with PKD. Listen here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…
-
Agios
@AgiosPharma
We're presenting positive Phase 3 ENERGIZE study data in a plenary session at @EHA_Hematology Congress on June 16. A live webcast can be accessed on our website and a replay will be archived for at least two weeks following the presentation. investor.agios.com/news-releases/news-release-details/agi… #eha2024
-
Agios
@AgiosPharma
One of our top highlights at FSCDR 2024 included hosting our second live recording of Cheat Codes: A Sickle Cell Podcast. During the session, leaders shared experiences of positive change from #sicklecell community-based organizations. Stay tuned for the episode release! (1/2)
Agios
@AgiosPharma
As we inch closer to #worldsicklecellday, tune in to previous Cheat Codes episodes featuring thought-provoking conversations with individuals who have firsthand experience with #scd. Listen to podcasts here: www.bloodstreammedia.com/cheat-codes (2/2)
-
Agios
@AgiosPharma
Pyruvate kinase (PK) deficiency is rare, but awareness shouldn’t be. By joining the Peak Registry, help doctors better understand how to diagnose, monitor, and manage #pkdeficiency. Learn more and join now here: peakregistry.com/Home/publicpage/patient-join-now-form #youngeha #hemasphere #eha2024
-
Agios
@AgiosPharma
Our CEO will be speaking at this month's @LongwoodLeaders event at MIT’s Koch Institute next week. This forum brings together experts in the #lifesciences industry to have discussions aimed at expanding advancements in the industry. www.longwoodhealthcareleaders.com/spring2024
-
Agios
@AgiosPharma
Hear from our CMO and Head of R&D Sarah Gheuens below as she outlines all of the details about @EHA_Hematology Congress. For more information about the event and our presentations, visit our #ehacongress2024 microsite: www.agios.com/eha-2024/
-
Agios
@AgiosPharma
As #worldsicklecellday approaches, we encourage you to learn from #sicklecell warriors. In the video below, Teonna shares how the support of the sickle cell community is especially helpful as she navigates other diseases and disorders while living with sickle cell disease.
-
Agios
@AgiosPharma
Happy #pridemonth! This June, we're honoring the LGBTQ+ community all month long through a variety of educational and celebratory events hosted by our Pride ERG group which seeks to create a supportive environment for LGBTQ+ members of our team and allies.
-
Agios
@AgiosPharma
At Agios, we aim to be the best advocates for those struggling with rare diseases and #blooddisorders. This #bloodadvocacyweek, we encourage you to visit the link below to donate blood, you could save someone’s life. www.sicklecelldisease.org/donate-blood-for-sickle-cell/
-
Agios
@AgiosPharma
We're proud to sponsor and present at the @FundSickleCell 2024 Annual Symposium & Scientific Meeting. We'll also be hosting a live episode recording of Cheat Codes at the event. Visit us at Booth #4 & learn more about our participation at #fscdr here: fscdr2024.eventscribe.net
-
Agios
@AgiosPharma
UPDATED TIME SLOT FOR PRESENTATION
We're presenting at @GoldmanSachs' 45th Annual Global Healthcare Conference on June 10. A live webcast can be accessed on our website and a replay will be archived for at least two weeks following the presentation. investor.agios.com/news-releases/news-release-details/upd… -
Agios
@AgiosPharma
Earlier this week we announced positive results from our global Phase 3 ENERGIZE-T study in adults with transfusion-dependent alpha- or beta- #thalassemia. Check out key takeaways from the data below.
-
Agios
@AgiosPharma
We are honored to be a bronze-level sponsor at the 2024 Living Rare, Living Stronger Patient & Family Forum! RSVP to join us and @RareDiseases in Los Angeles on June 8 to connect with the #raredisease community here: livingrare.org
-
Agios
@AgiosPharma
We're pleased to announce the global Ph. 3 ENERGIZE-T study in adults with transfusion-dependent alpha- or beta-#thalassemia achieved its primary endpoint of transfusion reduction response with potential to become a novel advancement in care for patients. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We're presenting data from the Phase 3 ENERGIZE study in a plenary session at #eha2024, highlighting the potential to provide a meaningful treatment option and first oral therapy for adults with non-transfusion-dependent alpha- or beta- #thalassemia.
ehaweb.org/congress/eha2024-hybrid-congress/registration/ -
Agios
@AgiosPharma
On this week’s episode, Dr. Z and Dr. C sit down with Dr. Alex Glaros, a rising star in sickle cell disease, who shares his story about his journey to become a pediatric hematologist. Listen here: www.bloodstreammedia.com/cheat-codes-episodes/the-warrior…
-
Agios
@AgiosPharma
Our CMO and Head of R&D will be participating in a panel at @GalienFdn Forum UK 2024 to discuss our patient-centric approach to #drugdevelopment. Learn more about the event here: prixgalien.co.uk/forum/ #prixgalien
-
Agios
@AgiosPharma
Agios has agreed to sell rights to our 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma. This deal boosts our financial independence for future PYRUKYND® launches and pipeline expansion. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
On the new episode of “Just Listen: Voice of #pkdeficiency Promotion,” host Dr. Rachael Grace talks with Jessica Kellar and her teenage son Travis about how to best prepare children and teenagers for the to transition to adult #pkd care. Listen here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…
-
Agios
@AgiosPharma
Want to support the pyruvate kinase (PK) deficiency community? Be a part of the Peak Registry, a real-world patient database that helps doctors, researchers and #pkdeficiency families better understand the disease. Learn more here: peakregistry.com/Home/publicpage/patients?page=patients
-
Agios
@AgiosPharma
We’re excited to participate in #eha2024! Seven abstracts led by our team and external collaborators will be presented and/or published, including data from our Phase 3 ENERGIZE study in non-transfusion-dependent #thalassemia within a plenary session. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Join us in watching a special #itd2024 interview series from @thalassaemiaTIF and the Thalassemia Advocacy Advisory Council (AAC), featuring patients and members of Thal AAC who share a mission to raise awareness for #thalassemia. Watch all interviews on TIF's profile.
TIF
@thalassaemiaTIF
Those living with #thalassaemia can do anything!
Tobias Larkin shares a heartwarming message as a member of the patient community.
Visit our website to hear more about what Tobias and the Thalassemia Advocacy Advisory Council are doing to #beawaresharecare.
#itd2024 -
Agios
@AgiosPharma
We're thrilled to be recognized in the Clinical Research Team of the Year category at this year's @Citeline Awards! We’re guided by a deep respect for science and a passion to change patients’ lives for the better, and we're thankful to have made a notable impact. #citelineawards
-
Agios
@AgiosPharma
Check out the latest version of our ThalassemiaNEWS newsletter which includes an interview with Dr. AIi Amid, co-author of ‘Guidelines for the Management of Alpha-Thalassaemia’, recently published by @thalassaemiaTIF and more. www.agios.com/rare-diseases/thalassemia/
-
Agios
@AgiosPharma
We are pleased to announce our newest social channel, "Ally Voices Rising," on Instagram – a platform to raise awareness about hemolytic anemias such as #thalassemia, #sicklecell disease, and #pkdeficiency. Check out @allyvoicesrising on Instagram here: www.instagram.com/allyvoicesrising/
-
Agios
@AgiosPharma
On #itd2024, we stand in solidarity with fighters, survivors, and champions battling this rare blood disorder. Meet Maria & Ann, true warriors living with #thalassemia here: vimeo.com/944048068?share=copy
Learn how you can support the community here: thalassaemia.org.cy/itd2024/theme/ -
Agios
@AgiosPharma
During #mentalhealthawarenessmonth, we're encouraging Agioi to #takeamentalhealthmoment and participate in a company-wide Move Challenge. We're aiming to reach one million steps by the end of May. Choose an option below, and let us know how many steps you think we'll take!
-
Agios
@AgiosPharma
We are honored to have supported The Nod to “Naz” Exhibit: A Tribute to Hertz Nazaire traveling art exhibit, presented by @SCDAAorg in Boston. Learn more about Hertz, his advocacy for #sicklecelldisease, and where you can visit the memorial exhibit here: www.hertznazairegallery.com
-
Agios
@AgiosPharma
We're presenting at the @BankofAmerica Securities 2024 Health Care Conference on 5/16. A live webcast can be accessed on our website and a replay will be archived for at least two weeks following the presentation. Access the webcast on 5/16 here: investor.agios.com/events/event-details/rbc-capital-marke…
-
Agios
@AgiosPharma
We're presenting at the @rbccm Global Healthcare Conference on 5/14. A live webcast can be accessed on our website during the presentation and a replay will be archived for at least two weeks following the presentation. Access the webcast on 5/14 here: investor.agios.com/events/event-details/rbc-capital-marke…
-
Agios
@AgiosPharma
Alejandra Watson, @PKDFoundation Board President/co-founder, has expanded the foundation's impact by building a supportive community on social media. Hear from Alejandra as she speaks to the importance of hearing others' stories within the #pyruvatekinasedeficiency community.
-
Agios
@AgiosPharma
Today, we reported our first quarter 2024 financial results and other business highlights. Tune into the live webcast this morning at 8 a.m. ET or watch the replay on our website in the Events & Presentations section. Read the full announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
#itd2024 is one week away, and alongside @thalassaemiaTIF, we're raising awareness of the #thalassemia community. This year's theme is ”Empowering Lives, Embracing Progress: Equitable and Accessible Thalassemia Treatment for All.” Learn more here: thalassaemia.org.cy/itd2024/theme/
-
Agios
@AgiosPharma
In honor of Pyruvate Kinase Deficiency (PKD) Day, we're highlighting those affected by #pyruvatekinase deficiency. Learn from Marie-Eve Noel, whose daughter is living with PKD, as she shares her experience with finding support from the PKD community and #advocates below.
-
Agios
@AgiosPharma
Did you know individuals with #pkdeficiency (PKD) rely on frequent blood transfusions? April 30th signifies the 120th day of the year, highlighting the lifespan of a healthy #redbloodcell (RBC). Watch the animation below to learn about the lifecycle of a RBC in patients with PKD.
-
Agios
@AgiosPharma
We are expanding our U.S. Sales team and offering #remotework positions across the country. Learn more about your opportunities to work with us on our LinkedIn page and search our open positions here: phe.tbe.taleo.net/phe03/ats/careers/v2/searchResults?org=…
-
Agios
@AgiosPharma
We're honored to be recognized in the Work Life Balance, Innovation, Purpose and Value, and Compensation categories as part of USA Today's 2024 @TopWorkplaces for Culture Excellence. We highly value employee feedback and are thrilled by this recognition! www.agios.com/inside-agios/
-
Agios
@AgiosPharma
On this episode of Cheat Codes: A Sickle Cell Podcast, Dr. Z and Dr. C interview Davinna Christian, Dr. Alex Glaros and Clifton Kirkman, II discussing clinical trial awareness. Tune in here: www.bloodstreammedia.com/cheat-codes-episodes/revving-up-…
-
Agios
@AgiosPharma
Our team took part in several community service events with organizations that make an impact locally. By building up our community, we are also furthering connections between colleagues and creating relationships that last a lifetime.
-
Agios
@AgiosPharma
We're reflecting on the success of our recent Agios Connect event in Boston! Our team came together from across the country to deepen connections, network, and make a positive impact in our local community. Thank you, Agioi, for making this a special time for all of us!
-
Agios
@AgiosPharma
PKD is a rare, hereditary disease characterized by chronic #hemolyticanemia. Because of its rarity and variable presentation, information on the disorder has been slow to accumulate. The Peak Registry seeks to change that. Learn more: peakregistry.com/Home/publicpage/patient-join-now-form
-
Agios
@AgiosPharma
We are pleased to share that Tsveta Milanova, CCO and Sarah Gheuens, CMO and Head of R&D, are featured panelists at this year's @OrphanConf event. For more information, read here: secure.terrapinn.com/V5/step1.aspx?E=10785&p=1. #worldorphanusa
-
Agios
@AgiosPharma
In observance of #earthday2024, we're reaffirming our commitment to environmental stewardship and corporate responsibility. Discover how we're taking steps toward helping our planet in our latest Environmental, Social, and Governance Report. investor.agios.com/static-files/64e58dc5-c0bb-4545-90d5-0…
-
Agios
@AgiosPharma
Our CFO Cecilia Jones will be participating in a panel on behalf of Latinos In Bio to speak about the future of the #biotech workforce! Learn more about the panel here: www.latinosinbio.org/events.html
-
Agios
@AgiosPharma
We will be hosting a conference call and live webcast on Thursday, May 2, at 8:00 a.m. EDT to report our first quarter 2024 financial results and other business highlights. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Last month at @reutersevents #pharmausa our very own Holly John spoke on a panel about the importance of listening to patients alongside other industry experts and patient advocate, Rucha Shah. We are so grateful to participate in this great event.
-
Agios
@AgiosPharma
We're proud to share our 2024 Environmental, Social and Governance (ESG) report which highlights Agios's diversity within our company, clinical trials, and throughout the life sciences industry. Read the full announcement and access the full report here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our Women Leadership & Inclusion ERG recently hosted a celebration for #whm2024 & #iwd2024. By amplifying voices of women, we reaffirm our commitment to creating a workplace where every individual feels empowered. Thank you to those who continue to pave the way for equality.
-
Agios
@AgiosPharma
What are the long-term complications of pyruvate kinase (PK) deficiency? Watch this video to learn more about the history of iron overload through patient data from the Peak Registry, an Agios-sponsored global patient database. More info here: peakregistry.com/Home/publicpage/patients?page=patients #aspho2024
-
Agios
@AgiosPharma
Remember to apply by Friday, April 5 to be considered as a recipient of our Clinical Fellowship Grant. Learn more: agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
Agios
@AgiosPharma
At Agios, we are dedicated to advancing independent scientific research in #classicalhematology and are seeking proposals for the Agios Hemolytic Anemias Clinical Fellowship Competitive Grant. To be considered, apply by April 5, 2024. Learn more here: agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
Today is International #medicalscienceliaisonday. We are taking the day to recognize our outstanding MSL team who helps establish connections within healthcare communities & facilitate scientific research to create medical breakthroughs. Thank you MSL team! #internationalmslday
-
Agios
@AgiosPharma
Are you or someone you know living with pyruvate kinase (PK) deficiency? U.S. residents can now enroll remotely in the Peak Registry, a global patient database for patients with #pkdeficiency, sponsored by Agios. Learn more and enroll here: peakregistry.com/Home/publicpage/patient-join-now-form
-
Agios
@AgiosPharma
In honor of #rarediseaseday, we showed off our stripes in support of #raredisease patients across the globe. We have a clear desire to listen and to understand patients' experiences & are dedicated to this community where treatment options are generally limited. #showyourstripes
-
Agios
@AgiosPharma
We're honored to announce that Agios is shortlisted for this year's @Citeline Awards in two categories - the Clinical Research Team of the Year and Clinical Trial Result of the Year. Check out the full shortlist at the link here: www.citeline.com/en/awards/citelineawards #citelineawards
-
Agios
@AgiosPharma
Our Sr. Director, Global Patient Advocacy will be participating in a panel at this year's @ReutersEvents Pharma USA 2024! She will join other experts and provide insight on how to advocate for patients in the most effective way possible. events.reutersevents.com/pharma/pharma-usa/agenda #repharmausa
-
Agios
@AgiosPharma
We're proud to announce that we have been highlighted as one of USA Today's 2024 @TopWorkplaces! We couldn't have achieved this without our Agioi fostering a successful environment for our research in #rarediseases. Learn more about our culture here: www.agios.com/inside-agios/culture/
-
Agios
@AgiosPharma
Our Clinical Fellowship Grant is accepting applications from qualified candidates through April 5. Last year's winner used our grant to research a treatment for hemolytic anemias in myelodysplastic syndromes. Apply for the grant here: agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
On this episode of Thal Pals, we introduce NinaMaria Badalamenti as our new co-host! NinaMaria is living with thalassemia and is a patient advocate, and alongside Dr. Kevin Kuo, the two discuss what’s new in #thalassemia. Tune in here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
This week, we hosted a very special event – the first live recording of Cheat Codes: A Sickle Cell Podcast. Dr. Alex Glaros joined us while patient advocates provided their perspectives on clinical trial participation. (1/2)
Agios
@AgiosPharma
Agios is devoted to promoting the need for #sicklecell education across the country & helping to promote #healthliteracy through this channel, so it was an honor to have shared this passion with listeners in person. Thanks to all who organized & participated in the event! (2/2)
-
Agios
@AgiosPharma
This year's theme for #iwd2024 is #inspireinclusion, and we're proud to play a part in encouraging individuals & organizations to create spaces where women from all walks of life can thrive. Learn more about the importance of International Women's Day: www.internationalwomensday.com
-
Agios
@AgiosPharma
We will be attending the 2024 Leerink Partners Global Biopharma Conference next week in Miami. This conference presents another opportunity for us to shed light on our research and how we are impacting patients' lives. Learn more: investor.agios.com/events/event-details/leerink-partners-…
-
Agios
@AgiosPharma
We're proud that our employees are as passionate about creating change in the world as we are. In honor of #employeeappreciationday, we asked our leadership team their favorite parts about working with their colleagues. Check out the video below highlighting our great Agioi.
-
Agios
@AgiosPharma
Today marks the second anniversary of FDA approval of PYRUKYND® (mitapivat). We are grateful to be celebrating this important milestone and continuing our positive impact for patients, caregivers, researchers, clinicians and other HCPs. Learn more here: www.pyrukynd.com
-
Agios
@AgiosPharma
Today on #rarediseaseday, learn from Tamara who is living with #pkdeficiency (PKD) and is an advocate for #rarediseases as president of @TwPKDnonprofit's support group. See below as she shares stories she's learned from others in the PKD community.
-
Agios
@AgiosPharma
Our Diversity Council kicked off an on-site planning meeting as part of our continued effort to prioritize diversity, equity & inclusion (#dei) initiatives. We have established a dedicated team that maintains a workplace where all can thrive. Learn more: www.agios.com/inside-agios/diversity/
-
Agios
@AgiosPharma
"A person with thalassemia is the strongest person you'll ever meet." Ralph is living with #thalassemia & while he is subject to symptoms like anemia, fatigue, jaundice & others, he hasn't let that stop him from enjoying life. Hear more below. #rarediseaseday
-
Agios
@AgiosPharma
We are pleased to sponsor the #rarediseaseday Forum, an event which recognizes the groundbreaking research and developments in progress in Massachusetts to create treatments for those living with #rarediseases. Learn more about this year's event here: www.massbio.org/events/listing/rare-disease-day-forum/
-
Agios
@AgiosPharma
We're proud to celebrate 2024's #blackhistorymonth theme, African Americans & the Arts, by adorning our elevators with stunning decals showcasing Black artistry. Each ride is a journey through history. Let's honor Black voices, contributions, & achievements every step of the way.
-
Agios
@AgiosPharma
Those living with #sicklecell disease are more likely to experience extreme pain, anemia, increased risk of infection, and stroke. But in the words of Rae, "we are more than our pain experience." Ahead of #rarediseaseday, hear from Rae below.
-
Agios
@AgiosPharma
Last year, we launched Red Cell Revolution (RCR) to lift voices of those living w/ #hemolyticanemias. At a recent RCR meeting, we discussed the need for blood donations, as we continue to hear stories about patients who are being denied transfusions due to blood shortages. (1/2)
Agios
@AgiosPharma
We're encouraging everyone who can to #donateblood & continue to keep patients' needs at the center of our mission. One selfless act could have a large impact on patients' lives. Learn more:
www.redcrossblood.org/donate-blood/how-to-donate/how-bloo… #savelives (2/2) -
Agios
@AgiosPharma
Meet NinaMaria, a warrior living with #thalassemia whose strength shines a light on the importance of awareness for those facing #rarediseases. As we inch toward #rarediseaseday, see the video below to hear about her experience living with thalassemia.
-
Agios
@AgiosPharma
We're pleased to announce that we'll be presenting at the Cowen Inc. 44th Annual Health Care Conference in Boston next month. Tune in to the live webcast following the presentation to gain valuable insights into our vision for the future. #cowenhealthcare investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today, we reported our fourth quarter and year end 2023 business highlights and financial results. Watch the replay of the webcast on our website in the Events & Presentations section. Read the press release here:
investor.agios.com/news-releases/news-release-details/agi… -
Agios
@AgiosPharma
Thal Pals welcomes a panel of teens living with #thalassemia to share their journey of managing the ups and downs. A lively, informative conversation for all ages, this is one you don’t want to miss!
www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut… -
Agios
@AgiosPharma
In time for #idwgs, we're excited to introduce our new Women Leadership & Inclusion Employee Resource Group. This internal organization aims to create a supportive space to help empower #womeninstem and women of color. Learn more below. www.agios.com/inside-agios/diversity/
-
Agios
@AgiosPharma
We had the honor of sponsoring @UpliftingAth's Young Investigator Draft. This special event honors incredible #raredisease researchers who are making a difference within the rare community. Agioi had a great time supporting & attending. Learn more here: charity.pledgeit.org/YID2024
-
Agios
@AgiosPharma
#rarediseaseday falls on the rarest day of the year, 2/29! We're looking forward to highlighting the community of warriors we work with all month long to bring awareness to those living with #sicklecelldisease, #pkdeficiency, and #thalassemia! Learn more: www.agios.com/rare-diseases/
-
Agios
@AgiosPharma
We will be hosting a conference call and live webcast to report our fourth quarter and year-end 2023 financial results and other business highlights. A live webcast can be accessed in the Investors section of our website. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
At Agios, we are dedicated to advancing independent scientific research in #classicalhematology and are seeking proposals for the Agios Hemolytic Anemias Clinical Fellowship Competitive Grant. To be considered, apply by April 5, 2024. Learn more here: agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
Our offices are closed today on #mlkday in recognition of visionary leader, Dr. Martin Luther King Jr., for his life's work to uplift oppressed and underrepresented voices and peacefully bring light to injustices.
-
Agios
@AgiosPharma
We had a great time presenting and building connections at #jpm24! Meetings like this serve as a reminder of all the important work being done for patients. We're proud to be part of this sector and among an elite group of companies focused on #rarediseases. (1/2)
Agios
@AgiosPharma
View our full presentation here: jpmorgan.metameetings.net/events/healthcare24/sessions/49… (2/2)
-
Agios
@AgiosPharma
Will you be at #jpm24 tomorrow? We'll see you bright and early at 7:30 a.m. PT in the Borgia Room!
Agios
@AgiosPharma
Another year, another #jpm24! Our recent topline data readout from the ENERGIZE Phase 3 trial kicks off a catalyst-rich period for Agios. Read more about what our CEO Brian Goff will be presenting at this year's conference: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
2023 marked a year of great progress for Agios & we're thrilled to announce anticipated 2024 milestones across our #raredisease portfolio. We're looking forward to sharing more at #jpm24 on 1/10. A webcast will be available during & following the event. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Another year, another #jpm24! Our recent topline data readout from the ENERGIZE Phase 3 trial kicks off a catalyst-rich period for Agios. Read more about what our CEO Brian Goff will be presenting at this year's conference: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
The Phase 3 ENERGIZE study in non-transfusion-dependent (NTD) #thalassemia hit its primary endpoint of hemoglobin response! Join our investor webcast at 8 a.m. ET for more on why this announcement is exciting for patients and the #raredisease community: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
In this episode of Cheat Codes, we speak with sickle cell warrior Ayana Johnson. Ayana is also Miss Teen Virginia ‘22, a teen ambassador of the @SCDAAorg, and founder of Ay’s Hope Cells. Listen as she discusses her journey with #sicklecelldisease: www.bloodstreammedia.com/cheat-codes-episodes/sickle-cell…
-
Agios
@AgiosPharma
Following a year of significant progress, it's time for a short break. We're using the last week of 2023 to relax and reset for an exciting year ahead. #happyholidays and see you in 2024!
-
Agios
@AgiosPharma
Check out the latest version of our ThalassemiaNews newsletter! In this edition, we highlighted The International Hemoglobinopathy Research Network (INHERENT) and discussed the value of patient registries and research networks in thalassemia. www.agios.com/wp-content/uploads/2023/12/THA_ALL-0090_THA…
-
Agios
@AgiosPharma
Over 350 unused Agios laptops were restored & donated to the Hendricks Foundation, a non-profit that helps bridge the digital divide & reduce e-waste by providing repaired & updated technology to children in their education. Read more about the org here: hendricks-foundation.org
-
Agios
@AgiosPharma
We're proud to sponsor @EMJReviews Hematology's recent interview with Drs. Rachael Grace and Julián Sevillal, who shared about the complications and range of severities experienced by children with #pyruvatekinasedeficiency. (1/2)
Agios
@AgiosPharma
The article discusses diagnosis management & investigational therapies in development, including our ongoing Phase 3 pediatric trial. Thanks to Agioi Patrick Tyler, Erin Laflam, & Rebecca McCracken for their help in bringing this article to fruition.
www.emjreviews.com/hematology/journal/emj-hematology-11-s… (2/2) -
Agios
@AgiosPharma
On this episode of Just Listen, Dr. Grace speaks with Carl Lander about how The Peak Registry seeks to help doctors and researchers better understand #pkdeficiency by assessing information on how patients are affected. podcasts.apple.com/us/podcast/peak-registry/id1595962009?…
-
Agios
@AgiosPharma
Our team left #ash2023 feeling inspired. What an incredible time joining together with the #hematology community and sharing abstracts of our own regarding our contributions and latest developments in #sicklecelldisease, #thalassemia and #pkdeficiency. Check out highlights below!
-
Agios
@AgiosPharma
We're participating in an industry theater session today at #ash23 for a collaborative discussion on the progress of our RISE UP Phase 2/3 clinical trial in #sicklecell disease. We're looking forward to having #sicklecellwarrior Golie join us! ash.confex.com/ash/2023/webprogram/Session25062.html
-
Agios
@AgiosPharma
We're pleased to share results from the Phase 2 portion of the global RISE UP study in #sicklecell disease. In this blind, placebo-controlled study, treatment demonstrated a statistically significant increase in hemoglobin response rate compared to placebo. (1/2)
Agios
@AgiosPharma
We are proud of our progress and look forward to building on these data through the Phase 3 portion of RISE UP. #ash23 Read the full announcement here: investor.agios.com/news-releases/news-release-details/agi… (2/2)
-
Agios
@AgiosPharma
As we inch toward one of #hematology's largest annual events, check out this video of our CMO and head of R&D as she touches on our #ash23 highlights, including data from the Phase 2 portion of the RISE UP study in #sicklecelldisease. www.agios.com/ash-2023/
-
Agios
@AgiosPharma
It's beginning to look a lot like #ash23! We're excited to present the latest on our efforts in #hematology, patient advocacy & more. Be sure to stop by booth #133 outside of our presentations and say hi! Learn all things Agios + ASH on our microsite here: www.agios.com/ash-2023/
-
Agios
@AgiosPharma
Agioi had a great time wrapping gifts for children in need as part of our annual Giving Tree efforts. We packaged a variety of presents & delivered them to families with life-threatening/life-limiting illnesses. We're proud to support @caringfchildren through these efforts. (1/2)
Agios
@AgiosPharma
Read about the organization and more ways to support here: frankccc.com (2/2)
-
Agios
@AgiosPharma
It's International PKD Day, dedicated to raising awareness of the needs & experiences of those with #pkdeficiency. See below as #patientadvocate Jill and President of @TwPKDnonprofit Tamara discuss the importance of sharing relationships with others in the PKD community. (1/2)
Agios
@AgiosPharma
Thank you to @2021PKDF and @TwPKDnonprofit, two nonprofits dedicated to serving patients and families living with PKD, for organizing this awareness day and working toward a brighter future for patients. Read more about it here: thrivewithpkd.org/international-pyruvate-kinase-deficiency/ (2/2)
-
Agios
@AgiosPharma
We're pleased to be recognized as one of the @BostonGlobe's Top Places to Work. We care deeply about our work and the people who count on us. This deep sense of caring enables us to do meaningful work for those with #rarediseases. See the full list here: www.bostonglobe.com/2023/11/29/magazine/top-large-compani…
-
Agios
@AgiosPharma
On this replay episode of the Thal Pals podcast, Dr. Kevin Kuo and Laurice Levine talk to the “mother of thalassemia” Dr. Nica Cappellini. They dive into her journey and how it has impacted our understanding of #thalassemia. Tune in here: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
We're excited to share positive clinical proof-of-concept has been achieved in the Phase 2a study of our investigational pyruvate kinase (PK) activator, AG-946, as a potential treatment for #anemia in adults with lower-risk myelodysplastic syndromes (LR-#mds). (1/2)
Agios
@AgiosPharma
Thank you to the patients who participated in this trial, our partners, study investigators and advisors in the patient and clinical communities for their partnership. We look forward to advancing the clinical program to Phase 2b. Read more: investor.agios.com/news-releases/news-release-details/agi… (2/2)
-
Agios
@AgiosPharma
On the latest episode of the Just Listen podcast, Dr. Grace welcomes Claire Egan, Sr. Genetic Counselor with InformedDNA to better understand the role of #genetic testing in #pyruvatekinasedeficiency. Listen to the episode here: podcasts.apple.com/us/podcast/genetics-in-pyruvate-kinase…
-
Agios
@AgiosPharma
Professor and #hematologist Clarisse Lobo and Dr. Kleber Fertrin are back in this episode of Cheat Codes! Both are passionate about #sicklecell care and research. Listen as they share their experience in both English and their native Portuguese. www.bloodstreammedia.com/cheat-codes-episodes/replay-inte…
-
Agios
@AgiosPharma
We had a wonderful time at the 2023 @thalassaemiaTIF International Conference in Malaysia presenting & networking with others in the #thalassemia space. We're grateful to come together to talk about the future of treatment. Check out some snapshots of our time at #tif2023 below.
-
Agios
@AgiosPharma
We are thrilled to be named one of @BioSpace's 2024 Best Places to Work. This list ranks the top life science employers in North America, and we are honored to be included among so many other wonderful companies. Check out the full list at www.biospace.com/best-places-to-work/
-
Agios
@AgiosPharma
We recently asked a few of our #sicklecellwarriors, advocates and community members to share what they #riseup for. This community of #warriors inspires us daily with their resilience, strength and determination. Check out their responses in the images below.
-
Agios
@AgiosPharma
We're presenting at the @thalassaemiaTIF Conference! Our oral presentation will focus on healthcare resource use for patients w/ alpha- & beta-thalassemia and our poster presentation will focus on health literacy in #thalassemia. Read more about #tif2023: tif2023.org
-
Agios
@AgiosPharma
We're excited to attend and present at the @thalassaemiaTIF International Conference in Malaysia alongside others in the #thalassemia space. Come visit us at Booth 5, and find more information about the conference here: tif2023.org #tif2023
-
Agios
@AgiosPharma
We're attending the 2023 @ASH_hematology 65th Annual Meeting and presenting a number of abstracts on our work in #sicklecelldisease, #thalassemia, #pkdeficiency, patient advocacy, and more. See our full list of presentations here: investor.agios.com/news-releases/news-release-details/agi… #ash2023
-
Agios
@AgiosPharma
Today, we reported our Q3 2023 business highlights and financial results. Tune into the live webcast this morning at 8 a.m. ET or watch the replay on our website in the Events & Presentations page. Read the press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We had a great time participating in the @MDSFoundation community walk fundraiser to drive awareness & accelerate research in the fight against myelodysplastic syndromes (#mds). The foundation held a total of 5 walks across the U.S. Learn more: www.mds-foundation.org #moveformds
-
Agios
@AgiosPharma
We are proud to share the founding of our new LatinX Employee Resource Group. Headed by our CFO Cecilia Jones, a native of Argentina, the group is a celebration of shared LatinX background, intended to create a network of support & visibility for our #latinx teammates.
-
Agios
@AgiosPharma
Our Senior Medical Director will be attending the @abhhoficial 2023 Brazilian Congress of Hematology, Hemotherapy and Cell Therapy (HEMO). We're looking forward to having a presence and connecting with some of the best in #hematology. Learn more here: www.hemo.org.br
-
Agios
@AgiosPharma
We're excited to have a number of presenters at the 18th Sickle Cell & Thalassaemia Conference (ASCAT), hosted by @EHA_Hematology, @BritSocHaem, and Annual Academy of Sickle Cell and Thalassaemia Conference. Learn about our speakers and the conference at ehaweb.org/meetings/ascat-2023/
-
Agios
@AgiosPharma
.@thalassaemiaTIF Executive Director Dr. Androulla Eleftheriou and author, Dr. Khaled Musallam are on the latest Thal Pals episode to discuss the new guidelines on non-transfusion dependent #betathalassemia. Listen in here: podcasts.apple.com/us/podcast/thalassaemia-international-…
-
Agios
@AgiosPharma
We had a wonderful time at the 2023 @RareDiseases & Orphan Products Breakthrough Summit. We enjoyed connecting and networking with other #raredisease advocates, experts, and stakeholders from across the globe. (1/2)
Agios
@AgiosPharma
We're proud that our patient vision project received recognition as a top poster/lighting round oral presentation, presented by patient advocate Rucha Shah. Check out a snapshot of Rucha's presentation and our team below. #nordsummit (2/2)
-
Agios
@AgiosPharma
We're proud to share that our RISE UP presentation won Oral Presentation of the Year at the @SCDAAorg 51st Annual National Convention. We're inspired by our wonderful patient advocates for their dedication to the #sicklecell community. Check out our presentation team below!
-
Agios
@AgiosPharma
We're reporting our Q3 2023 business highlights and financial results on Nov. 2, 2023 at 8 a.m. ET. A live webcast can be viewed under “Events & Presentations” in the Investors section of our website, or you can access a replay following the presentation. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our CEO Brian Goff provided opening remarks at a special event at the @SCDAAorg 51st National Convention honoring Hertz Nazaire, a powerful voice for the #sicklecell community. The event recognized Hertz and featured his work at an "in memoriam" art exhibit. (1/2)
Agios
@AgiosPharma
We're honored to play a role in remembering the life of Hertz. Take a moment to appreciate a snapshot of his work below. (2/2)
-
Agios
@AgiosPharma
We're sponsoring the @cooleysanemia Care Walk, a fundraising event for those living with #thalassemia. We also hosted our own walk, where Agioi enthusiastically supported the event. Learn how you can donate here: fundraising.thalassemia.org/fundraiser/4964283
-
Agios
@AgiosPharma
Flexibility is a core pillar of our culture, which means many colleagues are remote or hybrid. Moments where we can all be together are a cause for celebration, like our recent Fall Gathering. Nearly 350 Agioi gathered to celebrate our recent successes. Check out the event below.
-
Agios
@AgiosPharma
Listen to a replay of one of our most popular Just Listen podcast episodes! In this episode, Dr. Grace and patient advocate and #pkdeficiency TikTok influencer Karla dispel some of the biggest myths surrounding #pkdeficiency. pod.link/justlistenvoicesofpkd/episode/5c8e73abf76569a1af…
-
Agios
@AgiosPharma
Our Chief Commercial Officer Tsveta Milanova is speaking at the @LifeSciEvents 2023 Fierce New Products Planning Summit on October 17. Learn more about her speaking session and register for the summit here: www.newproductplanning.com
-
Agios
@AgiosPharma
We're excited to sponsor the @RareDiseases & Orphan Products Breakthrough Summit. The event brings together #raredisease advocates, experts & stakeholders to tackle the most pressing issues facing the community. Learn more here: nordsummit.org #nordsummit
-
Agios
@AgiosPharma
We believe in an evidence-based patient advocacy approach that gathers meaningful & actionable insights in partnership w/ the #sicklecell community. At the @SCDAAorg convention, 3 #warriors are presenting on warrior/KOL/industry collaborations. #scdaa2023 www.sicklecelldisease.org/get-involved/events/annual-nati…
-
Agios
@AgiosPharma
Our Head of R&D and CMO is speaking at the @SCDAAorg 51st Annual National Convention. We’re excited to share more about our clinical program #sicklecelldisease with the community! Learn more about #scdaa2023 here: www.sicklecelldisease.org/get-involved/events/annual-nati…
-
Agios
@AgiosPharma
We're excited to sponsor the @SCDAAorg 51st Annual National Convention held in Arlington, Virginia. This impactful event fosters the exchange of the latest scientific & clinical information related to #sicklecelldisease. Learn more & register here: www.sicklecelldisease.org/get-involved/events/annual-nati…
-
Agios
@AgiosPharma
Our Head of Global Scientific Communications and Publications, Global Medical Affairs Rebecca McCracken is speaking at the #masswest conference in San Diego on Friday, October 6. Learn more & register for the event here: www.mass-west.com/masswestcom/register
-
Agios
@AgiosPharma
Thank you to all who joined us in partnering with @SCCConsortium and the @AsOneFoundation for #sicklecelldiseaseawarenessmonth in support of their Back to School Fundraiser for students living with #sicklecelldisease in need of school supplies. (1/2)
Agios
@AgiosPharma
All donations will go toward supplies to ensure that #warriors are set up for success this school year. Learn how you can donate using the links below.
Direct donation: kindest.com/245664-sickle-cell-health-on-our-level OR kindest.com/245664-sickle-cell-health-on-our-level
Amazon wish list: www.amazon.com/hz/wishlist/ls/1ARB4TMIRE57S
(2/2) -
Agios
@AgiosPharma
As we near the end of #sicklecelldiseaseawarenessmonth, we continue to honor the unique gifts that #sicklecellwarriors bring to the world every day. To our #sicklecell community, share your own #scdgiftsfortheworld in the comments below!
-
Agios
@AgiosPharma
The latest issue of ThalassemiaNEWS is out. Read about the new @thalassaemiaTIF Guidelines for the Management of Non-transfusion Dependent β-thalassaemia, as well as new #thalassemia community resources and a clinical trials update. www.agios.com/wp-content/uploads/2023/09/THA-ALL-0069_Tha…
-
Agios
@AgiosPharma
We had a great time attending and sponsoring the @CayenneWellness 15th Annual Sickle Cell Disease Educational Summit, learning more about #sicklecelldisease and connecting with the community. Check out the photos below. #sicklecelldiseaseawarenessmonth
-
Agios
@AgiosPharma
Warriors, we have a special episode of the Cheat Codes podcast during #sicklecell Awareness Month with Ms. Regina Hartfield, President & CEO of the @SCDAAorg. Listen here: www.bloodstreammedia.com/cheat-codes-episodes/regina-hart…
-
Agios
@AgiosPharma
We're proud to share that our VP, U.S. Sales and Marketing William Lumpkin has been named one of the 2023 Top 25 Healthcare Technology Leaders of Houston by The Healthcare Technology Report. We're honored to have him on our team! Congrats to all honorees: thehealthcaretechnologyreport.com/the-top-25-healthcare-t…
-
Agios
@AgiosPharma
At our Agios Connect event earlier this year, we asked Agioi to answer the question, “What does it mean to you to be a patient ally?” Their answers resulted in a meaningful visual representation of how we live out patient allyship at Agios. vimeo.com/826948062?share=copy
-
Agios
@AgiosPharma
A few Agioi participated in the @SCDAAorg Walk in Detroit earlier this month. During #sicklecelldiseaseawarenessmonth and every day, we're committed to supporting organizations that amplify & uplift the voices of those with #sicklecelldisease. www.sicklecelldisease.org
-
Agios
@AgiosPharma
This #sicklecelldiseaseawarenessmonth, celebrate the unique gifts that #sicklecellwarriors bring to the world. Let these resilient #warriors and their gifts inspire you to share and embrace your own #scdgiftsfortheworld.
-
Agios
@AgiosPharma
We're grateful that PYRUKYND® (mitapivat) was named a finalist for the 2023 #biotechweekboston Awards in the Transformational Therapy category. We're proud of the positive impact PYRUKYND is having for #raredisease patients. Congrats to all the nominees! informaconnect.com/bwb-awards/awards/
-
Agios
@AgiosPharma
Join us in congratulating our Head of R&D and CMO Sarah Gheuens being named one of this year’s @PharmaVoice 100! Sarah is an invaluable leader on our team, and we're so proud to work with her daily. Congrats to Sarah and all on this year’s list. www.pharmavoice.com/news/pharmavoice100-pv100-pharma-lead…
-
Agios
@AgiosPharma
September is #sicklecelldiseaseawarenessmonth. This important month dispels myths and stigmas, and brings attention to the ongoing need for research, better care, and new treatments for those living with #sicklecelldisease. Learn more about the disease below.
-
Agios
@AgiosPharma
We're thrilled to have two Agioi presenting at the @CayenneWellness 15th Annual #sicklecelldisease Educational Summit; Amber Yates, MD & Ahmar Urooj Zaidi, MD. If you're attending, stop by our booth to learn about our RISE UP clinical trials. Read more: cayennewellness.org/2023-scd-educational-summit/
-
Agios
@AgiosPharma
Our VP, Head of Medical Affairs had the honor of judging for this year’s @InformaConnect BWB Awards in the Boston Innovation and Highlights categories. We're looking forward to 9/18 to hear the winners of each category. Learn more about the awards here: informaconnect.com/bwb-awards/
-
Agios
@AgiosPharma
We're a proud sponsor of the @CayenneWellness 15th Annual Sickle Cell Disease Educational Summit. This event delves into the multi-factorial aspects of #sicklecelldisease and #sicklecell trait awareness and education. #sicklecelldiseaseawarenessmonth cayennewellness.org/2023-scd-educational-summit/
-
Agios
@AgiosPharma
While #sicklecellwarriors live with #sicklecelldisease, one of the world's most common genetic disorders, they are not defined by the disease itself. Hear from warriors below as they share their special gifts and share your own #scdgiftsfortheworld!
-
Agios
@AgiosPharma
We're partnering with the @SCCConsortium and the @AsOneFoundation for #sicklecelldiseaseawarenessmonth in support of their Back to School Fundraiser. Each year, many students living with #sicklecelldisease are in need of school supplies.
Agios
@AgiosPharma
By sending #sicklecellwarriors & their loved ones to school with the right tools, we help them succeed and give their caregivers one less thing to worry about. All proceeds donated will go toward school supplies to ensure that Warriors are prepared for the new school year.
Agios
@AgiosPharma
Check out the links below to donate today.
Direct donation: kindest.com/245664-sickle-cell-health-on-our-level OR kindest.com/245664-sickle-cell-health-on-our-level
Amazon wish list: www.amazon.com/hz/wishlist/ls/1ARB4TMIRE57S -
Agios
@AgiosPharma
On this episode of the Cheat Codes podcast, Dr. Z and Dr. C talk to a panel of #sicklecellwarriors who were part of the RISE UP campaign, which was directed by the warriors to educate the community about our Phase 2 & 3 #sicklecelldisease trial. pod.link/1488189351
-
Agios
@AgiosPharma
Congratulations to Dr. Hadiyah Audil, hematology/oncology specialist at @MayoClinic & recipient of the Agios Hemolytic Anemia Clinical Fellowship Grant! Her research is focused on characterizing myelodysplastic syndromes (#mds) patients w/ associated non-immune hemolytic anemia.
-
Agios
@AgiosPharma
In honor of #sicklecelldiseaseawarenessmonth, we asked #sicklecellwarriors to share the unique gifts they bring to the world alongside their strength living with #sicklecelldisease. Tune into the video below to meet our first few warriors, and share your own #scdgiftsfortheworld!
-
Agios
@AgiosPharma
Life with thalassemia has unique challenges, even more so for teenagers! This week's Thal Pals podcast episode welcomes a panel of teens living with #thalassemia. A lively, informative conversation for all ages, this is one you don’t want to miss! pod.link/1639436269
-
Agios
@AgiosPharma
We're committed to uplifting the #patientvoice. Meet Ryan, a patient advocate living with #thalassemia. Ryan shares his lifelong journey navigating his condition, why a strong network of support is critical for him, and more here: vimeo.com/702891906
-
Agios
@AgiosPharma
We will be presenting at the @MorganStanley 21st Annual Global Healthcare Conference. A live webcast of the presentation will be accessible in the Investors section at agios.com & will be archived there following the presentation. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our offices will be closed and our employees will be offline August 28 to September 1, enjoying our annual #summershutdown. We're grateful to have such a dedicated team, and thank them for their hard work each and every day!
-
Agios
@AgiosPharma
On this episode of Just Listen, Dr. Rachael Grace and Dr. Sujit Sheth discuss iron overload and why it occurs in #pkdeficiency. Dr. Sujit Sheth explains the potential complications as well as the importance of managing and monitoring iron overload.
www.bloodstreammedia.com/just-listen-voices-of-pk-deficie… -
Agios
@AgiosPharma
We're proud to sponsor the 2023 @SickCells Coverage for SCD Summit, occurring virtually on 8/24. This annual event offers a collaborative space to discuss the changing landscape of healthcare coverage for #sicklecelldisease. Learn more & register at sickcells.org/coverage-for-scd-summit/2023-coverage-for-s…
-
Agios
@AgiosPharma
Dr. Parija Patel will be participating in an upcoming @WESTorg panel on #medicalaffairs career paths within the #biotech industry. She plans to share details about her role on our team in hopes to help those in search of their dream career. Learn more: www.westorg.org/2023-08-24-career-possibilities-medical-a…
-
Agios
@AgiosPharma
Join us in congratulating our Director, Patient Advocacy Janie Young Davis on receiving the @PLAN4Success Community Award for her unwavering dedication to the growth and empowerment of underserved youth. Learn more about the foundation here: www.plan-4success.org
-
Agios
@AgiosPharma
We're hiring! We have a number of open positions, both remote and in person. To learn more about how you can become a member of the growing Agios team and work to advance treatments for #rarediseases, see our open roles: phe.tbe.taleo.net/phe03/ats/careers/v2/jobSearch?act=redi…
-
Agios
@AgiosPharma
This month's episode of Cheat Codes features Dr. Carolyn Rowley and Elle Cole sharing their mission to increase the quality of life for individuals diagnosed with #sicklecelldisease in California by ensuring expert, unbiased, and comprehensive care. pod.link/1488189351
-
Agios
@AgiosPharma
We’re advancing potential medicines for diseases with no or limited approved treatments. Everything we do stems from our goal to meet unmet needs, offer hope & ultimately change lives. Hear more about what fuels us from CEO Brian Goff and thalassemia patient advocate Laurice.
-
Agios
@AgiosPharma
Building true partnerships with patient communities is a cornerstone of our approach. We asked Agioi to answer the question, “What does it mean to be a patient ally?” Their answers resulted in the mural below, a visual representation of how we live out patient allyship at Agios.
-
Agios
@AgiosPharma
On this episode of Thal Pals, host Dr. Kevin Kuo sits down with Professor Vip Viprakasit, one of the world's authorities in non-transfusion-dependent #thalassemia and alpha-thalassemia. A special portion of the episode will be in Thai for Thai listeners. pod.link/1639436269
-
Agios
@AgiosPharma
Meet Nathan, an Agios patient advocate who was diagnosed with #pkdeficiency at a young age and has been navigating the realities of this rare blood disease his whole life. We're proud to work with inspiring individuals like Nathan. #fueledbyconnections www.youtube.com/watch?v=V_Qhnc5FE6g
-
Agios
@AgiosPharma
We reported our Q2 2023 business highlights and financial results today. Watch the replay of our webcast from this morning on our website in the Events & Presentations section. Read the press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We're thrilled to announce an exclusive worldwide agreement w/ #rnai pioneers @Alnylam and add to our pipeline a novel preclinical siRNA targeting TMPRSS6 as a potential disease-modifying treatment for patients w/ #polycythemiavera. Read the press release: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Join us for an episode of Just Listen: Voices of PK Deficiency in which Dr. Grace and Dolores Dumas, living with #pkdeficiency, discuss the importance of self-advocacy throughout the diagnostic journey. Tune in here: www.bloodstreammedia.com/just-listen-voices-of-pk-deficiency
-
Agios
@AgiosPharma
We believe in being a good neighbor to our communities by helping to meet the fundamental needs around us, promoting health & science, supporting people living w/ rare diseases and advancing opportunities for all. Learn more about our commitment below.
-
Agios
@AgiosPharma
Patients living with #thalassemia, #pyruvatekinasedeficiency & #sicklecelldisease face a unique set of challenges in their daily lives. Listen as patients and physicians share a glimpse into a "day in the life" of those living with these chronic diseases. vimeo.com/820971889/fe7c94df12?share=copy
-
Agios
@AgiosPharma
Our Sr. Director, Patient Advocacy Holly John & our Sr. Director, Legal Andrea Eichman presented last week at the 3rd Annual Chief Patient Officer Summit in Boston, on the importance of collaboration between advocacy & compliance. Learn more: dgevents.com/event/chief-patient-officer-summit/ #cposummit
-
Agios
@AgiosPharma
We're pleased to share that we are sponsors of @TheBloodProjec1, a nonprofit, educational website for physicians & physicians-in-training dedicated to communicating the vital role of blood in health & disease. Learn more & find educational resources here: www.thebloodproject.com
-
Agios
@AgiosPharma
We're pleased to share that PYRUKYND® (mitapivat) was named a finalist for the 2023 #biotech Week Boston Awards in the Transformational Therapy category. Thanks to our CMO Sarah Gheuens, M.D., Ph.D., for championing the effort. Congrats to all finalists! informaconnect.com/bwb-awards/awards/
-
Agios
@AgiosPharma
Our goal is to find treatments & build connections with patients who have long felt isolated. We strive to be a voice and a source of hope for those living with chronic diseases. Hear from Laurice, living w/ #thalassemia, and Agios CEO Brian Goff to learn more.
-
Agios
@AgiosPharma
On this episode of Thal Pals: The Alpha Beta Revolution Podcast, host Laurice Levine sits down with news producer and #thalassemia patient NinaMaria Badalamenti to discuss working a full-time job while managing her disease. Listen to the episode here: pod.link/1639436269
-
Agios
@AgiosPharma
Our goal is to find effective treatments for genetically defined diseases worldwide. We recently announced data for our global RISE UP study in #sicklecelldisease. Here's a glimpse from our RISE UP site initiation visit in Nigeria. We're thankful for our global community!
-
Agios
@AgiosPharma
We're excited to attend the @SCCConsortium's 10th Annual Warriors Convention, July 18-23 in Houston. This event is a great opportunity to engage w/ the #sicklecell community, share advances in treatment & celebrate #sicklecellexcellence. Learn more here: www.sicklecellconvention.org
-
Agios
@AgiosPharma
Our "Patient Wall" features friends and family impacted by rare diseases and cancer. Building bonds and cultivating relationships are at the heart of our ability to create life-changing therapies for people with #rarediseases, (1/2)
Angelos Georgakis
@angelosgeo
Biotech Leaders, Stay Close to the Patients—Ideas for Inspiration
This is the Patient Wall at Agios Pharmaceuticals, adorned with the faces of people that Agios has helped throughout the years.
It serves as a reminder to everyone at the company that their work affects and saves real lives.
I discovered Agios' Patient Wall through Peter Smith's blog post on @LifeSciVC's website.
Peter and the team at Remix Therapeutics have created their own Patient Wall:
"Charles Kung, who has been at Agios for many years told @AlexHarding7 about the Patient Wall at Agios and how it inspired the company.
We loved that idea and decided to add our own electronic version, a big screen TV with photos of family and friends of Remix employees at our entrance that reminds us each day we are showing up to work to help patients.
It has become an important part of our culture for new employees to add photos; we get to know them better and remember we are all touched by disease in some way and our work has REAL meaning." — @petergsmith, CEO at Remix Therapeutics
During an interview with the @bios_community, Chris Gibson said,
"Here's the best advice I've ever gotten. When it's hard, go find a patient. Because when you're sick, all that matters is being healthy. It can reinstill all of the passion, energy and motivation. Keep yourself close to the patient." — @RecursionChris, CEO at Recursion
And everyone should stay close to the patients, not just the founders/CEOs:
"To build passion in the workplace, the former CEO of Novo Nordisk, Lans Sorensen had ALL the employees meet with patients and understand what their lives were like and how the company's products were transformative..."
Everyone in the biotech community, including the person writing this...we're into this because we want our lives to have made an impact on human health and patients.
But because the daily grind can easily consume us, a 5min conscious and deliberate weekly habit such as reflecting on our why, standing by the patient wall, talking to a patient, concluding a weekly team meeting with a reminder of our shared vision... can give access to hidden reservoirs of energy and motivation in both good and tough days...
Loving you, Angelos.
Agios
@AgiosPharma
and this wall serves as a reminder of the connections we have with patients which inspire us daily. We’re proud to see such a powerful legacy of patient commitment across a number of biotech companies. (2/2)
-
Agios
@AgiosPharma
We are reporting our Q2 2023 business highlights and financial results on August 3, 2023 at 8am ET. A live webcast can be viewed under “Events & Presentations” in the Investors section of our website, or you can access a replay following the presentation. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
What does it mean when a parent has pyruvate kinase (PK) deficiency? On today’s episode, Nathan Thompson discusses parenting with PK deficiency and all of the challenges associated with it alongside his daughter, Zoe. www.justlistenpod.com #pkdeficiency
-
Agios
@AgiosPharma
We're fueled by our commitment to finding life-changing innovations for patients. As a result, we challenge ourselves and our teammates every day. Explore how we blaze new trails and get to know all our values here: www.agios.com/about-us/values
-
Agios
@AgiosPharma
During our Agios Connect event, we asked patients & doctors questions during a panel discussion on #thalassemia, #pkdeficiency & #sicklecelldisease, and used their words to create a mural representing a "day in the life" of those living with these diseases. Check it out below.
-
Agios
@AgiosPharma
We're excited to sponsor this year's @cooleysanemia Foundation Patient Meeting being held on July 7-9 in Los Angeles. We're looking forward to engaging w/ the #thalassemia community & recording a live episode of the #thalpals podcast. Learn more here: web.cvent.com/event/a9799f99-cf53-4e67-851f-3fcd39c1e02b/…
-
Agios
@AgiosPharma
In honor of #independenceday, our offices are closed today and tomorrow. We wish all of you a safe holiday with friends and family.
-
Agios
@AgiosPharma
Listen to our CEO Brian Goff on the newest episode of @bradloncar's @BiotechTVHQ, as he shares details on our exciting and recently announced positive data from our Phase 2 study in #sicklecelldisease. Thanks for having us on the show!
BiotechTV
@BiotechTV
Agios Pharma had sickle cell disease data this morning for an oral pill it is developing. CEO Brian Goff describes how he sees it fitting into the competitive landscape. Full video: www.biotechtv.com/post/brian-goff-june-26-2023
-
Agios
@AgiosPharma
In this episode of Cheat Codes: A Sickle Cell Podcast, Dr. Z and Dr. C host a discussion about reproductive health and #sicklecelldisease, featuring warrior advocates Teonna Woolford, Cassandra Trimnell, and Rae Blaylark. Tune in here: pod.link/1488189351
-
Agios
@AgiosPharma
For #pridemonth2023, we've held various internal events to recognize the LGBTQIA+ community & further educate our team on #diversity & #inclusion, including hosting a virtual speaker/member of the LGBTQIA+ community who presented on creating inclusive workplaces & allyship. (1/2)
Agios
@AgiosPharma
We also shared wine from LGBTQIA+ winemakers, rainbow snacks, educational information on the history and significance of Pride Month and Pride-themed swag. We're proud supporters of this community and are committed to continuing to lift up its members. (2/2)
-
Agios
@AgiosPharma
At Agios, we’re motivated by the opportunity to change people’s lives for the better. Meet Jim, a patient advocate living w/ #pkdeficiency. At Agios, we're proud to work toward improving the lives of people like Jim. www.pyrukynd.com/support-and-resources/pyrukynd-stories/
-
Agios
@AgiosPharma
At Agios, we're guided by the voices of our #raredisease patients in all that we do. In the video below, hear from Laurice, living w/ #thalassemia, our CEO Brian Goff, & other Agioi – on how our mission builds hope for the future. #fueledbyconnections vimeo.com/822083970?share=copy
-
Agios
@AgiosPharma
Last week, we honored #worldsicklecellday. We're committed to being a #patientally for the sickle cell community. Hear from #sicklecellwarriors & physicians about what it means to them to be a patient ally. We're honored to elevate the voices of this resilient community each day.
-
Agios
@AgiosPharma
Following our Phase 2 update for our global RISE UP clinical trial, we'd like to thank the #sicklecell community. We appreciate your dedication & support in reaching this milestone. This is just the beginning in making a difference for those living with #sicklecelldisease.
-
Agios
@AgiosPharma
We're proud to announce the Phase 2 portion of the global RISE UP study in #sicklecelldisease met its primary endpoint of hemoglobin response. These results support proceeding with Phase 3. Read more about this exciting progression for patients here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
On today’s episode, we discuss navigating life and aging with #pyruvatekinasedeficiency with returning guests Jill Welle and Tamara Schryver. Listen here: pod.link/justlistenvoicesofpkd
-
Agios
@AgiosPharma
We recently hosted our first live patient education program, bringing together people w/ PK deficiency & their caregivers to learn & connect with one another. For many patients, this was their first time meeting others living with #pkdeficiency. Get a glimpse of the event below.
-
Agios
@AgiosPharma
We're excited to have sponsored the @CayenneWellness 4th Annual Virtual 24-Hour #worldsicklecellday Event on Monday, June 19. The global #sicklecell community connected through educational activities, resources, advocacy sessions & more! Learn more here: cayennewellness.org/fourth-annual-virtual-24-hour-world-s…
-
Agios
@AgiosPharma
In honor of #worldsicklecellday yesterday, get a glimpse into a day in the life of #sicklecellwarrior Luzibu – her pain, her fatigue, her tears. Individuals like Luzibu inspire us every day to raise the bar. Step into her shoes in the video below.
-
Agios
@AgiosPharma
Today on #worldsicklecellday, and every day, we strive to be #patientallies to the resilient and inspiring community of #sicklecellwarriors. We’re motivated by their stories and our mission to raise the bar. Warriors, we stand with you!
-
Agios
@AgiosPharma
Today, we commemorate #juneteenth. To recognize the significance of this day in our nation's history, our offices are closed today. #freedomday
-
Agios
@AgiosPharma
On this episode of Thal Pals, host Laurice Levine speaks with patient advocates Ralph Colasanti, Rucha Shah, and NinaMaria Badalamenti about how different generations of patients have dealt with managing their #thalassemia. Listen here: pod.link/1639436269
-
Agios
@AgiosPharma
Leading up to #worldsicklecellday, we're highlighting #sicklecelldisease warriors in our #connectionsaroundtheworld video series. Listen as Ulysse, living with sickle cell disease in Canada, shares the impact of connection with other patients. vimeo.com/742257761
-
Agios
@AgiosPharma
The #sicklecellwarrior community is ready for FSCDR. Visit us at booth 12.
-
Agios
@AgiosPharma
Every voice has value. We're driven to increase diversity in our industry and improve health equity by bettering representative diversity in healthcare. Take a look at some of the community initiatives we have in place and read more here: www.agios.com/wp-content/uploads/2023/03/2023-Agios-ESG-R…
-
Agios
@AgiosPharma
We’re committed to continuing to advance understanding of our approved medicine and its potential impact on people with #rarediseases. At #eha2023, we’re presenting a number of posters highlighting the real-world applicability of our approved PK deficiency treatment.
-
Agios
@AgiosPharma
Watch below as our Chief Medical Officer and Head of R&D Sarah Gheuens talks all things @EHA_Hematology Congress 2023. We're looking forward to seeing familiar faces and making new connections. vimeo.com/833689242
Agios
@AgiosPharma
We'll be sharing a number of presentations at #eha2023congress, all of which are detailed here: www.agios.com/eha-2023/
-
Agios
@AgiosPharma
We’re excited to attend @EHA_Hematology Congress and engage with so many others seeking to advance research & care for people with blood disorders. Find out more about the research we’re presenting and how to connect with us at the event. www.agios.com/eha-2023/ #eha2023congress
-
Agios
@AgiosPharma
We're proud to share that two Agioi are speaking at the 17th Annual @FundSickleCell and Educational Symposium and 46th Annual Sickle Cell Disease Scientific Meeting in Fort Lauderdale, FL. See details and read more about the event here: fscdr0623.eventscribe.net
-
Agios
@AgiosPharma
We’re excited to announce the launch of our new Agios Medical Twitter account for U.S. HCPs! If you’re a healthcare provider based in the U.S., please follow along for updates on our latest hemolytic anemia research and resources. x.com/agiosmedical
-
Agios
@AgiosPharma
In this episode, Dr. Z & Dr. C speak with Professor Clarisse Lobo & Dr. Kleber Fertrin about their experience with #sicklecelldisease in Brazil before turning to Professor Lobo & Dr. Fertrin who speak to the Brazilian community in their native language. pod.link/1488189351
-
Agios
@AgiosPharma
In the days leading up to World Sickle Cell Day, we want to highlight #sicklecelldisease warrior Loury, living in the U.K. Hear her share what the #sicklecell community means to her in the video below. #worldsicklecellday vimeo.com/754288521
-
Agios
@AgiosPharma
Happy 2023 #pridemonth from all of us at Agios! We are proud allies of the LGBTQIA+ community and strive to make those communities feel welcome, accepted and heard every day. We recognize you this month and all year long.
-
Agios
@AgiosPharma
These data are transformational for patients facing a progressive, life-threatening disease. We're proud of our early contributions to the development of this potential new treatment & congratulate the Servier team for making key progress in their pivotal Phase 3 INDIGO trial.
Servier Pharmaceuticals
@ServierPharma
Therapeutic progress in the low-grade glioma space has been stagnant for decades. Our latest data results in patients with IDH-mutant low-grade glioma present an opportunity to shift the treatment paradigm for patients living with this malignancy: servier.us/blog/servier-presents-transformational-data-fr…
-
Agios
@AgiosPharma
We will be presenting at the @GoldmanSachs 44th Annual Global Healthcare Conference, June 15 at 11 a.m. ET. A live webcast can be accessed in the Investors section at www.agios.com. A replay will be available after the presentation. Learn more at investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
May is #mentalhealthawarenessmonth. We want to take time to recognize the importance of conversation & action surrounding mental health, both inside and outside the workplace. See below for some highlights of the benefits we offer to support employee #mentalhealth here at Agios.
-
Agios
@AgiosPharma
Happy Memorial Day from all of us at Agios. Today we pause to honor and mourn the U.S. military personnel who lost their lives while serving in the United States armed forces. Thank you for your sacrifice for our country. #memorialday2023
-
Agios
@AgiosPharma
We had a wonderful time engaging with a broad network of stakeholders working together to advance rare disease drug development and access at the @OrphanConf in Washington, D.C. #worldorphanusa
-
Agios
@AgiosPharma
We're pleased that Catherine Owen is joining our board, bringing nearly 30 years’ experience commercializing transformative medicines. John Maraganore, is completing nearly a dozen years on our board, and Kaye Foster will become Lead Independent Director. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We strive to be champions of diversity, celebrating our employees' representative, experiential and cognitive differences – all of which contribute to our team's ongoing success. Learn more about our commitment to supporting diversity here: www.agios.com/wp-content/uploads/2023/03/2023-Agios-ESG-R…
-
Agios
@AgiosPharma
“Thalassemia patients are spread all over the world, so wherever you go, you have friends there.” Hear from Sohaib, living with thalassemia in the United Arab Emirates, on what community means to him. vimeo.com/815682818
-
Agios
@AgiosPharma
We have big goals when it comes to developing treatments for #rarediseases. This is why we encourage each of our team members to bring their whole selves to work and contribute in their own unique ways. Learn below about this value and our others here: www.agios.com/about-us/values/
-
Agios
@AgiosPharma
People with #rarediseases may feel misunderstood or isolated. That’s why our focus at Agios is on building connections and community. We listen to patients with humility and are guided by their voices in all that we do. #fueledbyconnections vimeo.com/822083970?share=copy
-
Agios
@AgiosPharma
We're committed to advancing equitable healthcare for all by listening to and lifting up diverse patient voices and focusing on underserved patient communities. Learn more: www.agios.com/wp-content/uploads/2023/03/2023-Agios-ESG-R…
-
Agios
@AgiosPharma
Our VP, Market Access & Government Affairs David Chapman will be speaking on a panel at the @OrphanConf about commercializing orphan products for rare diseases. We're thrilled to have him representing Agios at this event. Learn more here: www.terrapinn.com/conference/world-orphan-drug-congress-u… #worldorphanusa
-
Agios
@AgiosPharma
Today at the @rbccm Healthcare Conference, we shared that we completed enrollment of our ENERGIZE and ENERGIZE-T Phase 3 studies in thalassemia ahead of schedule. We’re continuing to press forward to advance a new potential treatment option for this community!
-
Agios
@AgiosPharma
The Red Cell Revolution is a new advocacy council funded by Agios and created to bring together hemolytic anemia communities, including #pkdeficiency, #thalassemia & #sicklecelldisease, to raise awareness about the experiences of people touched by these diseases.
-
Agios
@AgiosPharma
This Mother's Day, we'd like to recognize all the inspirational #raredisease mothers and their never ending resilience. Here are just a few of the patient moms and their children that we're honored to know and partner with. #mothersday2023
-
Agios
@AgiosPharma
We're looking forward to engaging with the hematology community and presenting a number of abstracts at the @EHA_Hematology Hybrid Congress, hosted virtually & in person in Frankfurt, Germany, on June 8-11. Read more about the data we're presenting: investor.agios.com/news-releases/news-release-details/agi… #eha23
-
Agios
@AgiosPharma
Join Dr. Z, Dr. C, and sickle cell warrior Dr. Oladipo Cole on the latest episode of the Cheat Codes podcast. Dr. Cole talks about his journey from a child living with #sicklecelldisease to a physician working in the disease state. pod.link/1488189351
-
Agios
@AgiosPharma
At Agios, our goal is to support access to our medicines for eligible patients who may benefit from them, allowing us to help as many people as possible today while investing in innovation to help even more people tomorrow. www.agios.com/wp-content/uploads/2023/03/2023-Agios-ESG-R…
-
Agios
@AgiosPharma
#thalassemia knows no borders. Neither does community. Meet the vibrant & supportive global #thalassemia community, and learn about our efforts around the world on behalf of this community, in this video. #internationalthalassemiaday vimeo.com/824110192?share=copy
-
Agios
@AgiosPharma
Today is #internationalthalassemiaday. We are committed to the global #thalassemia community of patients, caregivers and physicians. Take a look below to see how Agioi honor the thalassemia community today and every day.
-
Agios
@AgiosPharma
Looking forward to the @RareDiseases Living Rare Living Stronger event on May 6 in D.C. and hearing patient stories and connecting with the #raredisease community. Stop by our exhibit table if you're attending! livingrare.org #livingrareforum
-
Agios
@AgiosPharma
We reported our Q1 2023 business highlights and financial results today. Watch the replay of this morning's live webcast on our website. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
As #internationalthalassemiaday draws closer, hear from Tobias, a recent college graduate living with alpha-thalassemia. He shares his story with #thalassemia and how he navigates it alongside his favorite activities, including hiking, biking and more. vimeo.com/702892557
-
Agios
@AgiosPharma
In the latest episode of our Thal Pals podcast, our hosts take an existential dive into the concept of “disease burden” in #thalassemia. What is disease burden? How does it affect community members? And how does it correlate to quality of life? Tune in: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolution
-
Agios
@AgiosPharma
#internationalthalassemiaday is one week away & we're amplifying voices of patient advocates. NinaMaria was diagnosed with beta-thalassemia at 6 months old; now she raises awareness for #thalassemia & advocates for her own health in the process: vimeo.com/763828853
-
Agios
@AgiosPharma
Today is Pyruvate Kinase Deficiency Awareness Day. Join us in recognizing those whose lives are affected every day by #pkdeficiency, and hear from the co-founder/president of @2021PKDF below. #pkdawarenessday #pkdf vimeo.com/822082098
-
Agios
@AgiosPharma
We're honored that Agios was chosen as the @Citeline_Awards award recipient in the Excellence in Rare Disease Drug Development category, and shortlisted in two others. Congrats to all the finalists! pharmaintelligence.informa.com/citelineawards2023
-
Agios
@AgiosPharma
Tune in to our Just Listen podcast episode with Alejandra Watson and Laura Miller D'Angelo from the Pyruvate Kinase Deficiency Foundation (@2021PKDF). Learn about Alejandra’s experience as a caregiver and Laura’s experience living with #pkdeficiency: www.bloodstreammedia.com/just-listen-voices-of-pk-deficiency
-
Agios
@AgiosPharma
April 24-28 is #bloodadvocacyweek, which aims to raise awareness surrounding blood-related diseases and the need for blood donations within various patient communities. Learn more about donating blood at americasblood.org/advocacy/bloodadvocacyweek/
-
Agios
@AgiosPharma
We will be presenting at the @rbccm Global Healthcare Conference on Tuesday, May 16, at 9 a.m. ET. A live webcast can be accessed in the Investors section at www.agios.com. A replay will be available following the presentation. Learn more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We value diversity and inclusion and understand the importance of uplifting all voices within our company. Our differences are what make us versatile. Learn about how we embrace differences and check out all our values here: www.agios.com/about-us/values/
-
Agios
@AgiosPharma
We're committed to environmental stewardship and corporate responsibility and work to incorporate those values into all aspects of our work. In honor of #earthday2023, learn about our commitment to energy, solid waste, and water usage reduction here: www.agios.com/wp-content/uploads/2023/03/2023-Agios-ESG-R…
-
Agios
@AgiosPharma
On the latest episode of Just Listen: Voice of PK Deficiency, Dr. Rachael Grace talks with @DrHeeney about clinical trials and research in #rarediseases. Listen at pod.link/justlistenvoicesofpkd
-
Agios
@AgiosPharma
We’re pleased to welcome Jeff Capello to our Board of Directors, effective June 13. Jeff brings deep operational & financial expertise in life sciences. We’re grateful to Paul Clancy, who is stepping down after devoting a decade to supporting our mission. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are reporting our Q1 2023 business highlights and financial results on May 4, 2023 at 8 a.m. ET. A live webcast can be viewed under “Events & Presentations” in the Investors section of our website or you can access a replay following the presentation. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
On today's episode of Thal Pals, we hear from the “mother of thalassemia” Dr. Nica Cappellini, who has been at the heart of #thalassemia research and treatment for decades. Listen at pod.link/1639436269
-
Agios
@AgiosPharma
On today's episode of Cheat Codes, Dr. Z and Dr. C welcome Dr. Obiageli Nnodu. We take an in-depth look at the state of #sicklecelldisease in sub-Saharan Africa, Dr. Nnodu’s work in the region, and her journey to where she is today. Listen at pod.link/1488189351
-
Agios
@AgiosPharma
We're fueled by connections. By partnering with patients, healthcare providers, partners, colleagues, & others in the community, we can do more together than we ever could alone. At Agios, that’s why one of our values is Come Together. Explore our values: www.agios.com/about-us/values/
-
Agios
@AgiosPharma
Yesterday, we brought our whole company together for an energizing in-person event, Agios Connect. We heard from patient advocates, built STEM kits for under-resourced communities, and interacted in breakout sessions focused on our values, diversity, and more.
-
Agios
@AgiosPharma
We're proud to share our 2023 Environmental, Social & Governance Report, sharing updates on our corporate sustainability initiatives from 2022. This yearly report highlights our commitment to patients, employees, communities, and business ethics & values. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
For those at the CMO Summit 360°, hear from our CMO Sarah Gheuens at 4pm ET today! #cmosummit360 #cmo360
-
Agios
@AgiosPharma
Check out our latest issue of ThalassemiaNEWS, which includes an interview with thalassemia specialist Dr. Vip Viprakasit, an in-depth analysis of recent alpha-thalassemia publications, and more. www.agios.com/wp-content/uploads/2023/03/THA-ALL-0052-Tha…
-
Agios
@AgiosPharma
Today is International Medical Science Liaison Day. Join us in taking a moment to recognize our stellar MSL team, who actively support our trials, research and scientific exchange, and hold a vital role here at Agios. Thank you, MSL team, for all you do! #internationalmslday
-
Agios
@AgiosPharma
Learn more about the Agios sponsored Peak Registry – the longest registry of PK deficiency patients – in this new @BMJ_Open publication. This global registry increases knowledge about the full spectrum of disease for #pkdeficiency, a rare blood disorder. bmjopen.bmj.com/content/13/3/e063605.full
-
Agios
@AgiosPharma
We're happy to share that we're attending and sponsoring the @SCCConsortium's 7th Annual Leadership Summit in Atlanta, GA. We're thrilled to support this organization with a goal to harness and amplify the power of the patient voice. Learn more here: www.sicklecellevents.org/2023leadershipsummit
-
Agios
@AgiosPharma
We're accepting applications for our 2023 Agios Hemolytic Anemias Clinical Fellowship Research Grant through April 3, to support classical #hematology rising stars. See details below & check out the “Active RFAs/RFPs” tab to apply! agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
We're thrilled to sponsor @MassBio’s #rarediseaseday event today, highlighting groundbreaking & #patientdriven research happening here in MA, health disparities faced by this community, and the importance of building true partnerships with patients. www.massbio.org/events/listing/rare-disease-day-patients-…
-
Agios
@AgiosPharma
Here at Agios, we're driven by our core values, which guide all aspects of our work and how we build connections with patients, partners and each other. Learn about our first value, Aim High, and explore all our values at www.agios.com/about-us/values/
-
Agios
@AgiosPharma
Two years ago, we sold our oncology portfolio to Servier. Today's news serves as a major milestone for patients diagnosed with IDH-mutant low-grade glioma and underscores how @ServierPharma has been an excellent steward of those programs. www.servier.us/serviers-pivotal-phase-3-indigo-trial-meet…
-
Agios
@AgiosPharma
We're excited to attend and sponsor the @iascnapa 2023 virtual conference "Promoting Health Equity in Sickle Cell Disease." This important organization is grounded in its mission to improve care for people with #sicklecelldisease. Learn more here: www.iascnapa.org/2023conference
-
Agios
@AgiosPharma
We're proud to sponsor the @IINE's #internationalwomensday event for the fourth year. The annual event shines a light on immigrant & refugee women's achievements and raises funds to support the organization's services to those communities. Learn more: iine.org
-
Agios
@AgiosPharma
Today is #internationalwomensday! We're proud to have so many talented and inspiring women on our team, in leadership, research, and beyond. Take a look below at a few of our amazing Agioi in #leadership who are driving our mission on behalf of people with #rarediseases.
-
Agios
@AgiosPharma
Today is #employeeappreciationday! We are so grateful for our wonderful team who works with passion, creativity and dedication every day for patients. Our Agioi are what drive our success and build the culture that makes Agios a great place to work.
-
Agios
@AgiosPharma
We're honored to be shortlisted in three categories for the @Citeline_Awards: Excellence in Rare Disease Drug Development, Champion of Diversity & Inclusion in Clinical Research & Excellence in Patient Recruitment & Engagement. Congrats to the finalists! pharmaintelligence.informa.com/citelineawards2023
-
Agios
@AgiosPharma
We're presenting at the @TDCowen Annual Health Care Conference and @Oppenheimer Annual Healthcare Conference this month. Live webcasts will be archived for at least two weeks following each presentation and can be found here: investor.agios.com/news-events/events-presentations
-
Agios
@AgiosPharma
The Red Cell Revolution, founded & funded by Agios, was featured on all of our Agios-sponsored podcasts: Just Listen: Voices of PK Deficiency, Thal Pals: The Alpha Beta Revolution & Cheat Codes: A Sickle Cell Podcast. Find links to all three podcasts here: www.agios.com/patients-partners/patients-caregivers/patie…
-
Agios
@AgiosPharma
We're showing our pride for #rarediseaseday in partnership with the @rarediseaseday organization. Agioi are showing their support for the #raredisease community through the #shareyourcolours campaign. Learn more at: www.rarediseaseday.org
-
Agios
@AgiosPharma
In honor of #rarediseaseday, we're proud to launch Red Cell Revolution, an advocacy advisory council founded & funded by Agios aiming to bring together patients, caregivers & physicians from the PK deficiency, thalassemia & sickle cell disease communities. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We're looking for new Hemolytic Anemia Sales Specialists in locations including California and Washington D.C. If you're interested in joining our team, learn more about the role below and check out your opportunities to join Agios here: phe.tbe.taleo.net/phe03/ats/careers/v2/searchResults?org=…
-
Agios
@AgiosPharma
Hear from Ryan, who lives with #thalessamia, on why recognizing #blackhistorymonth is so important for driving health equity. His perspective brings light to the challenges the Black community has long faced when it comes to receiving the healthcare they deserve.
-
Agios
@AgiosPharma
Earlier this month, we shared insight from patient partners living with #pkdeficiency on what #rarediseaseday means to them. Today, we'd like to highlight more voices. Learn about how to share your voice and spread awareness for rare diseases here: rarediseases.org/rare-disease-day/
-
Agios
@AgiosPharma
We're excited to share that the Phase 2 portion of our RISE UP study has been fully enrolled. Thank you to the #sicklecell warrior community for their partnership, which enabled the completion of this milestone. Learn more: www.riseupstudy.com
-
Agios
@AgiosPharma
We hosted a conference call and live webcast today to report our fourth quarter 2022 financial results and other business highlights. It can be accessed using the link here: investor.agios.com/news-events/events-presentations
-
Agios
@AgiosPharma
We are reporting our Q4 2022 business highlights and financial results today. Join our live webcast at 8 a.m. ET or watch the replay on our website following the presentation. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Something revolutionary is coming on #rarediseaseday! When we recognize that we have so much in common despite our differences, we can amplify each other’s voices to drive change and progress. Stay tuned for more. #redcellrevolution vimeo.com/794568428
-
Agios
@AgiosPharma
We're accepting applications for our Clinical Fellowship Research Grant through 4/3. It aims to support #classicalhematology rising stars dedicated to research. Click the “Active RFAs/RFPs” tab in the link to apply and see last year's recipient below. agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
Today marks the one-year anniversary of the FDA approval of our first rare disease treatment! We're thrilled to celebrate this milestone and are humbled to be making a difference in the lives of patients. Learn about PYRUKYND® (mitapivat) here: www.pyrukynd.com
-
Agios
@AgiosPharma
In the weeks leading up to Rare Disease Day, we've caught up with a number of patients living with #pkdeficiency to hear what #rarediseaseday means to them. Take a moment to hear the voices of this community.
-
Agios
@AgiosPharma
Our Chief Technical Operations Officer spoke w/ @sciencewomen about his career, leadership style, motivations & more. Clive’s heart is in leadership, team building, and making an impact, and his passion for his work is what makes him an excellent leader. info.westorg.org/blog/getting-to-the-heart-of-west-leader…
-
Agios
@AgiosPharma
Tomorrow is the International Day of Women and Girls in Science. We're proud to have many inspiring and talented women at Agios, and are committed to uplifting women in science, both today & tomorrow. Take a moment today to recognize the #womenandgirlsinscience in your life.
-
Agios
@AgiosPharma
The transition from childhood to adulthood is tough, but #pkdeficiency presents unique challenges. On the latest Just Listen: Voices of PK Deficiency episode, Alejandra Watson @2021PKDF shares about her son Jonathan's journey from adulthood to college. www.bloodstreammedia.com/just-listen-voices-of-pk-deficie…
-
Agios reposted
The Rare Disease Company Coalition
@RareCoalition
The growing number of FDA-approved rare disease treatments is not a coincidence, rather an intentional result of policies outlined in the Orphan Drug Act. @AgiosPharma CEO Brian Goff shares how upholding & enhancing ODA will inspire more medical advances. #odaat40 #onerarevoice
-
Agios
@AgiosPharma
We're excited to partner w/ @UpliftingAth to increase diversity in #raredisease research by sponsoring their Health Equity Initiative, which supports #raredisease researchers from underrepresented backgrounds. upliftingathletes.org/young-investigator-draft
-
Agios
@AgiosPharma
Join us in revisiting one of our favorite episodes of #thalpals: The Alpha Beta Revolution. The late Merula Steagall and her daughter Dina of @abraleoficial talk about managing #thalassemia as a family. www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
With #rarediseaseday taking place on 2/28, we're bringing awareness to the #raredisease community & advocating for health equity for everyone living with a rare disease. Learn about the unmet needs of the diseases in our pipeline.
-
Agios
@AgiosPharma
Check out this popular episode replay of Cheat Codes: A Sickle Cell Podcast! Dr. Z and Dr. C talk to #themommabears: Yvonne Carroll, Adrienne Shapiro and Pat Corley. We also hear from Teonna Woolford, CEO of the @SickleRED20. www.bloodstreammedia.com/cheat-codes-episodes/legends-of-…
-
Agios
@AgiosPharma
In Dec. 2022, leaders & advocates in the #hematology space came together for @ASH_hematology’s 64th Annual Meeting. Check out this @PMLiVEcom article covering 5 trends from #ash22, including a nod to our approved treatment for #pkdeficiency. www.pmlive.com/pharma_intelligence/ASH_2022_bad_blood_but…
-
Agios
@AgiosPharma
February is #blackhistorymonth, and we want to take this opportunity to honor the Black community for their vast contributions to society, advocacy and science. Hear from #sicklecell warriors on the importance of recognizing Black accomplishments this month and beyond.
-
Agios
@AgiosPharma
We are reporting our 2022 Q4 and year-end business highlights and financial results on February 23, 2023 at 8 a.m. ET. A live webcast can be viewed in the Investors section at www.agios.com, or viewers can access a replay on our website. investor.agios.com/news-releases/news-release-details/agi…
-
Agios reposted
The Rare Disease Company Coalition
@RareCoalition
We are thrilled to announce our 2023 Committee Chairs! Thank you for your leadership and dedication to advancing greater awareness of the challenges and opportunities of discovering, developing and delivering treatments for those living with #rarediseases. #onerarevoice
-
Agios
@AgiosPharma
Join us in congratulating our Senior Director, Corporate Communications Jessi Rennekamp for serving as a 2023 Communications Committee Co-Chair for @RareCoalition. We're excited to have her as a part of this impressive group of leaders advancing the Coalition’s important work.
-
Agios
@AgiosPharma
We're excited to share the launch of @PKdeficiency's new app, MyPKD. The web app, available for U.S. #pkdeficiency patients ages 13+, allows patients & caregivers to track symptoms & share data w/ family, caregivers & more. Learn more at: mypkdapp.com #knowpkdeficiency
-
Agios
@AgiosPharma
We are thrilled to announce our 2023 Agios Hemolytic Anemias Clinical Fellowship Research Grant. This grant supports #classicalhematology rising stars dedicated to researching and treating hereditary #hemolyticanemias. Apply here (Active RFAs tab): agios.envisionpharma.com/ienv_agios/visiontracker/portal/…
-
Agios
@AgiosPharma
Our offices are closed today in recognition of the honorable Martin Luther King Jr. for his life's work to uplift oppressed and underrepresented voices and bring light to injustice. Thank you for your work, Dr. King.
-
Agios
@AgiosPharma
We had a great time presenting and connecting at the 41st Annual @JPMorgan Healthcare Conference. We're glad to have represented Agios' mission and important research for #rarediseases at such an impactful conference. Get a glimpse of our #jpm23 experience in the photos below.
-
Agios
@AgiosPharma
Our CEO Brian Goff will present on our mission and future at the 41st Annual @JPMorgan Healthcare Conference. View a live webcast of his presentation, taking place tomorrow, January 11 at 7:30 a.m. PT, here: investor.agios.com #jpm23
-
Agios
@AgiosPharma
We're pleased to announce our anticipated 2023 milestones and significant value-driving catalysts through 2026, which support our mission to transform patient outcomes in #rarediseases. Read the full release here: investor.agios.com/news-releases/news-release-details/agi… #jpm23
-
Agios
@AgiosPharma
We're proud to be part of this coalition that does great work on behalf of #raredisease patients, educating policymakers about developing medicines for these communities and advocating for policies that support innovation, early diagnosis, and access. #odaat40
The Rare Disease Company Coalition
@RareCoalition
Up until the Orphan Drug Act was enacted, only a handful of rare diseases had FDA-approved treatments, leaving patients feeling alone & forgotten. Today, more than 650 medicines have been approved for orphan conditions, giving patients courage to face the future. #odaat40
-
Agios
@AgiosPharma
We're excited to share that our RISE UP clinical trial was named #2 in the Top 10 Sickle Cell Disease Stories of 2022 by @sicklecell_news. This advance, along with the others, is a win for the whole #sicklecelldisease community. See the full list here: sicklecellanemianews.com/news/top-10-sickle-cell-disease-…
-
Agios
@AgiosPharma
Agios will be closed until January 2nd for our annual holiday shutdown as we all enjoy time off with our loved ones. We wish our community a safe and healthy holiday season and look forward to reconnecting in the new year.
-
Agios
@AgiosPharma
As part of our #seasonofservice, Agioi participated in a fleece blanket making day. The blankets will go to patients living w/ #pkdeficiency, #thalassemia, and #sicklecelldisease as part of a care package for transfusions or hospital stays.
-
Agios
@AgiosPharma
We are excited to present at the 41st Annual @jpmorgan Healthcare Conference. Our CEO Brian Goff will be speaking on 1/11 at 7:30 am PT. A live webcast can be viewed under "Events & Presentations" in the Investors section at www.agios.com. #jpm23 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
.@Guardian shared its top 10 science stories of 2022. The #5 story, “Inclusive Inroads,” includes research by our collaborators at @TheBethesdaLabs on behalf of the underserved global #sicklecelldisease community. So proud to partner with them! www.theguardian.com/science/2022/dec/18/the-10-biggest-sc…
-
Agios
@AgiosPharma
From FDA approvals and new leaders to community partnerships and beyond, it's been a busy year here at Agios. Take a look at a recap of the milestones we've achieved in 2022. We're grateful for our community and excited for what's to come in the new year.
-
Agios
@AgiosPharma
We enjoyed participating in the 64th @ASH_hematology Annual Meeting & Exposition. We're grateful for the time we had in New Orleans learning about and sharing the latest discoveries in #hematology. Take a look at some moments from the meeting below.
-
Agios
@AgiosPharma
Knowing the cause of hereditary anemias may help prevent long-term complications. That's why we partnered w/ @InformedDNA & @PerkinElmer to create Anemia ID, which offers no-cost genetic counseling and testing for 50+ genes. Learn more: www.anemiaid.com #ash22
-
Agios
@AgiosPharma
We are presenting new long-term data from our ongoing extension study in PK deficiency at the 64th @ASH_hematology Annual Meeting. Read the press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We're presenting new long-term data from our ongoing Phase 2 extension study in thalassemia at the 64th @ASH_hematology Annual Meeting. Read the press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Hear from our CEO Brian Goff as he shares why meetings like the 64th @ASH_hematology Annual Meeting & Exposition are an important opportunity to build and grow connections in the #hematology space. Learn more about Agios at #ash22: www.agios.com/ash-2022
-
Agios
@AgiosPharma
We're deeply saddened that one of thalassemia's strongest warriors, Merula Steagall, has passed away. During her lifetime, she made history in her home country of Brazil as a leader and advocate. Join us in honoring Merula by watching the video below. vimeo.com/773960602
-
Agios
@AgiosPharma
We're looking forward to participating at the 64th @ASH_hematology 2022 Annual Meeting & Exposition. See the website below to find booth and poster information, our #ash22 press releases, helpful links and more. www.agios.com/ash-2022
-
Agios
@AgiosPharma
We're excited to attend the 64th @ASH_hematology Annual Meeting & Exposition this year, where we will be presenting a broad set of clinical and translational data. Find us there at booth #2433, and learn more about our pipeline here: www.agios.com/pipeline/
-
Agios
@AgiosPharma
We're excited to share that our CMO and Head of R&D Sarah Gheuens, M.D., Ph.D. will be speaking during the Fearless Women Leaders in Life Sciences Summit, focused on the importance of women in leadership positions in the industry. Register here: momentumevents.com/fearlessinpharma/speakers/
-
Agios
@AgiosPharma
We're pleased to share the appointment of Tsveta Milanova as incoming chief commercial officer. She joins us w/ two decades of experience launching & expanding the reach of medicines in #raredisease and hematology. We're excited to welcome her to Agios! investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
In partnership with @InformedDNA and @PerkinElmer, we created Anemia ID, a program offering no-cost tests of 50+ genes and genetic counseling for patients with suspected hereditary anemias. To learn more visit: www.anemiaid.com #ash22
-
Agios
@AgiosPharma
Today is Int'l PK Deficiency Day. In honor of this important day, we hosted an event with Jill and Maaike, two patients living with #pkdeficiency across an ocean from one another, to hear their journeys with the disease and advocating for the community.
-
Agios
@AgiosPharma
We're proud to support the first annual International PK Deficiency Awareness Day today to help raise awareness of the needs and experiences of people living with #pkdeficiency, their caregivers, and family members. #internationalpkdday @TwPKDnonprofit
Thrive w/ Pyruvate Kinase Deficiency Organization
@TwPKDnonprofit
Near and dear, far and wide, WE are celebrating International PKD Day ❤️
#pkd #pkdcommunity #internationalpkdday #supportgroup #cometogether #advocate #pyruvatekinasedeficiency -
Agios
@AgiosPharma
Our team was thrilled to attend the @Citeline 2022 #scripawards ceremony in London last night. We're proud to be named a finalist in both the Best New Drug Award and the Community Partnership of the Year Award categories. Congrats to all of the winners and finalists!
-
Agios
@AgiosPharma
As National Family Caregivers Month comes to a close, we'd like to highlight Becky, whose daughter Remy is living with #pkdeficiency. Please join us in honoring her and the multitudes of other inspiring caregivers of people with rare and genetically defined diseases.
-
Agios
@AgiosPharma
Join us in giving back this #givingtuesday. @TwPKDnonprofit is raising funds to generate awareness and education for #pkdeficiency, a rare lifelong blood disorder, while continuing to support and build connections among the PK deficiency community.
-
Agios
@AgiosPharma
This #givingtuesday, consider donating blood. Blood donations are important for many people with chronic blood disorders including #thalassemia, #pkdeficiency, and #sicklecelldisease. Learn more in this @cooleysanemia video, which was funded by Agios: vimeo.com/776250764
-
Agios
@AgiosPharma
We’re thankful for dedicated patient advocacy organizations who tirelessly support, educate, advocate for, and build connections among patients and caregivers! Consider making a #givingtuesday donation to further their important work. Check out one example from @2021PKDF:
-
Agios
@AgiosPharma
We're happy to share that @EvaMarieG, Ph.D., our VP, Head of Medical Affairs, will be speaking at @FiercePharma's virtual summit on Launch Readiness for Medical Affairs & Communications Teams. Eva will be speaking on 12/1 at 12 p.m. ET. Learn more here: www.medaffairslaunch.com
-
Agios
@AgiosPharma
Happy Thanksgiving from all of us at Agios. We are #thankful every day for the wonderful communities in #pkdeficiency, #thalassemia, #sicklecelldisease, and beyond – and for our incredible team of Agioi whose dedication powers our work to change patients' lives.
-
Agios
@AgiosPharma
Check out the new episode of Just Listen: Voices of PK Deficiency, part of our caregiver series. Dr. Rachael Grace talks to Becky, mother of Remy, about caring for a small child with #pkdeficiency. Tune in here: podcasts.apple.com/us/podcast/pkd-parents-support-a-pkd-c… #nationalfamilycaregiversmonth
-
Agios
@AgiosPharma
Join us in applauding @drzsicklecell on being named a winner of the 2022 Stigma Warrior Award at the Howard University 2022 Conference on Stigma (@WhoCanYouTell). We're proud of our colleague for being recognized for his important work to reduce stigma in #sicklecelldisease.
-
Agios
@AgiosPharma
Check out this brand new episode of Cheat Codes: A Sickle Cell Podcast. Dr. Z and Dr. C are back! They speak with @biba_tinga, President & Executive Director of @sicklecellca. Tune in here: www.bloodstreammedia.com/cheat-codes-episodes/biba-tinga-…
-
Agios
@AgiosPharma
As part of our #agiosseasonofservice, our team members created short video stories for older adults who live in nursing homes and may be feeling isolated or lonely during the holidays. We hope these stories will build connections and spread joy during this time of year!
-
Agios
@AgiosPharma
November is #nationalfamilycaregiversmonth, a time to recognize and honor family caregivers across the country. Hear from caregiver Jill and her daughter Madison, who was diagnosed with a form of alpha thalassemia, as they share their story of resilience through #thalassemia.
Agios
@AgiosPharma
Watch Part 1 here: vimeo.com/702890904
Agios
@AgiosPharma
Watch Part 2 here: vimeo.com/702891452
-
Agios
@AgiosPharma
We’re kicking off our second annual #agiosseasonofservice! In Nov/Dec, Agioi are taking part in volunteer opportunities to make the world brighter, meet needs in our communities, support patients, and increase diversity in the life sciences.
-
Agios
@AgiosPharma
We're honored to be named one of the @BioSpace 2023 Best Places To Work as a top 5 winner in the Small to Mid-Size Companies category. We're thrilled to be recognized for our workplace culture, flexibility, values and pioneering work among so many other impressive companies.
BioSpace
@biospace
BioSpace’s 2023 Best Places to Work campaign celebrates the top 30 small and large biopharma employers across the U.S. See who made the list! www.biospace.com/best-places-to-work?hss_channel=tw-21793154
#biopharma #lifesciences #biospace -
Agios
@AgiosPharma
We had a great time at the @TwPKDnonprofit 60th Year Celebration of PK Deficiency as a Genetic Anemia Conference. Continued research in this space is vital for patients living with this chronic disease. Check out some of our favorite moments from the conference below. #60yearspkd
-
Agios
@AgiosPharma
We are excited to share that the European Commission has approved PYRUKYND® in the EU. With this milestone, we are proud to expand the positive impact of our first-in-class, oral PK activator, around the globe. investor.agios.com/news-releases/news-release-details/pyr…
-
Agios
@AgiosPharma
The #pkdeficiency community does so much to uplift one another. Hear from Marie-Eve, mom of 1-year-old Axel who has PK deficiency, as she shares her experiences as a caregiver and the support she has received from this resilient community. #60yearspkd vimeo.com/756424216
-
Agios
@AgiosPharma
The pyruvate kinase deficiency community has made significant progress since the first known case was diagnosed more than 60 years ago. Watch the video for a timeline of #pkdeficiency advances and learn more about PK deficiency here: www.agios.com/genetically-defined-diseases/pyruvate-kinas… #60yearspkd
-
Agios
@AgiosPharma
We're sponsoring the 60th Year Celebration of PK Deficiency as a Genetic Anemia Conference 2022. Hosted by @twpkdnonprofit and @thalassaemiaTIF, this is the first conference focused solely on pyruvate kinase deficiency. thrivewithpkd.org/thrive-conference/ #60yearspkd
-
Agios
@AgiosPharma
We will present 20+ abstracts at @ASH_hematology along with several of our collaborators. We are excited to take part in this impactful meeting and look forward to networking with colleagues in the #hematology space. #ash22 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are reporting our Q3 2022 business highlights and financial results today. Join our live webcast at 8 a.m. ET or watch the replay on our website. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
The 2nd issue of ThalassemiaNEWS is here! Each quarter, we publish the latest #thalessemia news for the patient and medical community. This issue includes analysis of recent publications, clinical trial news, patient resources & more. Read the issue here: www.agios.com/wp-content/uploads/2022/11/THA-ALL-0028_THA…
-
Agios
@AgiosPharma
Check out our new episode of Thal Pals: The Alpha Beta Revolution Podcast featuring Merula Steagall, founder of the Brazilian Blood Cancer Society (ABRALE). Merula is joined by her daughter Dina to talk about managing thalassemia as a family. Tune in: www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
Three Agioi are sharing tips on how to execute a successful digital medical affairs strategy at the 6th Digital Strategy & Innovation for Medical Affairs Summit. Read more about the event here: dgevents.com/event/6th-digital-strategy-innovation-for-me…
-
Agios
@AgiosPharma
Today, we announced that we have sold our rights to 5% royalties on U.S. net sales of Servier’s TIBSOVO® (ivosidenib tablets) to Sagard Healthcare Partners for a one-time payment of $131.8 million. Read more on the news here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our clinical development team had the opportunity to volunteer with the MA @lionsclubs District 33N yesterday and take part in their eyeglasses cleaning event. Together, we cleaned and prepped 1,750 pairs of glasses to be delivered to people in need of eyesight care worldwide!
-
Agios
@AgiosPharma
We're proud to share that our CCO Richa Poddar will be speaking on a @FierceBiotech panel tomorrow about transforming emerging R&D stage #pharmaceutical or #biotech companies into commercial-stage companies. Register and read more about the event here: pages.questexinfo.com/bluematterconsultingreg10252022/?pk…
-
Agios
@AgiosPharma
During last week’s @SCDAAorg event, we unveiled a music video created by Blaze and DeMitrious dedicated to their fellow #sicklecellwarriors who demonstrate incredible resilience and rise above the challenges of living with #sicklecelldisease. Watch here: vimeo.com/762730325
-
Agios
@AgiosPharma
We'll be hosting a conference call and live webcast on Thursday, Nov. 3 at 8am ET to report our Q3 2022 financial results and other business highlights. A live webcast can be accessed under "Events & Presentations" in the Investors section of our website. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Check out our latest podcast episode of Just Listen: Voices of PK Deficiency! Dr. Rachael Grace and patient advocate & TikTok influencer Karla Chichester dispel even more of the biggest myths surrounding PK deficiency. pod.link/justlistenvoicesofpkd/episode/5a835f8ea6dadba695…
-
Agios
@AgiosPharma
We're looking forward to participating at @ascatconference in London. We'll be hosting two symposia as well as presentations and are thrilled to continue to advance innovation for people with hemolytic anemias. Read more about the conference here: www.ascat2022.com
-
Agios
@AgiosPharma
We're excited to attend @JADPRO Live 2022: The Annual @APSHOorg Meeting in Aurora, CO, along with 1,000 nurse practitioners, pharmacists and other HCPs who are dedicated to improving patient care. Visit us at our booth #804! jadprolive.com #jadprolive #apsho
-
Agios
@AgiosPharma
It’s #hispanicheritagemonth – an important time to honor and celebrate the many contributions, diverse cultures and extensive history of the American Latinx community. Join us in observing and learning more here: www.rd.com/article/what-is-hispanic-heritage-month/
-
Agios
@AgiosPharma
Our CEO and CMO/Head of R&D will be presenting at the 50th @SCDAAorg Conference this weekend. We’re honored to engage with the #sicklecelldisease community at this milestone event. web.cvent.com/event/02f945cf-b334-4340-87d7-82d56cb515c1/…
-
Agios
@AgiosPharma
Check out our latest episode of Cheat Codes: A Sickle Cell Podcast. In this episode, we hear more about the Sickle Cell Warriors Convention and the work of @SCCConsortium. Tune in here: www.bloodstreammedia.com/cheat-codes-episodes/a-what-just… #cheatcodes #sicklecell #sicklecellwarriors
-
Agios
@AgiosPharma
We’re looking forward to attending @ArenaIntOCT this week. Our Sr. Director of Patient Advocacy & our Medical Director will be sharing a keynote on creating more patient-centric trials & the role that patient advocates play. Read more here: www.arena-international.com/octnewengland/ #octisvirtual
-
Agios
@AgiosPharma
Check out our latest podcast episode of Just Listen: Voices of PK Deficiency! Dr. Rachael Grace and patient advocate & TikTok influencer Karla Chichester dispel some of the biggest myths surrounding PK deficiency. pod.link/justlistenvoicesofpkd/episode/267e7da2ec7016fed3…
-
Agios
@AgiosPharma
Check out our latest podcast episode of Thal Pals: The Alpha Beta Revolution. In this episode, we hear form Ralph Colasanti about his story and his important work as president of @cooleysanemia. www.bloodstreammedia.com/thal-pals-the-alpha-beta-revolut…
-
Agios
@AgiosPharma
Shout-out to all the #sicklecellwarriors who co-created the RISE UP study and campaign with us! Check out the video below for a behind-the-scenes look at this partnership. #sicklecellawarenessmonth #fueledbyconnections www.youtube.com/watch?v=i5UiIkt3YTc
-
Agios
@AgiosPharma
Although #sicklecelldisease is considered to be a rare disease in the U.S. and EU, it is one of the most common genetic disorders in the world. Learn about the disease in the video below and read more on our website: www.agios.com/genetically-defined-diseases/sickle-cell-di… #sicklecellawarenessmonth
-
Agios
@AgiosPharma
Newborn screening is important for early diagnosis and intervention for many genetically defined diseases including #sicklecelldisease. It’s also a #healthequity concern as most states do not screen for all recommended conditions. #newbornscreeningawarenessmonth
The Rare Disease Company Coalition
@RareCoalition
Newborn screening is a proven public health program that screens approx 4mil U.S. newborns each year to detect serious, often fatal, genetic conditions that can be treated if diagnosed early. Learn more about the conditions screened in your state. www.babysfirsttest.org/newborn-screening/states #2022nbs
-
Agios
@AgiosPharma
We are honored to be named an ESG Gamechanger to Watch in this year’s @CohnReznick’s Gamechangers in ESG Awards. This program salutes the inspiring environmental, social and governance (ESG) initiatives that companies across industries are undertaking. www.cohnreznick.com/insights/cohnreznick-announces-gamech…
-
Agios
@AgiosPharma
In honor of #sicklecellawarenessmonth, we hosted a lunch & learn with #sicklecellwarriors Dima & Kadeem. They shared their experiences living with #sicklecelldisease, the challenges they have faced in receiving care for their condition, some of their triumphs and more.
-
Agios
@AgiosPharma
We're excited to have been named a finalist in two categories of @PharmaScrip's 2022 SCRIP Awards: Community Partnership of the Year for our RISE UP campaign w/ Sickle Cell Warriors and Best New Drug Award for PYRUKYND® (mitapivat). Congrats to all finalists! #scripawards
-
Agios
@AgiosPharma
#sicklecellawarenessmonth is all about building connections and amplifying voices. Hear from #sicklecellwarrior Ulysse as he shares his story of meeting someone else living with #sicklecelldisease for the first time & how building a connection assured him that he is not alone.
-
Agios
@AgiosPharma
In the latest episode of Cheat Codes: A Sickle Cell Podcast, Dr. Z and Dr. C speak with #sicklecell advocates best known as “The Momma Bears” and Teonna Woolford, CEO of the Sickle Cell Reproductive Health Organization. Listen to the episode here: podcasts.apple.com/us/podcast/legends-of-sickle-cell-the-…
-
Agios
@AgiosPharma
We’re thrilled to welcome Cecilia Jones to our team as our incoming CFO. Cecilia brings more than two decades of experience in financial leadership roles and will help drive our mission on behalf of rare and genetically defined disease capabilities. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our CMO will be presenting at the 9th Advancing Women’s Leadership Skills and Opportunities in Pharma & Healthcare event on Monday, 9/19. She will discuss career growth and authenticity in a male-dominant workplace. Learn about the event here: dgevents.com/event/9th-advancing-womens-leadership-skills…
-
Agios
@AgiosPharma
We’re pleased to announce a positive CHMP opinion for our FDA-approved medicine for adults with PK deficiency. Learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Our Senior Director of Patient Advocacy and Dr. Ahmar Zaidi are presenting at the @SickleCellON 2022 Sickle Cell Awareness Month Symposium in Toronto, Canada this weekend! Read more about the event and the presentations here: www.eventbrite.ca/e/2022-sickle-cell-disease-awareness-mo…
-
Agios
@AgiosPharma
Our medical director will be speaking alongside other panelists about #sicklecell disease history and trait education at the @CayenneWellness Annual Sickle Cell Disease Education Seminar. Join us virtually by registering for the event here: cayennewellness.org/2022-scd-virtual-seminar/
-
Agios
@AgiosPharma
We were pleased to join #raredisease patients and caregivers at the @GlobalGenes 2022 RARE Patient Advocacy Summit. Read more: globalgenes.org/event/rare-patient-advocacy-summit/
#ggsummit22 #globalgenes -
Agios
@AgiosPharma
Today we joined the #sicklecell community virtually for the 11th Annual Sickle Cell Disease Therapeutics Conference and discussed the latest advances and future trends for treating people with sickle cell disease.
scdconference.com
#scdtc -
Agios
@AgiosPharma
Meet Dr. Rhea Hans of @PhxChildrens, the first recipient of our Hemolytic Anemias Fellowship Grant! Her research may identify early predictors of acute chest syndrome, the leading cause of death in young #sicklecellwarriors, to improve patient outcomes. www.agios.com/news/researching-early-indicators-of-heart-…
-
Agios
@AgiosPharma
Following a successful first half of 2022, our team will be using next week to relax and take a well-deserved rest during our summer shutdown. We will return the following week rejuvenated and ready to continue to raise the bar for ourselves and the patients we serve.
-
Agios
@AgiosPharma
Check out this @PharmaVoice “First 90 Days” interview with our CEO Brian Goff! He shares about why he joined Agios, his vision for the company, and his dedication to #raredisease patients. www.pharmavoice.com/news/agios-pharmaceuticals-brian-goff…
-
Agios
@AgiosPharma
During our company-wide #agiosconnect meeting this summer, several patient and caregiver guests shared their experiences with PK deficiency, alpha- and beta-thalassemia & sickle cell disease. We look forward to continuing to build new and deeper connections! #fueledbyconnections
-
Agios
@AgiosPharma
Check out the new episode of our Just Listen: Voices of PK Deficiency podcast about myAgios Patient Support Services! Hear from our own Janie Davis as guest host, patient support managers Liz & Nefar, & PK deficiency patient/myAgios user Pramesh Sharma. pod.link/justlistenvoicesofpkd/episode/fdc2436b09906ff843…
-
Agios
@AgiosPharma
Making a difference is in our DNA. At our company-wide #agiosconnect meeting, our team made blankets and care packages for patients, STEM kits with @SciScientists, and meal kits with @Rise2030.
-
Agios
@AgiosPharma
At our company-wide #agiosconnect meeting this summer, we enjoyed seeing so many Agioi in person, presentations from colleagues and leaders including new CEO Brian Goff, hands-on community service, a patient panel and musical performances from #sicklecellwarriors.
-
Agios
@AgiosPharma
We enjoyed hosting the Bellaamane family today for an alpha-thalassemia lunch & learn and roundtable. We learned about Mustapha and Ilyas’ experiences living with #thalassemia, perspectives from mom Amina and big sister Sara, and how they manage the disease as a family.
-
Agios
@AgiosPharma
We’re proud to announce that data from our pivotal Phase 3 ACTIVATE-T study of PYRUKYND® were published in @TheLancetHaem. Read the full announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Introducing “Thal Pals: The Alpha Beta Revolution,” a new Agios podcast for thalassemia patients and caregivers! Hosted by Dr. Kevin Kuo, thal advocate and clinician, Thal Pals provides critical education and voices from the thal community. Tune in here: pod.link/1639436269
-
Agios
@AgiosPharma
On the latest episode of Cheat Codes: A Sickle Cell Podcast, Dr. Z and Dr. C speak with father/son duo, Dr. Charles Jonassaint & Jude Jonassaint, as well as Sickle Cell Warrior and founder of @SickleCell101, Cassandra Trimnell. #legendsofsicklecell podcasts.apple.com/us/podcast/legends-of-sickle-cell-dr-c…
-
Agios
@AgiosPharma
We’re thrilled to announce the appointments of Rahul Ballal, Ph.D., chief executive officer of Imara Inc., and Cynthia Smith, former chief commercial officer of ZS Pharma, Inc., to our board of directors. Read more about Rahul and Cynthia here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re excited to share that data from our Phase 2 study in #thalassemia has been published in @TheLancet! Learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
After being named an In Vivo Rising Leader, our CMO and Head of R&D Sarah Gheuens talked with @INVIVOnow about the responsibility of providing new therapies to rare disease populations, building trust with historically underserved communities, and more. invivo.pharmaintelligence.informa.com/IV146659/Fueled-By-…
-
Agios
@AgiosPharma
We were thrilled to host a lunch & learn with #thalassemia patient advocates, Merula and Dina! This mother/daughter duo plays a very important role w/ @ABRASTA, the largest thalassemia patient advocacy organization in Brazil. Thank you to Merula and Dina for sharing their story!
-
Agios
@AgiosPharma
Join us in giving a warm welcome to Brian Goff as he joins us for his first official week as our CEO! We’re looking forward to Agios’ next chapter as we continue to build connections and pioneer therapies for patients in need.
-
Agios
@AgiosPharma
Today we reported our Q2 2022 business highlights and financial results. Check out our press release for more info: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Attention #sicklecellwarrior — The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Golie.
-
Agios
@AgiosPharma
The #sicklecellwarrior community is ready to step into the ring. Join the RISE UP clinical trial challenging pain crises and anemia. Get the details: riseupstudy.com
-
Agios
@AgiosPharma
Check out our new quarterly thalassemia newsletter, created to keep the medical and patient communities in touch with the latest #thalassemia developments! In this edition, take a look at recent publications, clinical trial updates and more: www.agios.com/wp-content/uploads/2022/07/THA-ALL-0021_Tha…
-
Agios
@AgiosPharma
Are you ready #sicklecellwarrior? The new RISE UP sickle cell clinical trial from Agios is now open for enrollment. Get the details: riseupstudy.com
-
Agios
@AgiosPharma
In the latest episode of the Just Listen: Voices of PK Deficiency podcast, Dr. Grace hosts Dr. David Nathan and Jill Welle for a conversation about the evolution of PK Deficiency. Listen here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We are thrilled to be included as a finalist for the @FiercePharma Marketing Awards for both our PYRUKYND Launch in the New Brand Launch category and for our RISE UP campaign in the Multicultural Campaigns category. Congrats to all of the finalists! www.digitalpharmaeast.com/digitalpharmaeastcom/2022-final…
-
Agios
@AgiosPharma
Living with or loving someone with a rare disease can be isolating. That’s why connections are important and why building partnerships is a cornerstone for Agios. Hear from patients around the world about what connections mean to them. #fueledbyconnections vimeo.com/728925022
-
Agios
@AgiosPharma
We will host a webcast conference call of our second quarter financial results on Thursday, August 4, at 8:00 a.m. ET. You can find details on how to tune in on our website here: investor.agios.com/news-events/events-presentations
-
Agios
@AgiosPharma
As we begin an exciting new chapter with incoming CEO Brian Goff, we remain passionate about building connections and pioneering therapies for people with genetically defined diseases. Hear why Brian is looking forward to leading our team.
-
Agios
@AgiosPharma
We are pleased to welcome Brian Goff as our incoming CEO and a member of our board of directors. Current CEO Jackie Fouse, Ph.D., will transition to the role of chair of the board of directors. Read more about this exciting announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Dominique. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
Did you listen to the latest episode of Just Listen: Voices of PK Deficiency? Hear from Bianca Basset, a disability consultant from Australia who is living with PK deficiency, about her experience with self-advocacy. Check it out here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Dr. Z and Dr. C are back with another Cheat Codes episode in our Legends of Sickle Cell series! In this episode, Dr. Russell Ware talks about his work on behalf of the sickle cell community and his approach to mentorship. Check it out here: podcasts.apple.com/us/podcast/cheat-codes-a-sickle-cell-p…
-
Agios
@AgiosPharma
On this episode of hear Just Listen: Voices of PK Deficiency we hear from two #raredisease patients and advocates, Bianca Basset & Patrick James Lynch, as they discuss their ups and downs with self-advocacy and how they craft their stories. Listen here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like DeMitrious. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
We believe in equitable access to healthcare and in patients’ rights to make their own choices with their doctors. We also commit to being a respectful place for all our team members and support each person’s right to make individual choices and have individual beliefs.
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Blaze. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Tristian. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
The #sicklecellwarrior community is ready to step into the ring. Join the RISE UP clinical trial challenging pain crises and anemia. See enrollment details: www.riseupstudy.com
-
Agios
@AgiosPharma
We were proud to partner with Cayenne Wellness and the Sickle Cell Community Consortium on the 24-hour celebration this Sunday in honor of World Sickle Cell Day! Our own Ahmar Zaidi presented at the celebration and information on our RISE UP clinical study was displayed.
Sickle Cell Consortium
@SCCConsortium
This year on June 19th, we’re celebrating for 24 hours in honor of #worldsicklecellday. Join us to show the world “sickle cell has no color!” Click here facebook.com/events/s/world-sickle-cell-day-2022/36292878… to join our Facebook event page to stay in the know.
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Golie. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
Happy Father's Day to the dads at Agios! We're grateful for you and the work you do for patient communities every day. #fathersday2022
-
Agios
@AgiosPharma
As we honor #juneteenth, we reaffirm our commitment to health equity and creating a workplace that celebrates differences. Today and every day, we honor the experiences and diversity of our team, communities, and the patients we serve. Learn more: nmaahc.si.edu/explore/stories/what-juneteenth
-
Agios
@AgiosPharma
June 19th is #worldsicklecellday, and members of our team shared how they are honoring this important day. We’re proud to be allies of the #sicklecell community, amplifying their voices and advocating for improved care. www.agios.com/genetically-defined-diseases/sickle-cell-di…
-
Agios
@AgiosPharma
Attention #sicklecellwarrior – The new RISE UP sickle cell clinical trial is now open for enrollment. See more stories from Warriors like Teonna. Get the details: www.riseupstudy.com
-
Agios
@AgiosPharma
In recognition of next week's #worldsicklecellday, hear from DeMitrious, #sicklecellwarrior, about the need for a solid connection between those innovating potential new #sicklecelldisease treatments & the #sicklecell community. #nothingforuswithoutus vimeo.com/718800338
-
Agios
@AgiosPharma
Are you ready #sicklecellwarrior? The new RISE UP sickle cell clinical trial from Agios is now open for enrollment. Learn more: www.riseupstudy.com
-
Agios
@AgiosPharma
Last week we celebrated Pride Month at our HQ! The event featured delicious food, decorations and a competitive game of bingo. We also raised over $1500 for @TEFMass Thank you to everyone who donated & thank you to our Pride employee group for hosting such a fun event! #pride2022
-
Agios
@AgiosPharma
We'll be hosting a virtual investor event on Monday, June 13 in conjunction with the 2022 @EHA_Hematology Congress. #eha2022 Access the webcast here:
investor.agios.com/events/event-details/agios-eha-2022-in… -
Agios
@AgiosPharma
It’s your time, #sicklecellwarrior. The RISE UP sickle cell clinical trial from Agios challenging pain crises and anemia is now open for enrollment. See Warrior Stories: www.riseupstudy.com
-
Agios
@AgiosPharma
As part of our participation at the 2022 @EHA_Hematology Congress, we're presenting new clinical data regarding the impact of our first-in-class PK activator for adults with PK deficiency. #eha2022 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Congrats to former Agioi Kevin Marks for starting a new journey with @GVteam He joined former Agios CEO @schenkein's life science investment team following his time at Novartis & ~12 years on our team. Read about Kevin's exciting mission with GV: endpts.com/exclusive-gvs-david-schenkein-turns-to-a-famil…
-
Agios
@AgiosPharma
We're joining the broader #hematology community at @EHA_Hematology! We're looking forward to sharing our latest clinical data and learning the newest developments in diagnosis and treatment. Learn more about our involvement at #eha2022 here: www.agios.com/eha-2022/
-
Agios
@AgiosPharma
To celebrate #pridemonth2022, we'll be hosting speakers for our team on creating LGBTQIA+ inclusive spaces & current events within the LGBTQIA+ community, as well as making hand-painted art journals for LGBTQIA+ youth. #celebratedifferences
-
Agios
@AgiosPharma
This week, members of our team will share their learnings from the discovery and development of our FDA-approved treatment for #pkdeficiency at the Boston Pharmaceutical & BioScience Society (Boston-PBSS) webinar. Register here: www.pbss.org/aspx/eventInfo.aspx?eID=773
-
Agios
@AgiosPharma
Our team had a great time at the @LS_Cares Boston Impact Breakfast this morning! We’re proud to sponsor this event and help drive this important work to help end poverty in the Greater Boston area.
-
Agios
@AgiosPharma
We're a proud sponsor of @mscdaorg's Sickle Cell Education Day. As part of the virtual event, our Medical Director Amber Yates, MD, FAAP will present the latest from our #sicklecell program. Learn more: marylandsicklecelldisease.org/upcoming-events/sickle-cell…
-
Agios
@AgiosPharma
In this latest episode of Just Listen: Voices of PK Deficiency, Morgan and John, two people living with PK deficiency, share their stories about the importance of self-advocacy when it comes to care. Check it out here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Today we announced an evolution in our research organization. Learn more: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today marks the one year anniversary of @RareCoalition. We are proud to be a founding member and use our #onerarevoice to inform policymakers about #raredisease treatment development so that positive changes can be realized. www.rarecoalition.com
-
Agios
@AgiosPharma
A strong support network is critical for helping #thalassemia patients like Ryan get the care and treatment they need. In honor of yesterday's #internationalthalassemiaday, Ryan shares his lifelong journey of living with thalassemia. #itd2022 vimeo.com/702891906
-
Agios
@AgiosPharma
Today is #internationalthalassemiaday, & we're partnering w/ the community to raise awareness. We encourage you to take action to create change & help transform the lives of millions of people across the globe. For ways to get involved, see here: thalassaemia.org.cy/itd2022/ #itd2022
-
Agios
@AgiosPharma
This week, our own Huijun Wang, Director of Cheminformatics, presented at #bioit22 on her groundbreaking work leveraging #artificialintelligence in drug discovery. Congrats, Huijun! www.bio-itworldexpo.com/ai-pharma-biotech
-
Agios
@AgiosPharma
Thalassemia is a blood disorder caused by inherited mutations in the alpha- or beta-globin genes. People with alpha- & beta-thal can experience symptoms including anemia, jaundice and more. Read about our dedication to #thalassemia patients here: www.agios.com/genetically-defined-diseases/thalassemia/ #itd2022
-
Agios
@AgiosPharma
Today we reported our Q1 2022 business highlights and financial results. Check out our press release for more info: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Hear from Tobias, a recent college graduate who is living with alpha-thalassemia, as he talks about how #thalassemia impacts his everyday life and how he manages it alongside some of his favorite activities including hiking, biking and more. vimeo.com/702892557
#itd2022 -
Agios
@AgiosPharma
Back for a new season of Cheat Codes, our own Ahmar U. Zaidi, MD (Dr. Z) & Michael U Callaghan, MD (Dr. Mike) debut a series about the “Legends of Sickle Cell”! This episode features Dr. Michael DeBaun & #sicklecellwarrior legend Shamonica Wiggins. podcasts.apple.com/us/podcast/cheat-codes-a-sickle-cell-p…
-
Agios
@AgiosPharma
We were so grateful for the opportunity to connect with #sicklecellwarrior Dominique Friend @Sickle1000 yesterday as part of our Connections Week! Thank you, Dominique, for sharing your experience, advice and sense of humor with us!
-
Agios
@AgiosPharma
Today our Agios Connections Week continued with a chance for conversation and socializing! On-site employees took a break to enjoy a dessert from a local food truck and chat, while remote Agioi grabbed a cocktail for virtual conversation roulette to connect with coworkers online!
-
Agios
@AgiosPharma
For our second day of Connections Week, we partnered w/ @Generus_Co on a virtual community service event making soap for refugees. Our amazing team loves to make a difference & were grateful for the opportunity to give back to those in need – and learn about soapmaking too!
-
Agios
@AgiosPharma
#internationalthalassemiaday is May 8 and we'll be featuring patients & caregivers & their experiences with the disease. Meet Jill, caregiver to her daughter Madison, who opens up about the challenges of living with thalassemia at a young age.
#itd2022 vimeo.com/702891452 -
Agios
@AgiosPharma
Hear from AAC member and Founder and Board President of the Pyruvate Kinase Deficiency Foundation, Alejandra Watson, on the latest episode of Just Listen: Voices of PK Deficiency! Listen here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Connections are so important to our culture at Agios, so we are dedicating an entire week to it! This week we will host events & activities to grow connections between our employees & patients, our communities & each other! Learn more about our culture: www.agios.com/inside-agios/culture/
-
Agios
@AgiosPharma
At Agios, we strive to open the door to our industry and increase diversity in the life sciences through participating in the programs like the @MassBioEd Life Sciences Apprenticeship program and @ProjectOnramp Internships. Read more in our #esg Report www.agios.com/about-us/corporate-social-responsibility/
-
Agios
@AgiosPharma
We’re proud to support @CitySprouts mission to advance hands-on science education and a healthier planet through urban gardens in local schools. On behalf of our team, we’re donating to help support programming for an additional 1,000 students! #earthday
-
Agios
@AgiosPharma
Happy Earth Day! Today and every day, we are committed to working together to sustain our environment and support a healthier planet for all.
-
Agios
@AgiosPharma
On the latest episode of Just Listen: Voices of PK Deficiency, we introduce the work of the Pyruvate Kinase Deficiency AAC - an international group of experts including patients, caregivers, advocates, and clinicians. Listen here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Congrats to our CMO Sarah Gheuens for being named one of @INVIVOnow’s 2022 Rising Leaders! The leaders were chosen based on achievements, creativity & strong leadership qualities, and their ability to drive new, unique health initiatives. Read more here: insights.citeline.com/IV125039/In-Vivos-2022-Rising-Leade…
-
Agios
@AgiosPharma
Even before the pandemic, Agios was dedicated to embracing flexibility. We used our learnings from the pandemic to initiate our “Reimagining Work” pilot program to give our team complete flexibility in when and where they work. Read more in our #esg Report www.agios.com/wp-content/uploads/2022/04/2022-Agios-ESG-R…
-
Agios
@AgiosPharma
Good luck to Agioi Bruce Car, Dave Pirman and Andy Worth as they prepare to run the @bostonmarathon on Monday! A special congrats to Dave & Bruce who have been fundraising and will be running to support @BayCoveMA
-
Agios
@AgiosPharma
Our own Ahmar Zaidi and Jeremie Estepp were honored to speak and be recognized for their partnerships with the sickle cell community at the “Art in The Park” event in Las Vegas on April 2. This was a great first in-person event for #sicklecellwarriors in Las Vegas!
-
Agios
@AgiosPharma
We're proud to announce that data from the pivotal Phase 3 ACTIVATE study of PYRUKYND ® (mitapivat) were published on April 14, 2022 in the New England Journal of Medicine. Read more and see the link to the publication in the announcement below! investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We were honored to be recognized as an “Excellence in Rare Disease Drug Development” finalist at the @Pharma_Intell Citeline Awards ceremony last week. Congratulations to all finalists, who have made important contributions in biopharma R&D. #citeline_awards
-
Agios
@AgiosPharma
Patients are the true experts in their disease, and their partnership in clinical trials is essential for developing meaningful new innovations. Read more in our #esg Report about how we incorporate the patient voice into our trial development. www.agios.com/wp-content/uploads/2022/04/2022-Agios-ESG-R…
-
Agios
@AgiosPharma
Coming soon: A clinical trial for you, #sicklecellwarrior. For your fellow Warriors. For the future development of
#sicklecell treatments. -
Agios
@AgiosPharma
The fight against #sicklecell is hard—and we’re rising to the challenge. Sickle cell won’t stop us when we fight it together,
#sicklecellwarrior -
Agios
@AgiosPharma
We’re excited to launch our 2022 ESG! We are proud to support ESG initiatives that are aligned with our culture and values and that may positively impact the patients we serve, our employees, our communities, and our world. Read more here www.agios.com/wp-content/uploads/2022/04/2022-Agios-ESG-R… #esg #csr
-
Agios
@AgiosPharma
Coming soon: We're joining the fight against #sicklecell and stand alongside the #sicklecellwarrior community.
-
Agios
@AgiosPharma
Did you catch the latest episode of Just Listen: Voices of #pkdeficiency? Hear from the Founder and Board President of the #pyruvatekinasedeficiency Foundation (@2021PKDF), Alejandra Watson, here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
The deadline to apply for the first Agios Hemolytic Anemias Clinical Fellowship Grant Award program has been extended through 2022! Applications will be evaluated on a rolling basis. Learn more here: agios.envisionpharma.com/vt_agios/
-
Agios
@AgiosPharma
On the latest episode of Just Listen: Voices of PK Deficiency podcast, Alejandra Watson and Laura Miller D'Angelo of @2021PKDF share more about the organization, as well as their experiences as caregiver and patient, respectively. Tune in! podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We're presenting at @Oppenheimer 32nd Annual Virtual Healthcare Conference today at 1:20 p.m. ET. The live webcast will be available for viewing during the presentation and up to two weeks after the event. Tune in: investor.agios.com/news-events/events-presentations #opcohc22
-
Agios
@AgiosPharma
Stay tuned for the next episode of Just Listen: Voices of #pkdeficiency podcast, coming on Wednesday! The episode will feature Alejandra Watson & Laura Miller D'Angelo of #pyruvatekinasedeficiency Foundation (@2021PKDF). Catch up on other episodes here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We’re proud to sponsor the @IINE's virtual celebration of International Women’s Day tomorrow! The event honors the achievements of immigrant & refugee women who have made a difference in New England & around the world. Register here: iine.org/registeriwd22/ #womenshistorymonth
-
Agios
@AgiosPharma
Catch our presentation at the @Cowen_Inc 42nd Annual Virtual Healthcare Conference on Monday at 9:10 a.m. ET. Tune in to the live webcast to hear our latest company updates: investor.agios.com/news-events/events-presentations #cowenhealthcare
-
Agios
@AgiosPharma
We #standwithukraine. Along with many colleagues in life sciences, we pledge to cease business involvement in Russia until the restoration of peace and democracy in a sovereign Ukraine. Join us! medium.com/@BusinessLeadersForUkraine/call-for-business-l…
-
Agios
@AgiosPharma
Today is #rarediseaseday! Today, and every day, we remain committed to improving the lives of people with #rarediseases.
-
Agios
@AgiosPharma
We're looking forward to presenting at the @Cowen_Inc 42nd Annual Virtual Healthcare Conference and @Oppenheimer's 32nd Annual Virtual Healthcare Conference in March! See the links to the webcasts here: investor.agios.com/news-events/events-presentations
#cowenhealthcare #opcohc22 -
Agios
@AgiosPharma
Did you catch the newest episode of Just Listen: Voices of PK Deficiency? Tune in to hear from Tamara Schryver and Carl Lander of Thrive with PK Deficiency (@TwPKDnonprofit). Listen here or wherever you get your podcasts! podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We wouldn’t be where we are today without the important contributions of Black healthcare providers and researchers. Daunte Davis, #sicklecell warrior, reminds us all to recognize these contributions as we celebrate #blackhistorymonth.
-
Agios
@AgiosPharma
Today we’re reporting Q4 and FY 2021 business highlights and financial results, as well as recent updates including last week’s FDA approval of PYRUKYND® (mitapivat). Check out our press release for more info. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re proud to be a sponsor of @MassBio’s #rarediseaseday event, which recognizes research being done in MA to improve care for people living w/ #rarediseases & how we can better address health inequity & racial disparities in the community. Register here: massbio.microsoftcrmportals.com/event/?event=2022_Rare_Di…
-
Agios
@AgiosPharma
This year, as we recognize #blackhistorymonth, we reached out to members of the #sicklecell community to get their perspectives on the importance of the month. Mia Robinson, sickle cell warrior, reminds us to celebrate Black history 365 days a year.
-
Agios
@AgiosPharma
Dr. Amber Yates shares her journey transitioning from a hematologist to working as part of our team focused on #pkdeficiency and other hemolytic anemias. We're happy to have her with us to help make a difference for people w/ genetically defined diseases. vimeo.com/678890334
-
Agios
@AgiosPharma
Wonderful @BostonGlobe article featuring stories from participants and a principal investigator in our #pkdeficiency clinical program. The approval of the first therapy for this rare blood disorder was only possible because of the collaboration of so many. #fueledbyconnections
Anissa Gardizy
@anissagardizy8
The FDA approved @AgiosPharma's pill for pyruvate kinase deficiency, a rare blood disorder.
It's the company's first commercial product since the sale of its cancer business to Servier for up to $2 billion
www.bostonglobe.com/2022/02/17/business/agios-wins-fda-ap… for @BostonGlobe -
Agios
@AgiosPharma
We are committed to serving and partnering with the #pkdeficiency community and to maximizing our positive impact through robust support, education and access programs. #fueledbyconnections
-
Agios
@AgiosPharma
Here at Agios, we are #fueledbyconnections. Working together with patients, caregivers, advocates and healthcare professionals helped pave the road to developing the first FDA-approved treatment for #pkdeficiency.
-
Agios
@AgiosPharma
We're so excited to share that the FDA approved our first #geneticallydefineddisease medication – the first therapy for a serious, rare blood disorder. We have studied this medication for 7+ years in the clinic & are proud to deliver it to patients today! investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
For the 2nd year, we’re excited to be a Gallagher Best-in-Class employer! We’re dedicated to providing our team with a flexible and inclusive benefits, which makes it extra special to be recognized for our commitment to supporting employee wellbeing.
-
Agios
@AgiosPharma
New episode of Just Listen: Voices of PK Deficiency! Tune in to hear from the leaders of Thrive with PK Deficiency (@TwPKDnonprofit), Tamara Schryver and Carl Lander and learn about their experiences living with this rare blood disorder. podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We celebrate the contributions and accomplishments of the Black community, including our own team members and individuals in the patient communities we serve. #blackhistorymonth
-
Agios reposted
Pyruvate Kinase Deficiency International Alliance
@2021PKDF
It's our first annual PKD Day! Thanks to our partners, stakeholders and PKD Community for their support today. After 60 years it feels great to be able to call a day "our own" and celebrate! <3
-
Agios
@AgiosPharma
Do you live with #pkdeficiency or care for someone who does? Hope to see you at the upcoming #knowpkdeficiency webinar, “Listening to the Community: How Communication Impacts the Patient Experience”. Register: www.knowpkdeficiency.com/patient-programs
-
Agios
@AgiosPharma
Today is the first annual PK Deficiency Day! Organized by @2021PKDF #pkdday raises awareness for the ~3-8K people living w/ #pkdeficiency, a rare blood disorder, in the US/EU5 and their caregivers. We are proud to work together with this community. www.pkdf.org/pyruvate-kinase-deficiency-day
-
Agios
@AgiosPharma
When asked about the healthcare industry and #blackhistorymonth, Cory Lewis - a #sicklecell warrior - eloquently recognized the opportunity for increased understanding and trust.
-
Agios
@AgiosPharma
#rarediseaseday is coming up at the end of February! We’re proud to serve patients with rare diseases and are committed to continuing to build strong and collaborative partnerships with these communities to help those in need. #rarediseaseday
-
Agios
@AgiosPharma
We will host a webcast conference call of our fourth quarter and year end 2021 financial results on Thursday, Feb. 24, 2022, at 8:00 a.m. ET. You can find details on how to tune in on our website here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
André Harris is a #sicklecell warrior. We recently asked André why he thinks the healthcare industry should recognize #blackhistorymonth. As a true warrior, he reminds us of the need for reflection, but also the need to look to the future.
-
Agios reposted
Know PK Deficiency
@PKdeficiency
Getting family and friends to understand the impact of PK deficiency can sometimes be difficult, as Becky has experienced. The website knowpkdeficiency.com is a great resource that patients and caregivers can use to help educate others. #knowpkdeficiency
-
Agios
@AgiosPharma
We are always looking for new ways to improve #healthequity for people living with a #raredisease, including access to diagnosis, high-quality healthcare and social opportunity. #rarediseaseday
-
Agios
@AgiosPharma
Congratulations to the #raredisease researchers who were drafted for @UpliftingAth Young Investigator Draft! We’re thrilled to support innovation and diversity in rare disease research.
Uplifting Athletes
@UpliftingAth
🚨ʙʀᴇᴀᴋɪɴɢ ɴᴇᴡꜱ
Meet the top 9 rare disease research prospects that will be selected at 2022 Young Investigator Draft presented by @CSLBehring! Each researcher selected receives $20,000! Learn about them here --> upliftingathletes.org/yid -
Agios
@AgiosPharma
Congratulations to the @LS_Cares 2022 grant recipients! These 28 nonprofit organizations are doing amazing work combating poverty and alleviating its effects through improving education, basic needs, and economic sustainability in Greater Boston.
Life Science Cares
@LS_Cares
We truly couldn't be more excited about our incredible cohort of nonprofits. Check out this video to see some of their reactions to receiving the news about our partnership: youtu.be/fsV_i_nmrkY
#lscimpact -
Agios
@AgiosPharma
We are honored to be a sponsor of @UpliftingAth Underrepresented Researchers in Medicine Initiative, which celebrates and supports young #raredisease researchers from diverse backgrounds, providing better representation for patients from all walks of life. #rarediseaseday
Uplifting Athletes
@UpliftingAth
𝗬𝗼𝘂𝗻𝗴 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿 𝗗𝗿𝗮𝗳𝘁 🔜 𝗙𝗲𝗯. 𝟱
Celebrate the young investigative researchers that are looking to increase understanding of rare diseases!
Join us from your home or in person and secure your ticket 🎟️-> yid.ticketbud.com/upliftingathletes
#wetacklerare -
Agios
@AgiosPharma
Did you catch the second episode of our podcast Just Listen: Voices of PK Deficiency? Guest interviewer and PK deficiency patient Jill Welle interviews our CMO, Sarah Gheuens – be sure to check it out here or wherever you listen to your podcasts: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We launched the first Agios Hemolytic Anemias Clinical Fellowship Grant Award program! The grant is intended to increase the number of skilled clinicians committed to providing comprehensive care for those living w/ non-malignant hematological disorders. agios.envisionpharma.com/vt_agios/
-
Agios
@AgiosPharma
In episode 2 of our podcast Just Listen: Voices of PK Deficiency, guest interviewer and PK deficiency patient Jill Welle sits down to speak with our CMO Sarah Gheuens. Check out the episode here: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
On Monday, January 17 we will be closed to observe Martin Luther King, Jr. Day. We celebrate his legacy and reflect on his fight for freedom, equality and dignity for all. #mlkday
-
Agios
@AgiosPharma
As a company serving people with blood disorders, this is an issue close to our hearts. Please consider donating to help provide blood to patients in need.
American Red Cross
@RedCross
We're facing a national blood crisis.
Doctors are having to make tough choices about who receives transfusions and who has to wait. You can help by making an appointment to give at rdcrss.org/3JXls3M or these 3 other ways. -
Agios
@AgiosPharma
Our CEO Jackie Fouse will present at the 40th Annual @jpmorgan Healthcare Conference on Wednesday, 1/12 at 7:30am ET. Check out the live webcast or watch the play on the Investors section of our website here: investor.agios.com/news-events/events-presentations #jpm22
-
Agios
@AgiosPharma
It's a new year, and we've got a new website to share! Check out our fresh look for a new take on how we are building connections and pioneering therapies for people with genetically defined diseases. www.agios.com #fueledbyconnections
-
Agios
@AgiosPharma
We are proud to announce our 2022 key milestones and priorities that will drive our transition to a commercial-stage genetically defined disease company along with the expansion of our robust clinical and research portfolio. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Agios will be closed until January 2nd for our annual winter shutdown. We hope everyone has a safe and happy holiday. We look forward to helping more patients in 2021!
-
Agios
@AgiosPharma
As part of our “Season of Service,” we partnered with the @RedCross to donate blood at locations across the U.S. As a company serving people with blood disorders, we’re proud to give back in our communities and help provide blood donations to patients in need!
-
Agios
@AgiosPharma
We got in the giving spirit this holiday season by putting together STEAM (science, technology, engineering, art, and math) kits for children who are staying long-term in the hospital. What an inspiring way to spread joy together!
-
Agios
@AgiosPharma
The #pkdeficiency Advocacy Advisory Council, sponsored by Agios, provides a great educational resource on the experiences of people living with #pkdeficiency. Check it out on the @thalassaemiaTIF website: thalassaemia.org.cy/news/the-aac-white-paper-on-pyruvate-…
-
Agios
@AgiosPharma
We are proud to participate in the @MassBioEd Life Sciences Apprenticeship Program, which is geared toward increasing diversity in the life sciences & meeting company needs for skilled workers. Learn more about the apprenticeship program here: commonwealthmagazine.org/opinion/apprenticeships-create-n…
-
Agios
@AgiosPharma
Did you catch the first episode of the Just Listen: Voices of PK Deficiency podcast? Hear from #pkdeficiency patient, Nathan Thompson, as he shares his journey, facing the challenges of living with PK Deficiency & what he has learned. podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We're #fueledbyconnections. Tune in to this episode of Cheat Codes: A Sickle Cell Podcast w/ CMO Sarah Gheuens & special guest host, patient advocate Blaze Eppinger to learn about our #sicklecelldisease clinical program & how we partner w/ the community.
podcasts.apple.com/us/podcast/46-fueled-by-connections-ag… -
Agios
@AgiosPharma
New episode alert! On the first episode of Just Listen: Voices of PK Deficiency, we hear from #pkdeficiency patients Jill Welle & Nathan Thompson as they take us through their stories about living with PK Deficiency. Tune in wherever you get your podcasts! podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
Check out the first full episode of the Just Listen: Voices of PK Deficiency podcast, available December 15! This episode features #pkdeficiency patient, Jill Welle. Listen wherever you get your podcasts! podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de…
-
Agios
@AgiosPharma
We’re pleased to announce that we’ve expanded Anemia ID, which provides genetic testing for people with suspected hereditary anemias. The program now offers no-cost genetic counseling through @InformedDNA as well! www.anemiaid.com
-
Agios
@AgiosPharma
We enjoyed connecting with the #hematology community at #ash21. For a recap of our presentations, new data and what it means for the patients, caregivers and other communities we serve, check out our presentation from this morning's investor event here: investor.agios.com/events/event-details/ash-investor-event
-
Agios
@AgiosPharma
To cap off #ash21, we reported new data from the ongoing long-term extension study assessing the duration of effects of our investigational therapy for #pkdeficiency, including impact on hemoglobin and transfusion burden. See more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
View the data from the long-term extension period of our Phase 2 study in adults with #thalassemia, as well as learn about our ENERGIZE and ENERGIZE-T pivotal studies. #ash21 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today we announced new data from investigator-led studies of our potential treatment for #sicklecelldisease. Thank you to our collaborators at the @NIH and @UMCUtrecht Read the full release. #ash21 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We're excited to be back at the @ASH_hematology Annual Meeting & Expo to engage with clinicians, researchers and the hematology community at-large. Check out the list of our oral presentations! #ash21
-
Agios
@AgiosPharma
This holiday season, we were thrilled to help 81 families facing life-threatening illnesses as part of our annual Giving Tree program in partnership with the Frank & Rosemary Iovieno Caring for Children Foundation! We can’t wait for the kids to open their gifts!
-
Agios
@AgiosPharma
This past weekend we were proud to sponsor a symposium at the @thalassaemiaTIF Conference on pyruvate kinase activation and its therapeutic potential across hemolytic anemias. Thank you to all who participated!
-
Agios
@AgiosPharma
An environment that supports mental health and bringing our whole selves to work is critical to our mission of making a difference for people with genetically defined diseases. Find out more in this @BostonGlobe feature sponsored by @HarvardPilgrim
sponsored.bostonglobe.com/harvard-pilgrim-health-care/emp… -
Agios
@AgiosPharma
We are excited to participate in the upcoming @thalassaemiaTIF Conference this week! We look forward to engaging with different stakeholders as we work together to help improve the quality of life for those living with rare blood disorders.
TIF
@thalassaemiaTIF
As the #tif2021🩸is rapidly approaching, we would like to acknowledge & thank our #sponsors @bmsnews, @AgiosPharma & @bluebirdbio for supporting our mission & making this groundbreaking event possible!
More about our sponsors & #supporters👇
tifeducation.org/sponsors/
#thalassaemia -
Agios
@AgiosPharma
Introducing Just Listen: Voices of PK Deficiency Podcast! Join us as we share patient and caregiver stories as well as the latest research, developments, and science from leaders in PK deficiency. Tune in: podcasts.apple.com/us/podcast/just-listen-voices-of-pk-de… #pkdeficiency #knowpkdeficiency
-
Agios
@AgiosPharma
Thanks to @SciScientists for hosting a hybrid lunch & learn at Agios to share about your mission to inspire interest in STEM among elementary school kids! We had a great time putting on our 5th grade thinking caps and participating in a sample lesson on cleaning up oil spills.
-
Agios
@AgiosPharma
We are thrilled to announce the appointment of Richa Poddar to the role of chief commercial officer. Richa joined Agios nearly six years ago and played a significant role in shaping our portfolio and launching Agios’ first two commercial medications. investor.agios.com/news-releases/news-release-details/agi…
Agios
@AgiosPharma
We thank current CCO Darrin Miles for his meaningful contributions, including his foundational work to position us well for our first genetically defined disease product launch. We wish him the best in his new role as CEO of a private biotech company.
-
Agios
@AgiosPharma
This week we hosted a hybrid all-company event to connect with each other, our communities and patients! We held a panel discussion with a #pkdeficiency patient & ended with an event so everyone could spend time getting to know each other. And of course, there was food for all!
-
Agios reposted
BloodStream Media
@BloodStrmMedia
On Oct 29, #hertznazaire (@Nazaire73), a prominent #sicklecellwarrior and prolific artist, passed away suddenly.
In his honor, we're re-publishing @drzsicklecell's interview w/ him for #cheatcodespod.
Thank you, Hertz.
You're already sorely missed.
#gonetoosoon
#sicklecell -
Agios
@AgiosPharma
This open enrollment we’re excited to announce a new lifestyle spending account benefit for the Agios team! This Agios-funded account provides reimbursement for personal & wellness expenses, and employees choose how to use funds. #workperks #wellness www.agios.com/careers/benefits/
-
Agios
@AgiosPharma
We are looking forward to #ash21 and sharing new data across our #pkdeficiency, #thalassemia and #sicklecelldisease programs! Check out our accepted abstracts: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We are proud to announce that we have initiated two Phase 3 studies – ENERGIZE and ENERGIZE-T – in not regularly transfused and regularly transfused adults with α- and β-thalassemia, underserved patient communities with significant unmet medical needs. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Today we released our Q3 2021 earnings. You can read the full press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Catch the latest episode of Cheat Codes with CCO Darrin Miles, Head of Patient Advocacy Holly John and special guest host, Blaze Eppinger! The episode highlights our approach to partnering with #sicklecell warriors and our perspective on healthcare access. #fueledbyconnections
-
Agios
@AgiosPharma
Such a tremendous loss in the #sicklecell warrior community. Your voice, your art and your spirit will carry on. Rest In Power, Hertz Nazaire (@Nazaire73)
Elle Cole (She/her)
@Cleverlychangin
When I think of sickle cell. I see a picture of Hertz Nazaire (@Nazaire73) and his famous painting in my mind. I hate to say goodbye to a man who changed the way we see sickle cell. RIP Hertz we always remember you!
#sicklecelldisease #sicklecell #riphertznazaire -
Agios
@AgiosPharma
We are privileged to get to spend time with Jonathan and his mom, Alejandra! We’re thankful that Jonathan trusted us to help tell his story with PK deficiency and we can’t wait to share his inspiring journey. #knowpkdeficiency
Know PK Deficiency
@PKdeficiency
Our journey continued in Walled Lake, Michigan. Last weekend, we were with Jonathan and his mom, Alejandra. Jonathan lives with PK deficiency and they’re sharing their experiences to help the world #knowpkdeficiency.
-
Agios
@AgiosPharma
We will host a webcast conference call of our third quarter 2021 financial results on November 3, 2021 at 8:00 a.m. Tune in!
-
Agios
@AgiosPharma
We’re so lucky to get to know people like Becky, who is a caregiver for her daughter with PK deficiency. Take a look at this behind-the-scenes photo when we were welcome into her family’s home to help them share their experiences with this disease. #knowpkdeficiency
Know PK Deficiency
@PKdeficiency
Welcome to Billings, Montana! We talked to Becky and her family yesterday. Becky’s daughter lives with PK deficiency, and she and her family shared their experiences. In the next few months, we will be featuring their inspiring story. Stay tuned! #knowpkdeficiency
-
Agios
@AgiosPharma
Our patient advocacy team is growing! We’re excited to share that Janie Davis & Phill Okwo have joined Holly John. The team is committed to connecting with PK deficiency, thalassemia & sickle cell disease patients & partnering with these communities. Welcome, Janie & Phill!
-
Agios
@AgiosPharma
Congratulations to our CEO Jackie Fouse on being named one of the @BosBizJournal's 2021 Power 50: The Movement Makers. We’re proud to have a CEO who works every day to create meaningful change in our communities! @BosBizEvents #bbjpower50 www.bizjournals.com/boston/news/2021/10/13/2021-power-50-…
-
Agios
@AgiosPharma
We’re excited to partner with @LS_Cares in their official launch of #lsconetoone, a program connecting students underrepresented in the industry with career exploration opportunities & strong professional networks. What a great way to start #massstemweek lifesciencecares.org/news/new-life-science-industry-progr…
-
Agios
@AgiosPharma
Last week a group of Agioi got together to complete the JP Morgan Corporate Challenge around our Cambridge office. Congratulations to all of this year’s finishers! #jpmcc
-
Agios
@AgiosPharma
The @RareDiseases #nordsummit provides an important opportunity for advocates & leaders to come together & make positive changes for the community. We're excited to hear from #raredisease stakeholders virtually starting on 10/18. Check out the agenda! nordsummit.org/agenda/
-
Agios
@AgiosPharma
We’re proud to share DeMitrious’s music video introducing Agios & our #sicklecelldisease research that debuted at the @SCDAAorg Convention! We’re lucky to be able to partner w/ sickle cell warriors to create connections & raise awareness. #scdunstoppable vimeo.com/626685816
-
Agios
@AgiosPharma
We were so excited to unveil the name of our Phase 2/3 #sicklecelldisease study at the @SCDAAorg Convention. The study name & logo were developed in partnership with a group of sickle cell warriors from around the world. #nothingforyouwithoutyou #scdunstoppable
-
Agios
@AgiosPharma
We are a proud sponsor of the annual @RareDiseases & Orphan Products Breakthrough Summit happening virtually on October 18-19. #nordsummit nordsummit.org
-
Agios
@AgiosPharma
Providing benefits that are inclusive of all employees at every life stage is an important part of our values. We’re excited to partner with @CarrotFertility to offer fertility and family-forming benefits to support our growing, diverse workforce. www.agios.com/careers/benefits/
-
Agios
@AgiosPharma
Agios is proud to partner with @LS_Cares on the new One-to-One career mentoring initiative! This program provides local under-resourced college students with access to industry professionals for one-on-one conversations around networking and career exploration.
-
Agios
@AgiosPharma
Congrats to our Sr. Director of Marketing, Stephanie Mason! She's been recognized as a Top 25 @DTCPerspectives Marketer of the Year for her efforts on our #knowpkdeficiency campaign, which was designed to raise awareness for @PKDeficiency. dtcperspectives.com/dtcn/2021-top-dtc-marketers-of-the-year/
-
Agios
@AgiosPharma
Meet Deji Oluyadi, Associate Director of Clinical Development. It’s employees like Deji that make our culture so special!
-
Agios
@AgiosPharma
We're looking forward to exploring critical topics affecting millions of Americans impacted by #rarediseases at the @RareDiseases Breakthrough Summit on October 18-19. Register by 10/4 & join us for these important discussions! #nordsummit
nord.cventevents.com/event/777ab435-f3a6-47cd-9f69-603daf… -
Agios
@AgiosPharma
Thank you to our own Holly John and Ahmar Zaidi for hosting a hybrid Lunch & Learn for our team today celebrating #sicklecell Warriors! We loved learning more and celebrating the progress the community has achieved in the past 5 years.
-
Agios
@AgiosPharma
We are committed to partnering with the sickle cell community to shed light on the need for research and treatment of #sicklecelldisease. Join us in recognizing sickle cell warriors and honoring their experiences and journeys. #sicklecellawarenessmonth vimeo.com/611701615
-
Agios
@AgiosPharma
Today our scientists hosted a hybrid Agios Science Day to showcase their latest projects. We loved being able to see the innovative research our teams have been working on. Thank you to everyone who participated!
-
Agios
@AgiosPharma
We’re excited to sponsor the Rare Disease Film Festival for the 2nd year! This festival features moving, short documentary films about people living w/ #rarediseases & gives us an opportunity to better understand those we seek to serve. Register here: informaconnect.com/rare-disease-film-festival/
-
Agios
@AgiosPharma
We’re proud to be an employer partner of @MassBioEd's Life Sciences Apprenticeship Program and support the creation of career paths jobs in the #lifesciences. Learn more at the Launch Event on 9/23! www.massbioed.org/event/apprenticeshiplaunch/ #mbeapprenticeship
-
Agios
@AgiosPharma
This #sicklecellawarenessmonth, we’d like to welcome you into our space through this virtual tour of Agios, led by #sicklecell warrior DeMitrious. We’re proud to be a place where science meets heart, and meaningful connections fuel new innovations. vimeo.com/600398975
-
Agios
@AgiosPharma
Congrats to @SickleCellMI on 50 years of supporting individuals living with #sicklecelldisease. As part of the celebration, we are sponsoring the Sickle Cell Matters Virtual Walk happening all month long. It’s time to get active! www.scdaami.org/2021-sickle-cell-matters-walk
-
Agios
@AgiosPharma
We are proud to stand with the #raredisease community to urge policymakers to consider the negative impact that changing the #orphandrugtaxcredit would have on one of America’s most underserved medical populations. #onerarevoice
The Rare Disease Company Coalition
@RareCoalition
Read our statement against proposed changes to the #orphandrugtaxcredit in #buildbackbetter Act which would deliver a devastating blow to #raredisease patients & companies dedicated to delivering treatments for them. We urge #congress to consider these impacts. #onerarevoice
-
Agios
@AgiosPharma
We're proud to stand with a community that inspires us every day. #sicklecell warrior, Blaze, shares his experience with the disease in a moving poem. During #sicklecellawarenessmonth & going forward, we’ll keep working toward the goal of advancing care for #sicklecelldisease.
-
Agios
@AgiosPharma
We are a proud sponsor of the @CayenneWellness 13th Annual #sicklecelldisease Educational Seminar. Register by clicking the link below to engage with the community in raising awareness of the multi-factorial aspects of sickle cell disease. cayennewellness.org/2021-scd-virtual-seminar-2/
-
Agios
@AgiosPharma
Our CMO, Sarah Gheuens, is presenting at the Sickle Cell Disease Therapeutics Conference on 9/15 to share our #sicklecelldisease research & how #sicklecell Warriors have inspired us & helped shape our clinical program. Register & tune in at 1:50 p.m. ET! www.cvent.com/events/EventInactive.aspx?e=d3f87f33-b824-4…
-
Agios
@AgiosPharma
We are looking forward to joining the community virtually on Sept. 15 for the Sickle Cell Disease Therapeutics Conference to discuss the latest advancements and future trends for treating patients with #sicklecelldisease. Register for the event here: scdconference.com
-
Agios
@AgiosPharma
We are excited to connect with the #sicklecelldisease community virtually at the @CayenneWellness Seminar on Sept. 16-18. Hear from professionals and advocates in the #sicklecelldisease space, including team members of our own. Learn more & register here: cayennewellness.org/2021-scd-virtual-seminar-2/
-
Agios
@AgiosPharma
Meet Sandra King, Associate Director/Principal Scientist, Chemistry. We’re lucky to have you on our team, Sandra!
-
Agios
@AgiosPharma
Congrats to our Chairman & former CEO David @schenkein for his recognition in @endpts 20 most influential biopharma R&D execs. As CEO for ~10 years, he grew Agios into a publicly traded biotech with 500 employees, 2 approved drugs & a strong pipeline. endpoints.news/from-bench-to-boardroom-20-of-the-most-inf…
-
Agios
@AgiosPharma
We're excited to attend the ASH @ConquerSCD meeting this Friday & proud to be a part of a coalition that amplifies the voices of the sickle cell community & helps improve outcomes for those with #sicklecelldisease. Learn more about the coalition here: www.scdcoalition.org
-
Agios
@AgiosPharma
September is #sicklecellawarenessmonth. We’re proud to partner with the #sicklecell community and amplify their voices. Learn more about our commitment to #sicklecelldisease through the inspiring video and song created by #sicklecell warrior, DeMitrious. vimeo.com/599662287
-
Agios
@AgiosPharma
We’re excited to welcome our team back after our Summer Shutdown by kicking off our 6-month Reimagined Work experiment! Each location-agnostic team member has the choice to work in-person, remotely, or hybrid according to what works best for their own personal needs.
-
Agios
@AgiosPharma
As we wrap up @SCCConsortium's 8th Annual Warrior's Convention, we're reflecting on the inspiring stories from #sicklecell Warriors and look forward to continuing the important conversations with the community. #warriorsconvention21
-
Agios
@AgiosPharma
We are celebrating all the progress that has been made in the #sicklecelldisease community at @SCCConsortium's #warriorsconvention21 thanks to the resilience of so many warriors. We’re committed to learning and partnering with warriors to drive new advances.
-
Agios
@AgiosPharma
As summer begins to wind down, Agios will be closed next week for our annual Summer Shutdown. We hope our employees enjoy their time off and have a safe and relaxing Labor Day!
-
Agios
@AgiosPharma
Congratulations to our friends and former teammates at @ServierPharma! We’re proud of all your hard work and so excited about what this approval means for patients with previously treated IDH1-mutated cholangiocarcinoma.
Servier Pharmaceuticals
@ServierPharma
#breakingnews: Today we announced the FDA has approved our treatment for previously treated IDH1-mutated cholangiocarcinoma. Learn more: servier.us/blog/tibsovo_fda_approval_idh1-mutated_cca/
-
Agios
@AgiosPharma
We're honored to be named a @Citeline_Awards finalist in the Excellence in Rare Disease Drug Development category for our team’s execution of our ACTIVATE and ACTIVATE-T studies in #pkdeficiency. Congrats to all of the finalists! #citeline_awards
-
Agios
@AgiosPharma
LinkedIn users! 7 in 10 biotech companies name diversity, equity and inclusion as a top priority. In response, @IAmBiotech launched a new LinkedIn group to help connect biotech employers and under-represented #stem candidates. Learn how you can join and why it matters below!
-
Agios
@AgiosPharma
Let's hear it for #sicklecell Warriors! @SCCConsortium's 8th Annual Sickle Cell Patient and Family Symposium is kicking off today, amplifying the knowledge and experiences of #sicklecell patients and caregivers. #warriorsconvention21 www.sicklecellconvention.org
-
Agios
@AgiosPharma
myAgios offers tailored support and resources for people living with PK deficiency, with a dedicated Patient Support Manager who will work with them to address their specific needs. Learn more here: www.myagios.com
-
Agios
@AgiosPharma
We’re proud to sponsor @SCCConsortium's 8th Annual Sickle Cell Patient and Family Symposium! We look forward to engaging with the community virtually at this important and meaningful event next week. #warriorsconvention21 #sicklecell www.sicklecellconvention.org
Sickle Cell Consortium
@SCCConsortium
We are going to have an amazing 8th Annual Warriors Convention and that’s largely due to our sponsors. Without our sponsors, we would not be able to bring the community this amazing convention.
Register Today: www.sicklecellconvention.org
#warriorsconvention21 #sicklecell -
Agios
@AgiosPharma
Check out this amazing article about Wendy Xia, our VP of Supply Chain! Wendy’s commitment to going above and beyond for our patients inspires us every day – we’re proud to have her on our Agios team!
American Healthcare Leader
@AHL_Magazine
Wendy Xia brings her emphasis on building and maintaining relationships to @Agios Pharmaceuticals, where she helps strengthen connection between the company and the patients it serves. Read more: americanhealthcareleader.com/2021/wendy-xia/
-
Agios
@AgiosPharma
We're sponsoring the Sickle Cell Adult Provider Network (SCAPN) Symposium being held virtually at 2-5pm today at @nih_nhlbi's Annual SCD Research Meeting! It's not too late to register and tune in to these educational discussions about #sicklecelldisease. www.nhlbi.nih.gov/events/2021/nhlbis-2021-annual-sickle-c…
-
Agios
@AgiosPharma
Our NDA for an investigational #pyruvatekinasedeficiency therapy has been accepted by @US_FDA and granted Priority Review – an important milestone on the path to delivering the first potentially disease-modifying therapy for people with this #raredisease. investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Building on her impactful leadership at Agios over the last two years, we are excited that Dr. Sarah Gheuens will become our CMO, effective Sept. 1, with the retirement of Chris Bowden. Thank you, Chris, for your impactful work – and congratulations, Sarah!
-
Agios
@AgiosPharma
We were happy to support @FurnitureTrust1 's local school supplies donation drive by donating both new supplies & previously loved supplies from employees who have decided to work remotely more often. We are now proud winners of the “Best Filled Donation Station” award!
-
Agios
@AgiosPharma
We're looking forward to engaging in an important conversation about new scientific and clinical developments in #sicklecelldisease at @nih_nhlbi's Annual SCD Research Meeting starting today! More information on the virtual event here: www.nhlbi.nih.gov/events/2021/nhlbis-2021-annual-sickle-c…
-
Agios
@AgiosPharma
Last week our summer interns wowed us with their end of internship presentations. We’re so grateful to all of our interns for their contributions this summer!
-
Agios
@AgiosPharma
Did you know that we’ve partnered with @PKIGenomics to offer a no-cost genetic testing program for diagnosing people with suspected hereditary anemias? Check out Anemia ID: www.anemiaid.com #knowpkdeficiency
-
Agios reposted
The Rare Disease Company Coalition
@RareCoalition
We call on @POTUS and Congress to recognize the unique circumstances of #raredisease treatment development when considering #drugpricing policies & not ignore the unmet needs of rare disease patients awaiting treatments. Full statement here: www.rarecoalition.com/2021/08/12/the-rare-disease-company… #onerarevoice
-
Agios
@AgiosPharma
Congratulations to our friends and former colleagues at @ServierPharma on the AGILE study meeting its primary endpoint! We’re so proud of you – and importantly, excited for what it means for patients with IDH1-mutated Acute Myeloid Leukemia.
Servier Pharmaceuticals
@ServierPharma
Today we announced positive topline results from our global Phase 3 study in patients with previously untreated IDH1-mutated acute myeloid leukemia or #aml. Read more: servier.us/blog/servier-announces-positive-topline-data-f…
-
Agios
@AgiosPharma
Today we released our Q2 2021 earnings. You can read the full press release here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Yesterday we had the pleasure of a visit from Sickle Cell Warrior DeMitrious Wyant! He spoke with our team about his journey with #scd & helped us with a special project that we can’t wait to share soon! Thank you for sharing your story and incredible talent with us, DeMitrious!
-
Agios
@AgiosPharma
We already introduced you to the newest Agios babies – it been a busy pandemic – but we couldn’t forget about our fur babies! Meet the newest pandemic pets who have joined our Agios family.
-
Agios
@AgiosPharma
We had an amazing opportunity with @kidsintechorg, @CBALowell and @LS_Cares to sponsor STEM-themed backpacks for students in Lowell, MA! Our Agioi enjoyed making slime and building lava lamps with future STEM leaders and can’t wait to see what their futures hold.
-
Agios
@AgiosPharma
We’re hiring! We are opening new positions within the Commercial Operations & Analytics department supporting our pipeline and launch activities. Check out the Senior Director, Commercial Analytics position and other opportunities on our careers page! phe.tbe.taleo.net/phe03/ats/careers/v2/viewRequisition?or…
-
Agios
@AgiosPharma
We will host a webcast conference call of our second quarter 2021 financial results on July 29, 2021 at 8:00 a.m. Read more here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Congrats to @2021PKDF and @TwPKDnonprofit on launching as the first US-based #pkdeficiency advocacy organizations, dedicated to raising awareness and providing resources for the PK deficiency community. Check out their websites!
-
Agios reposted
The Rare Disease Company Coalition
@RareCoalition
We are committed to ensuring that all people living with #rarediseases can benefit from the latest medical innovations. We strive for diversity in clinical trials and advocate for equitable, timely access to potentially life-saving treatments. #onerarevoice @AgiosPharma
-
Agios
@AgiosPharma
Our employees have had a busy year during the pandemic – and not just at work! We’ve been excited to welcome some new members to the Agios family.
-
Agios
@AgiosPharma
Happy Independence Day! We’re closed on Monday, July 5th in observance of the holiday – we hope you can all celebrate with family and friends.
-
Agios
@AgiosPharma
Welcome to the new members of the Rare Disease Company Coalition! We look forward to working together to help patients in need. #raredisease
The Rare Disease Company Coalition
@RareCoalition
We welcome @Atarabio @ChiesiGRD @HorizonNews and Stealth BioTherapeutics to our Coalition, a unified voice of life science companies committed to discovering, developing and delivering #raredisease treatments for the patients we serve. www.rarecoalition.com/2021/06/30/the-rare-disease-company… #onerarevoice
-
Agios
@AgiosPharma
Yes to summer! Those who didn’t come into the office enjoyed some time together with a virtual cocktail class last week. #hybridwork
-
Agios
@AgiosPharma
We have officially submitted a Marketing Authorisation Application to the European Medicines Agency for the treatment of adults with #pkdeficiency in the European Union. Read more on the announcement here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Join us and @RareDiseases & the #raredisease community online for the #livingrareforum. This year’s agenda will feature a lineup of experts to educate patients, caregivers & medical professionals. Register here: nord.cventevents.com/event/b36932ce-27a7-4b1f-98ec-a0f575…
-
Agios
@AgiosPharma
We’re grateful to our Pride ERG for hosting an insightful conversation with Trevor Boylston about his journey and how to build empathy and understanding for transgender & LGBQ+ individuals. #pride2021 #pridemonth
-
Agios
@AgiosPharma
From cancer and vaccines to #pyruvatekinasedeficiency, discover how biotechnology can unlock #naturesbuildingblocks to improve and help save lives. www.naturesbuildingblocksseries.com
-
Agios
@AgiosPharma
We’re proud to be an ally and continue to celebrate #pridemonth – especially since we got to do it in person yesterday afternoon! #pride2021
-
Agios
@AgiosPharma
We applaud the @RareCoalition for making progress on this important effort!
The Rare Disease Company Coalition
@RareCoalition
On behalf of our #raredisease company members, we applaud the introduction of Cures 2.0 by @RepFredUpton and @RepDianaDeGette and encourage Congress to account for the unique circumstances in rare disease treatment development. #onerarevoice
-
Agios
@AgiosPharma
myAgios® patient support services for people living with #pkdeficiency and their caregivers is here! Read more on how we're connecting patients/caregivers with a dedicated Patient Support Manager here: investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Tune in to the latest episode of Cheat Codes: A Sickle Cell Podcast where hosts @drzsicklecell and @hemagineer talk about the ins-and-outs of last month's @FundSickleCell Symposium. Listen and get all the highlights from the virtual conference here: cheatcodes.libsyn.com/what-just-happened-best-of-sickle-c…
-
Agios
@AgiosPharma
We are pleased to announce we have submitted a New Drug Application (NDA) to the FDA for the treatment of adults with #pkdeficiency www.globenewswire.com/news-release/2021/06/21/2250093/0/e…
-
Agios
@AgiosPharma
It is important to learn from #raredisease patients & medical professionals to inform the development of potential new therapies for patients. We’re looking forward to opportunities to learn and connect with others at @RareDiseases #livingrareforum nord.cventevents.com/event/b36932ce-27a7-4b1f-98ec-a0f575…
-
Agios
@AgiosPharma
Wishing all our Agios Dads a very Happy Fathers’ Day! We appreciate you almost as much as your kids do.
-
Agios
@AgiosPharma
World Sickle Cell Day and Juneteenth are two important days to our people at Agios. That’s why we’re giving everyone today off to choose how they want to honor these significant days. #wscd2021 #juneteenth
-
Agios
@AgiosPharma
It’s been inspiring to see these amazing warriors from around the globe all week. Thanks to each of you for sharing your perspectives in support of #wscd2021!
-
Agios
@AgiosPharma
Zakareya is a #wscd2021 warrior from Bahrain, a country with 9,000+ SCD warriors!
-
Agios
@AgiosPharma
Thanks to the Timmerman Report for highlighting our CCO, Darrin Miles, as a prominent Black leader in the industry. We think he’s pretty great, too! #juneteenth2021
Timmerman Report
@timmermanreport
Recognizing 22 Black Biotech Leaders for Juneteenth. timmermanreport.com/2021/06/on-juneteenth-honoring-22-bla…
-
Agios
@AgiosPharma
Meet Jadon, another #wscd2021 Warrior who’s ready to shine the light on this complex puzzle.
-
Agios
@AgiosPharma
We love that goal, Ulysse. Let’s use #wscd2021 to bring attention to this disease and the need for more resources.
-
Agios
@AgiosPharma
#naturesbuildingblocks is now live! We were thrilled to take part in this incredible series, presented by @biotechIntl and @IAmBiotech, which shares stories of the biotechnology industry’s contributions to the world www.naturesbuildingblocksseries.com
-
Agios
@AgiosPharma
You and your daughter are in our hearts, too. Please join us for #wscd2021 to show support.
-
Agios
@AgiosPharma
We are excited to announce our participation in the #naturesbuildingblocks film series, which launches tomorrow! Tune in for breathtaking stories of science, innovation and imagination.
-
Agios
@AgiosPharma
Sickle Cell Disease Warrior Quintissa hopes #wscd2021 helps people around the world understand the disease and its impact.
-
Agios
@AgiosPharma
We’re ready for #wscd2021 this week, are you? Join us in celebrating this amazing community, filled with incredible warriors like Sharonda!
-
Agios
@AgiosPharma
Make sure to check out our posters on mitapivat in #pkdeficiency at #eha2021
-
Agios
@AgiosPharma
Learn more about our various studies in #pkdeficiency at #eha2021
-
Agios
@AgiosPharma
Our posters at #eha2021 highlight our genetically defined disease research in #pkdeficiency and #thalassemia
-
Agios
@AgiosPharma
We’re pleased to announce updated data from our Phase 2 study of mitapivat in patients with #thalassemia. #eha2021 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
We’re pleased to announce updated data from our Phase 3 studies, ACTIVATE and ACTIVATE-T, of mitapivat in patients with #pkdeficiency. #eha2021 investor.agios.com/news-releases/news-release-details/agi…
-
Agios
@AgiosPharma
Tune in to our #eha2021 Investor Event to hear from our CEO Jackie Fouse, our CMO Chris Bowden & our two key opinion leaders, Dr. Andreas Birkedal Glenthøj and Dr. Kevin Kuo to discuss our clinical trial data of mitapivat in #pkdeficiency and #thalassemia. investor.agios.com/events/event-details/agios-virtual-eha…
-
Agios
@AgiosPharma
Don’t miss our #eha2021 oral presentations focused on mitapivat clinical data in #pkdeficiency and #thalassemia.
-
Agios
@AgiosPharma
Our #eha2021 site is now live! You can check out our medical booth, patient resources, presentations and learn more about our genetic testing program, AnemiaID. www.agios.com/eha-2021/
-
Agios
@AgiosPharma
The #sicklecelldisease community is facing new challenges due to #covid19 and a gap in education resources to support their young warriors who are learning remotely. Will you partner with us, @CRISPRTX in donating to @SCCConsortium COVID-19 relief fund? kindest.com/553255-sickle-cell-covid-relief-fund





























































































































































































































































































































































































































































































































































































































































